TW201226390A - Diamine, polyimide precursor, polyimide, liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element - Google Patents
Diamine, polyimide precursor, polyimide, liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element Download PDFInfo
- Publication number
- TW201226390A TW201226390A TW100131309A TW100131309A TW201226390A TW 201226390 A TW201226390 A TW 201226390A TW 100131309 A TW100131309 A TW 100131309A TW 100131309 A TW100131309 A TW 100131309A TW 201226390 A TW201226390 A TW 201226390A
- Authority
- TW
- Taiwan
- Prior art keywords
- diamine
- liquid crystal
- acid
- group
- crystal alignment
- Prior art date
Links
- 150000004985 diamines Chemical class 0.000 title claims abstract description 136
- 239000004973 liquid crystal related substance Substances 0.000 title claims description 198
- 239000002243 precursor Substances 0.000 title claims description 38
- 239000004642 Polyimide Substances 0.000 title claims description 9
- 229920001721 polyimide Polymers 0.000 title claims description 9
- 239000000463 material Substances 0.000 title description 7
- 125000000962 organic group Chemical group 0.000 claims abstract description 26
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 25
- 229930195734 saturated hydrocarbon Natural products 0.000 claims abstract description 20
- 125000005843 halogen group Chemical group 0.000 claims abstract description 13
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract 4
- 239000003795 chemical substances by application Substances 0.000 claims description 72
- 125000003277 amino group Chemical group 0.000 claims description 37
- 239000000758 substrate Substances 0.000 claims description 37
- 150000000000 tetracarboxylic acids Chemical class 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 14
- 229910052731 fluorine Inorganic materials 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 7
- 125000001153 fluoro group Chemical group F* 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 238000001354 calcination Methods 0.000 claims description 4
- 229920002098 polyfluorene Polymers 0.000 claims description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 6
- 239000000243 solution Substances 0.000 description 119
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 98
- 239000002253 acid Substances 0.000 description 70
- 238000006243 chemical reaction Methods 0.000 description 69
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 67
- 230000015572 biosynthetic process Effects 0.000 description 67
- -1 diamine compound Chemical class 0.000 description 64
- 238000003786 synthesis reaction Methods 0.000 description 62
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 55
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 46
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 46
- 239000007787 solid Substances 0.000 description 46
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 42
- 239000000203 mixture Substances 0.000 description 42
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 39
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 38
- 229920000768 polyamine Polymers 0.000 description 38
- 230000000052 comparative effect Effects 0.000 description 36
- 239000012299 nitrogen atmosphere Substances 0.000 description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- 238000000034 method Methods 0.000 description 32
- 150000002430 hydrocarbons Chemical group 0.000 description 31
- 108010039918 Polylysine Proteins 0.000 description 29
- 229920000656 polylysine Polymers 0.000 description 29
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 28
- 239000002904 solvent Substances 0.000 description 28
- 229920000642 polymer Polymers 0.000 description 27
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 25
- 125000006158 tetracarboxylic acid group Chemical group 0.000 description 25
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 24
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- 238000002156 mixing Methods 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 238000003756 stirring Methods 0.000 description 21
- 150000002148 esters Chemical class 0.000 description 19
- 238000003860 storage Methods 0.000 description 19
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 18
- 239000003960 organic solvent Substances 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 229920000232 polyglycine polymer Polymers 0.000 description 14
- 210000002858 crystal cell Anatomy 0.000 description 13
- 108010094020 polyglycine Proteins 0.000 description 13
- 108010026466 polyproline Proteins 0.000 description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 11
- 239000002585 base Substances 0.000 description 11
- 239000003054 catalyst Substances 0.000 description 11
- 150000002500 ions Chemical class 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 238000007639 printing Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229910000104 sodium hydride Inorganic materials 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 8
- 230000032683 aging Effects 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 230000001976 improved effect Effects 0.000 description 8
- 229910052707 ruthenium Inorganic materials 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 7
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- 239000012298 atmosphere Substances 0.000 description 7
- 239000011737 fluorine Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000012312 sodium hydride Substances 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- 150000008064 anhydrides Chemical class 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 5
- 230000007547 defect Effects 0.000 description 5
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical group C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000005227 gel permeation chromatography Methods 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- 229920005575 poly(amic acid) Polymers 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 4
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 4
- CTMHWPIWNRWQEG-UHFFFAOYSA-N 1-methylcyclohexene Chemical compound CC1=CCCCC1 CTMHWPIWNRWQEG-UHFFFAOYSA-N 0.000 description 4
- LSKONYYRONEBKA-UHFFFAOYSA-N 2-Dodecanone Chemical compound CCCCCCCCCCC(C)=O LSKONYYRONEBKA-UHFFFAOYSA-N 0.000 description 4
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 4
- FFWSICBKRCICMR-UHFFFAOYSA-N 5-methyl-2-hexanone Chemical compound CC(C)CCC(C)=O FFWSICBKRCICMR-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 101000651211 Homo sapiens Transcription factor PU.1 Proteins 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- 229920000037 Polyproline Polymers 0.000 description 4
- 101000836070 Rattus norvegicus Serine protease inhibitor A3L Proteins 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- 102100027654 Transcription factor PU.1 Human genes 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 4
- 239000004305 biphenyl Substances 0.000 description 4
- XUPYJHCZDLZNFP-UHFFFAOYSA-N butyl butanoate Chemical compound CCCCOC(=O)CCC XUPYJHCZDLZNFP-UHFFFAOYSA-N 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 150000002466 imines Chemical class 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 4
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 4
- 150000004032 porphyrins Chemical group 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- PPPFYBPQAPISCT-UHFFFAOYSA-N 2-hydroxypropyl acetate Chemical compound CC(O)COC(C)=O PPPFYBPQAPISCT-UHFFFAOYSA-N 0.000 description 3
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 3
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 3
- 241000234282 Allium Species 0.000 description 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 101000701853 Rattus norvegicus Serine protease inhibitor A3N Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000002723 alicyclic group Chemical group 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 description 3
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940116333 ethyl lactate Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229940057867 methyl lactate Drugs 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 238000006068 polycondensation reaction Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- RYNQKSJRFHJZTK-UHFFFAOYSA-N (3-methoxy-3-methylbutyl) acetate Chemical compound COC(C)(C)CCOC(C)=O RYNQKSJRFHJZTK-UHFFFAOYSA-N 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 2
- SBHHKGFHJWTZJN-UHFFFAOYSA-N 1,3-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C)(C(O)=O)C1C(O)=O SBHHKGFHJWTZJN-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- LAVARTIQQDZFNT-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-yl acetate Chemical compound COCC(C)OCC(C)OC(C)=O LAVARTIQQDZFNT-UHFFFAOYSA-N 0.000 description 2
- PNBCGVPSRHMZDO-UHFFFAOYSA-N 1-(1-propoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCCOCC(C)OCC(C)OC(C)=O PNBCGVPSRHMZDO-UHFFFAOYSA-N 0.000 description 2
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- RQUBQBFVDOLUKC-UHFFFAOYSA-N 1-ethoxy-2-methylpropane Chemical compound CCOCC(C)C RQUBQBFVDOLUKC-UHFFFAOYSA-N 0.000 description 2
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 2
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 2
- ONDSSKDTLGWNOJ-UHFFFAOYSA-N 1-methoxyhexan-2-ol Chemical compound CCCCC(O)COC ONDSSKDTLGWNOJ-UHFFFAOYSA-N 0.000 description 2
- FXNDIJDIPNCZQJ-UHFFFAOYSA-N 2,4,4-trimethylpent-1-ene Chemical group CC(=C)CC(C)(C)C FXNDIJDIPNCZQJ-UHFFFAOYSA-N 0.000 description 2
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 2
- XXXFZKQPYACQLD-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl acetate Chemical compound CC(=O)OCCOCCO XXXFZKQPYACQLD-UHFFFAOYSA-N 0.000 description 2
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 2
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- HXDLWJWIAHWIKI-UHFFFAOYSA-N 2-hydroxyethyl acetate Chemical compound CC(=O)OCCO HXDLWJWIAHWIKI-UHFFFAOYSA-N 0.000 description 2
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- JRXXEXVXTFEBIY-UHFFFAOYSA-N 3-ethoxypropanoic acid Chemical compound CCOCCC(O)=O JRXXEXVXTFEBIY-UHFFFAOYSA-N 0.000 description 2
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 2
- HTNUUDFQRYBJPH-UHFFFAOYSA-N 3-methoxypropanehydrazide Chemical compound COCCC(=O)NN HTNUUDFQRYBJPH-UHFFFAOYSA-N 0.000 description 2
- RHLVCLIPMVJYKS-UHFFFAOYSA-N 3-octanone Chemical compound CCCCCC(=O)CC RHLVCLIPMVJYKS-UHFFFAOYSA-N 0.000 description 2
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 2
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical group CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 2
- XDYLWBWPEDSSLU-UHFFFAOYSA-N 4-(3-carboxyphenyl)benzene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C(C(O)=O)C(C(O)=O)=CC=2)C(O)=O)=C1 XDYLWBWPEDSSLU-UHFFFAOYSA-N 0.000 description 2
- BMTZEAOGFDXDAD-UHFFFAOYSA-M 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium;chloride Chemical compound [Cl-].COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1 BMTZEAOGFDXDAD-UHFFFAOYSA-M 0.000 description 2
- NEQFBGHQPUXOFH-UHFFFAOYSA-N 4-(4-carboxyphenyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(C(O)=O)C=C1 NEQFBGHQPUXOFH-UHFFFAOYSA-N 0.000 description 2
- UHNUHZHQLCGZDA-UHFFFAOYSA-N 4-[2-(4-aminophenyl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=CC=C(N)C=C1 UHNUHZHQLCGZDA-UHFFFAOYSA-N 0.000 description 2
- QNVNLUSHGRBCLO-UHFFFAOYSA-N 5-hydroxybenzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC(O)=CC(C(O)=O)=C1 QNVNLUSHGRBCLO-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- RHBBAUZSNTXFCC-UHFFFAOYSA-N CC1=C(C=C(C=C2)N=C2C=C(C=C2)NC2=CC(C=C2)=NC2=C2[N+]([O-])=O)NC2=C1 Chemical compound CC1=C(C=C(C=C2)N=C2C=C(C=C2)NC2=CC(C=C2)=NC2=C2[N+]([O-])=O)NC2=C1 RHBBAUZSNTXFCC-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 101710142113 Serine protease inhibitor A3K Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QJPRQRIGOBEVNW-UHFFFAOYSA-N [O-][N+](=O)c1c2ccc(cc3ccc(cc4ccc(cc5ccc1[nH]5)n4)[nH]3)n2 Chemical compound [O-][N+](=O)c1c2ccc(cc3ccc(cc4ccc(cc5ccc1[nH]5)n4)[nH]3)n2 QJPRQRIGOBEVNW-UHFFFAOYSA-N 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- RRIRSNXZGJWTQM-UHFFFAOYSA-N butyl 3-methoxypropanoate Chemical compound CCCCOC(=O)CCOC RRIRSNXZGJWTQM-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- QYQADNCHXSEGJT-UHFFFAOYSA-N cyclohexane-1,1-dicarboxylate;hydron Chemical compound OC(=O)C1(C(O)=O)CCCCC1 QYQADNCHXSEGJT-UHFFFAOYSA-N 0.000 description 2
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 2
- WOSVXXBNNCUXMT-UHFFFAOYSA-N cyclopentane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C(C(O)=O)C1C(O)=O WOSVXXBNNCUXMT-UHFFFAOYSA-N 0.000 description 2
- 229960000978 cyproterone acetate Drugs 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 2
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 2
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229940117360 ethyl pyruvate Drugs 0.000 description 2
- 150000008282 halocarbons Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- LVPMIMZXDYBCDF-UHFFFAOYSA-N isocinchomeronic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)N=C1 LVPMIMZXDYBCDF-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 2
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- OBKARQMATMRWQZ-UHFFFAOYSA-N naphthalene-1,2,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 OBKARQMATMRWQZ-UHFFFAOYSA-N 0.000 description 2
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 description 2
- RXOHFPCZGPKIRD-UHFFFAOYSA-N naphthalene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C(=O)O)=CC=C21 RXOHFPCZGPKIRD-UHFFFAOYSA-N 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 229920001568 phenolic resin Polymers 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- JCMFJIHDWDKYIL-UHFFFAOYSA-N propyl 3-methoxypropanoate Chemical compound CCCOC(=O)CCOC JCMFJIHDWDKYIL-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 2
- GJAWHXHKYYXBSV-UHFFFAOYSA-N quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- BDBIAZNDFPUJFD-UHFFFAOYSA-N tert-butyl n-quinolin-6-ylcarbamate Chemical compound N1=CC=CC2=CC(NC(=O)OC(C)(C)C)=CC=C21 BDBIAZNDFPUJFD-UHFFFAOYSA-N 0.000 description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- OLQWMCSSZKNOLQ-ZXZARUISSA-N (3s)-3-[(3r)-2,5-dioxooxolan-3-yl]oxolane-2,5-dione Chemical compound O=C1OC(=O)C[C@H]1[C@@H]1C(=O)OC(=O)C1 OLQWMCSSZKNOLQ-ZXZARUISSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- CWZQYRJRRHYJOI-UHFFFAOYSA-N 1,1,1-trimethoxydecane Chemical compound CCCCCCCCCC(OC)(OC)OC CWZQYRJRRHYJOI-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- JDGFELYPUWNNGR-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydropentalene-1,3,4,6-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C2C(C(=O)O)CC(C(O)=O)C21 JDGFELYPUWNNGR-UHFFFAOYSA-N 0.000 description 1
- NSZYKXMFFCRNJB-UHFFFAOYSA-N 1,2,3,4-tetramethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C)(C(O)=O)C(C)(C(O)=O)C1(C)C(O)=O NSZYKXMFFCRNJB-UHFFFAOYSA-N 0.000 description 1
- DVGGYXXTNYZERM-UHFFFAOYSA-N 1,2,5-oxadiazole-3,4-dicarboxylic acid Chemical compound OC(=O)C1=NON=C1C(O)=O DVGGYXXTNYZERM-UHFFFAOYSA-N 0.000 description 1
- CCKODBHYAPROLJ-UHFFFAOYSA-N 1,2,5-thiadiazole-3,4-dicarboxylic acid Chemical compound OC(=O)C1=NSN=C1C(O)=O CCKODBHYAPROLJ-UHFFFAOYSA-N 0.000 description 1
- MQQRFOXFIPBFOV-UHFFFAOYSA-N 1,2-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C(O)=O)C1(C)C(O)=O MQQRFOXFIPBFOV-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- HFHARFNUBJTTGI-UHFFFAOYSA-N 1,3-thiazole-4,5-dicarboxylic acid Chemical compound OC(=O)C=1N=CSC=1C(O)=O HFHARFNUBJTTGI-UHFFFAOYSA-N 0.000 description 1
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 description 1
- WTAPZWXVSZMMDG-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 WTAPZWXVSZMMDG-UHFFFAOYSA-N 0.000 description 1
- DQVRVXRIKVWXQH-UHFFFAOYSA-N 1,8-bis(oxiran-2-yl)-4,6-bis(oxiran-2-ylmethyl)octane-3,5-diol Chemical compound C1OC1CC(C(O)C(CCC1OC1)CC1OC1)C(O)CCC1CO1 DQVRVXRIKVWXQH-UHFFFAOYSA-N 0.000 description 1
- YFOOEYJGMMJJLS-UHFFFAOYSA-N 1,8-diaminonaphthalene Chemical compound C1=CC(N)=C2C(N)=CC=CC2=C1 YFOOEYJGMMJJLS-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- COLYDFXUNAQRBZ-UHFFFAOYSA-N 1-(1-ethoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCOCC(C)OCC(C)OC(C)=O COLYDFXUNAQRBZ-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 1
- HASUCEDGKYJBDC-UHFFFAOYSA-N 1-[3-[[bis(oxiran-2-ylmethyl)amino]methyl]cyclohexyl]-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1CC(CN(CC2OC2)CC2OC2)CCC1)CC1CO1 HASUCEDGKYJBDC-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 1
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 1
- VPUAYOJTHRDUTK-UHFFFAOYSA-N 1-ethylpyrrole Chemical compound CCN1C=CC=C1 VPUAYOJTHRDUTK-UHFFFAOYSA-N 0.000 description 1
- 125000006021 1-methyl-2-propenyl group Chemical group 0.000 description 1
- HWPZZUQOWRWFDB-UHFFFAOYSA-N 1-methylcytosine Chemical compound CN1C=CC(N)=NC1=O HWPZZUQOWRWFDB-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- VOSLIUIVGWBSOK-UHFFFAOYSA-N 1-n-phenylbenzene-1,2,4-triamine Chemical compound NC1=CC(N)=CC=C1NC1=CC=CC=C1 VOSLIUIVGWBSOK-UHFFFAOYSA-N 0.000 description 1
- VFJKDYZXRQEJJX-UHFFFAOYSA-N 1-nitro-3,4-dihydro-2h-quinoline Chemical class C1=CC=C2N([N+](=O)[O-])CCCC2=C1 VFJKDYZXRQEJJX-UHFFFAOYSA-N 0.000 description 1
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 1
- PUFWGUZSDHANBX-UHFFFAOYSA-N 1-phenyl-9h-fluorene Chemical group C=12CC3=CC=CC=C3C2=CC=CC=1C1=CC=CC=C1 PUFWGUZSDHANBX-UHFFFAOYSA-N 0.000 description 1
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 1
- GBURUDXSBYGPBL-UHFFFAOYSA-N 2,2,3-trimethylhexanedioic acid Chemical compound OC(=O)C(C)(C)C(C)CCC(O)=O GBURUDXSBYGPBL-UHFFFAOYSA-N 0.000 description 1
- CHUGKEQJSLOLHL-UHFFFAOYSA-N 2,2-Bis(bromomethyl)propane-1,3-diol Chemical compound OCC(CO)(CBr)CBr CHUGKEQJSLOLHL-UHFFFAOYSA-N 0.000 description 1
- WKRCUUPMCASSBN-UHFFFAOYSA-N 2,2-diethylbutanedioic acid Chemical compound CCC(CC)(C(O)=O)CC(O)=O WKRCUUPMCASSBN-UHFFFAOYSA-N 0.000 description 1
- BTUDGPVTCYNYLK-UHFFFAOYSA-N 2,2-dimethylglutaric acid Chemical compound OC(=O)C(C)(C)CCC(O)=O BTUDGPVTCYNYLK-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 description 1
- 229940075142 2,5-diaminotoluene Drugs 0.000 description 1
- BWAPJIHJXDYDPW-UHFFFAOYSA-N 2,5-dimethyl-p-phenylenediamine Chemical group CC1=CC(N)=C(C)C=C1N BWAPJIHJXDYDPW-UHFFFAOYSA-N 0.000 description 1
- YXOKJIRTNWHPFS-UHFFFAOYSA-N 2,5-dimethylhexane-1,6-diamine Chemical compound NCC(C)CCC(C)CN YXOKJIRTNWHPFS-UHFFFAOYSA-N 0.000 description 1
- FKUJGZJNDUGCFU-UHFFFAOYSA-N 2,5-dimethylterephthalic acid Chemical compound CC1=CC(C(O)=O)=C(C)C=C1C(O)=O FKUJGZJNDUGCFU-UHFFFAOYSA-N 0.000 description 1
- UPQDHGRRFJDNOG-UHFFFAOYSA-N 2-(1,1-diphenylethyl)propanedioic acid Chemical compound C=1C=CC=CC=1C(C(C(O)=O)C(O)=O)(C)C1=CC=CC=C1 UPQDHGRRFJDNOG-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- JZUMVFMLJGSMRF-UHFFFAOYSA-N 2-Methyladipic acid Chemical compound OC(=O)C(C)CCCC(O)=O JZUMVFMLJGSMRF-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- UTENGZNBNPABQE-UHFFFAOYSA-N 2-[3-(carboxymethyl)-1-adamantyl]acetic acid Chemical compound C1C(C2)CC3CC1(CC(=O)O)CC2(CC(O)=O)C3 UTENGZNBNPABQE-UHFFFAOYSA-N 0.000 description 1
- SLWIPPZWFZGHEU-UHFFFAOYSA-N 2-[4-(carboxymethyl)phenyl]acetic acid Chemical compound OC(=O)CC1=CC=C(CC(O)=O)C=C1 SLWIPPZWFZGHEU-UHFFFAOYSA-N 0.000 description 1
- CABMTIJINOIHOD-UHFFFAOYSA-N 2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O CABMTIJINOIHOD-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- AQHFCRYZABKUEV-UHFFFAOYSA-N 2-chloro-5-methoxybenzoic acid Chemical compound COC1=CC=C(Cl)C(C(O)=O)=C1 AQHFCRYZABKUEV-UHFFFAOYSA-N 0.000 description 1
- VGENLUFKUDLPGI-UHFFFAOYSA-N 2-ethoxy-1-propan-2-yloxypropane Chemical compound CCOC(C)COC(C)C VGENLUFKUDLPGI-UHFFFAOYSA-N 0.000 description 1
- KBGLIBWPBYLNNK-UHFFFAOYSA-N 2-ethoxypropyl acetate Chemical compound CCOC(C)COC(C)=O KBGLIBWPBYLNNK-UHFFFAOYSA-N 0.000 description 1
- HGUYBLVGLMAUFF-UHFFFAOYSA-N 2-methoxybenzene-1,4-diamine Chemical compound COC1=CC(N)=CC=C1N HGUYBLVGLMAUFF-UHFFFAOYSA-N 0.000 description 1
- OBCSAIDCZQSFQH-UHFFFAOYSA-N 2-methyl-1,4-phenylenediamine Chemical compound CC1=CC(N)=CC=C1N OBCSAIDCZQSFQH-UHFFFAOYSA-N 0.000 description 1
- AXBSJNMACVSTKJ-UHFFFAOYSA-N 2-methyl-3-pentylbutanedioic acid Chemical compound CCCCCC(C(O)=O)C(C)C(O)=O AXBSJNMACVSTKJ-UHFFFAOYSA-N 0.000 description 1
- TVHXQIGBVCWCIS-UHFFFAOYSA-N 2-phenyl-1,3-thiazole-4,5-dicarboxylic acid Chemical compound S1C(C(O)=O)=C(C(=O)O)N=C1C1=CC=CC=C1 TVHXQIGBVCWCIS-UHFFFAOYSA-N 0.000 description 1
- VSZJLXSVGVDPMJ-UHFFFAOYSA-N 2-phenylterephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C=2C=CC=CC=2)=C1 VSZJLXSVGVDPMJ-UHFFFAOYSA-N 0.000 description 1
- GTNSMRWEGPZCIK-UHFFFAOYSA-N 2H-purine-1,3-diamine Chemical compound NN1CN(C2=NC=NC2=C1)N GTNSMRWEGPZCIK-UHFFFAOYSA-N 0.000 description 1
- IDLHKTJAQPHECG-UHFFFAOYSA-N 3,4-bis(methoxycarbonyl)cyclobutane-1,2-dicarboxylic acid Chemical compound COC(=O)C1C(C(O)=O)C(C(O)=O)C1C(=O)OC IDLHKTJAQPHECG-UHFFFAOYSA-N 0.000 description 1
- QVNDSQQNODQYJM-UHFFFAOYSA-N 3,4-diphenylcyclobutane-1,2-dicarboxylic acid Chemical compound OC(=O)C1C(C(O)=O)C(C=2C=CC=CC=2)C1C1=CC=CC=C1 QVNDSQQNODQYJM-UHFFFAOYSA-N 0.000 description 1
- KPKOSOUTWDOOIW-UHFFFAOYSA-N 3,5-bis(4-aminophenoxy)benzoic acid Chemical compound C1=CC(N)=CC=C1OC1=CC(OC=2C=CC(N)=CC=2)=CC(C(O)=O)=C1 KPKOSOUTWDOOIW-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- LJQFYBCLMVVNAQ-UHFFFAOYSA-N 3-(2-aminoethyl)aniline Chemical compound NCCC1=CC=CC(N)=C1 LJQFYBCLMVVNAQ-UHFFFAOYSA-N 0.000 description 1
- LPCINXWHNYBINL-UHFFFAOYSA-N 3-(3-aminopropyl)aniline Chemical compound NCCCC1=CC=CC(N)=C1 LPCINXWHNYBINL-UHFFFAOYSA-N 0.000 description 1
- LIMMUKMKUYFDIW-UHFFFAOYSA-N 3-(4-aminobutyl)aniline Chemical compound NCCCCC1=CC=CC(N)=C1 LIMMUKMKUYFDIW-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- NISGEPOVWWUNLB-UHFFFAOYSA-N 3-(5-aminopentyl)aniline Chemical compound NCCCCCC1=CC=CC(N)=C1 NISGEPOVWWUNLB-UHFFFAOYSA-N 0.000 description 1
- RNLHGQLZWXBQNY-UHFFFAOYSA-N 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine Chemical compound CC1(C)CC(N)CC(C)(CN)C1 RNLHGQLZWXBQNY-UHFFFAOYSA-N 0.000 description 1
- ZDBWYUOUYNQZBM-UHFFFAOYSA-N 3-(aminomethyl)aniline Chemical compound NCC1=CC=CC(N)=C1 ZDBWYUOUYNQZBM-UHFFFAOYSA-N 0.000 description 1
- RHRNYXVSZLSRRP-UHFFFAOYSA-N 3-(carboxymethyl)cyclopentane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CC1C(C(O)=O)CC(C(O)=O)C1C(O)=O RHRNYXVSZLSRRP-UHFFFAOYSA-N 0.000 description 1
- HBLPYXIZPMDWIO-UHFFFAOYSA-N 3-(methylaminomethyl)aniline Chemical compound CNCC1=CC=CC(N)=C1 HBLPYXIZPMDWIO-UHFFFAOYSA-N 0.000 description 1
- CKOFBUUFHALZGK-UHFFFAOYSA-N 3-[(3-aminophenyl)methyl]aniline Chemical compound NC1=CC=CC(CC=2C=C(N)C=CC=2)=C1 CKOFBUUFHALZGK-UHFFFAOYSA-N 0.000 description 1
- FGWQCROGAHMWSU-UHFFFAOYSA-N 3-[(4-aminophenyl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CC1=CC=CC(N)=C1 FGWQCROGAHMWSU-UHFFFAOYSA-N 0.000 description 1
- UVUCUHVQYAPMEU-UHFFFAOYSA-N 3-[2-(3-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound NC1=CC=CC(C(C=2C=C(N)C=CC=2)(C(F)(F)F)C(F)(F)F)=C1 UVUCUHVQYAPMEU-UHFFFAOYSA-N 0.000 description 1
- POTQBGGWSWSMCX-UHFFFAOYSA-N 3-[2-(3-aminopropoxy)ethoxy]propan-1-amine Chemical compound NCCCOCCOCCCN POTQBGGWSWSMCX-UHFFFAOYSA-N 0.000 description 1
- HLPDWKADNKYPEI-UHFFFAOYSA-N 3-[2-(methylamino)ethyl]aniline Chemical compound CNCCC1=CC=CC(N)=C1 HLPDWKADNKYPEI-UHFFFAOYSA-N 0.000 description 1
- DKKYOQYISDAQER-UHFFFAOYSA-N 3-[3-(3-aminophenoxy)phenoxy]aniline Chemical compound NC1=CC=CC(OC=2C=C(OC=3C=C(N)C=CC=3)C=CC=2)=C1 DKKYOQYISDAQER-UHFFFAOYSA-N 0.000 description 1
- XGQOUNRKDKNBOC-UHFFFAOYSA-N 3-[3-(methylamino)propyl]aniline Chemical compound CNCCCC1=CC=CC(N)=C1 XGQOUNRKDKNBOC-UHFFFAOYSA-N 0.000 description 1
- DFOCUWFSRVQSNI-UHFFFAOYSA-N 3-[4-(2-carboxyethyl)phenyl]propanoic acid Chemical compound OC(=O)CCC1=CC=C(CCC(O)=O)C=C1 DFOCUWFSRVQSNI-UHFFFAOYSA-N 0.000 description 1
- GHTNUVUDNKDAES-UHFFFAOYSA-N 3-[4-(methylamino)butyl]aniline Chemical compound CNCCCCC1=CC=CC(N)=C1 GHTNUVUDNKDAES-UHFFFAOYSA-N 0.000 description 1
- NQIXOLQSTCNTKL-UHFFFAOYSA-N 3-[5-(methylamino)pentyl]aniline Chemical compound CNCCCCCC1=CC=CC(N)=C1 NQIXOLQSTCNTKL-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- CRORGGSWAKIXSA-UHFFFAOYSA-N 3-methylbutyl 2-hydroxypropanoate Chemical compound CC(C)CCOC(=O)C(C)O CRORGGSWAKIXSA-UHFFFAOYSA-N 0.000 description 1
- HSSYVKMJJLDTKZ-UHFFFAOYSA-N 3-phenylphthalic acid Chemical compound OC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1C(O)=O HSSYVKMJJLDTKZ-UHFFFAOYSA-N 0.000 description 1
- LJMPOXUWPWEILS-UHFFFAOYSA-N 3a,4,4a,7a,8,8a-hexahydrofuro[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1C2C(=O)OC(=O)C2CC2C(=O)OC(=O)C21 LJMPOXUWPWEILS-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- WECDUOXQLAIPQW-UHFFFAOYSA-N 4,4'-Methylene bis(2-methylaniline) Chemical compound C1=C(N)C(C)=CC(CC=2C=C(C)C(N)=CC=2)=C1 WECDUOXQLAIPQW-UHFFFAOYSA-N 0.000 description 1
- ICNFHJVPAJKPHW-UHFFFAOYSA-N 4,4'-Thiodianiline Chemical compound C1=CC(N)=CC=C1SC1=CC=C(N)C=C1 ICNFHJVPAJKPHW-UHFFFAOYSA-N 0.000 description 1
- ZWIBGDOHXGXHEV-UHFFFAOYSA-N 4,4-dimethylheptane-1,7-diamine Chemical compound NCCCC(C)(C)CCCN ZWIBGDOHXGXHEV-UHFFFAOYSA-N 0.000 description 1
- OPQVOOASZKDKBH-UHFFFAOYSA-N 4,8-dioxoadamantane-1,3-dicarboxylic acid Chemical compound C1C(C2=O)CC3CC2(C(O)=O)CC1(C(=O)O)C3=O OPQVOOASZKDKBH-UHFFFAOYSA-N 0.000 description 1
- LNPMZQXEPNWCMG-UHFFFAOYSA-N 4-(2-aminoethyl)aniline Chemical compound NCCC1=CC=C(N)C=C1 LNPMZQXEPNWCMG-UHFFFAOYSA-N 0.000 description 1
- AIVVXPSKEVWKMY-UHFFFAOYSA-N 4-(3,4-dicarboxyphenoxy)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C(C(O)=O)=C1 AIVVXPSKEVWKMY-UHFFFAOYSA-N 0.000 description 1
- OMNVECQLILUEFL-UHFFFAOYSA-N 4-(3-aminopropyl)aniline Chemical compound NCCCC1=CC=C(N)C=C1 OMNVECQLILUEFL-UHFFFAOYSA-N 0.000 description 1
- GVRCJOCNGNCTIY-UHFFFAOYSA-N 4-(3-carboxypropanoyloxy)cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)CCC(=O)OC1CCC(C(O)=O)C(C(O)=O)C1 GVRCJOCNGNCTIY-UHFFFAOYSA-N 0.000 description 1
- QYIMZXITLDTULQ-UHFFFAOYSA-N 4-(4-amino-2-methylphenyl)-3-methylaniline Chemical compound CC1=CC(N)=CC=C1C1=CC=C(N)C=C1C QYIMZXITLDTULQ-UHFFFAOYSA-N 0.000 description 1
- PHPXSWXCZWIGBS-UHFFFAOYSA-N 4-(4-aminobutyl)aniline Chemical compound NCCCCC1=CC=C(N)C=C1 PHPXSWXCZWIGBS-UHFFFAOYSA-N 0.000 description 1
- WVDRSXGPQWNUBN-UHFFFAOYSA-N 4-(4-carboxyphenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C=C1 WVDRSXGPQWNUBN-UHFFFAOYSA-N 0.000 description 1
- ZKHSQOFXDNNEGD-UHFFFAOYSA-N 4-(5-aminopentyl)aniline Chemical compound NCCCCCC1=CC=C(N)C=C1 ZKHSQOFXDNNEGD-UHFFFAOYSA-N 0.000 description 1
- BFWYZZPDZZGSLJ-UHFFFAOYSA-N 4-(aminomethyl)aniline Chemical compound NCC1=CC=C(N)C=C1 BFWYZZPDZZGSLJ-UHFFFAOYSA-N 0.000 description 1
- FTAMTADBFJSWRE-UHFFFAOYSA-N 4-(methylaminomethyl)aniline Chemical compound CNCC1=CC=C(N)C=C1 FTAMTADBFJSWRE-UHFFFAOYSA-N 0.000 description 1
- SXPGQGNWEWPWQZ-UHFFFAOYSA-N 4-(triethoxymethyl)dodecan-1-amine Chemical compound NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SXPGQGNWEWPWQZ-UHFFFAOYSA-N 0.000 description 1
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 1
- ZWUBBMDHSZDNTA-UHFFFAOYSA-N 4-Chloro-meta-phenylenediamine Chemical compound NC1=CC=C(Cl)C(N)=C1 ZWUBBMDHSZDNTA-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- GAMSSMZJKUMFEY-UHFFFAOYSA-N 4-[(4-carboxyphenyl)disulfanyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1SSC1=CC=C(C(O)=O)C=C1 GAMSSMZJKUMFEY-UHFFFAOYSA-N 0.000 description 1
- ZSQIQUAKDNTQOI-UHFFFAOYSA-N 4-[1-(4-aminophenyl)cyclohexyl]aniline Chemical compound C1=CC(N)=CC=C1C1(C=2C=CC(N)=CC=2)CCCCC1 ZSQIQUAKDNTQOI-UHFFFAOYSA-N 0.000 description 1
- DODZITHJXOKQAB-UHFFFAOYSA-N 4-[1-(4-aminophenyl)decyl]aniline Chemical compound C=1C=C(N)C=CC=1C(CCCCCCCCC)C1=CC=C(N)C=C1 DODZITHJXOKQAB-UHFFFAOYSA-N 0.000 description 1
- MEKBJJDSFDITCS-UHFFFAOYSA-N 4-[10-(4-aminophenyl)decyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCCCCCCCC1=CC=C(N)C=C1 MEKBJJDSFDITCS-UHFFFAOYSA-N 0.000 description 1
- ISESBQNCWCFFFR-UHFFFAOYSA-N 4-[2-(4-amino-2-methylphenyl)ethyl]-3-methylaniline Chemical group CC1=CC(N)=CC=C1CCC1=CC=C(N)C=C1C ISESBQNCWCFFFR-UHFFFAOYSA-N 0.000 description 1
- BEKFRNOZJSYWKZ-UHFFFAOYSA-N 4-[2-(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(N)C=C1 BEKFRNOZJSYWKZ-UHFFFAOYSA-N 0.000 description 1
- NNIPOYNUFNLQMO-UHFFFAOYSA-N 4-[2-(methylamino)ethyl]aniline Chemical compound CNCCC1=CC=C(N)C=C1 NNIPOYNUFNLQMO-UHFFFAOYSA-N 0.000 description 1
- HESXPOICBNWMPI-UHFFFAOYSA-N 4-[2-[4-[2-(4-aminophenyl)propan-2-yl]phenyl]propan-2-yl]aniline Chemical compound C=1C=C(C(C)(C)C=2C=CC(N)=CC=2)C=CC=1C(C)(C)C1=CC=C(N)C=C1 HESXPOICBNWMPI-UHFFFAOYSA-N 0.000 description 1
- HPUJEBAZZTZOFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)-2,2-dimethylpropoxy]aniline Chemical compound C=1C=C(N)C=CC=1OCC(C)(C)COC1=CC=C(N)C=C1 HPUJEBAZZTZOFL-UHFFFAOYSA-N 0.000 description 1
- WUPRYUDHUFLKFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(OC=2C=CC(N)=CC=2)=C1 WUPRYUDHUFLKFL-UHFFFAOYSA-N 0.000 description 1
- KWFFEQXPFFDJER-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)propoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCOC1=CC=C(N)C=C1 KWFFEQXPFFDJER-UHFFFAOYSA-N 0.000 description 1
- BMIUMBLWVWZIHD-UHFFFAOYSA-N 4-[3-(4-aminophenyl)propyl]aniline Chemical compound C1=CC(N)=CC=C1CCCC1=CC=C(N)C=C1 BMIUMBLWVWZIHD-UHFFFAOYSA-N 0.000 description 1
- ZFMLLVBCHBKYCJ-UHFFFAOYSA-N 4-[3-(methylamino)propyl]aniline Chemical compound CNCCCC1=CC=C(N)C=C1 ZFMLLVBCHBKYCJ-UHFFFAOYSA-N 0.000 description 1
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 1
- DPDYBERBCHCODD-UHFFFAOYSA-N 4-[4-[10-[4-(4-aminophenoxy)phenoxy]decoxy]phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OCCCCCCCCCCOC(C=C1)=CC=C1OC1=CC=C(N)C=C1 DPDYBERBCHCODD-UHFFFAOYSA-N 0.000 description 1
- HHLMWQDRYZAENA-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]-1,1,1,3,3,3-hexafluoropropan-2-yl]phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=C(C(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)(C(F)(F)F)C(F)(F)F)C=C1 HHLMWQDRYZAENA-UHFFFAOYSA-N 0.000 description 1
- QZTURPSSWBAQMO-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]ethyl]phenoxy]aniline Chemical group C1=CC(N)=CC=C1OC(C=C1)=CC=C1CCC(C=C1)=CC=C1OC1=CC=C(N)C=C1 QZTURPSSWBAQMO-UHFFFAOYSA-N 0.000 description 1
- KMKWGXGSGPYISJ-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]propan-2-yl]phenoxy]aniline Chemical compound C=1C=C(OC=2C=CC(N)=CC=2)C=CC=1C(C)(C)C(C=C1)=CC=C1OC1=CC=C(N)C=C1 KMKWGXGSGPYISJ-UHFFFAOYSA-N 0.000 description 1
- HSDAXNMOGHTBPQ-UHFFFAOYSA-N 4-[4-[3-[4-(4-aminophenoxy)phenoxy]propoxy]phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OCCCOC(C=C1)=CC=C1OC1=CC=C(N)C=C1 HSDAXNMOGHTBPQ-UHFFFAOYSA-N 0.000 description 1
- ZUBYRLIOGYHFCP-UHFFFAOYSA-N 4-[4-[5-[4-(4-aminophenoxy)phenoxy]pentoxy]phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OCCCCCOC(C=C1)=CC=C1OC1=CC=C(N)C=C1 ZUBYRLIOGYHFCP-UHFFFAOYSA-N 0.000 description 1
- WFSDXCOAVMIEIO-UHFFFAOYSA-N 4-[4-[9-[4-(4-aminophenoxy)phenoxy]decoxy]phenoxy]aniline Chemical compound NC1=CC=C(OC2=CC=C(OCCCCCCCCC(C)OC3=CC=C(C=C3)OC3=CC=C(C=C3)N)C=C2)C=C1 WFSDXCOAVMIEIO-UHFFFAOYSA-N 0.000 description 1
- SLHXQWDUYXSTPA-UHFFFAOYSA-N 4-[5-(4-aminophenoxy)pentoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCOC1=CC=C(N)C=C1 SLHXQWDUYXSTPA-UHFFFAOYSA-N 0.000 description 1
- MJZXFMSIHMJQBW-UHFFFAOYSA-N 4-[5-(4-aminophenyl)-1,3,4-oxadiazol-2-yl]aniline Chemical compound C1=CC(N)=CC=C1C1=NN=C(C=2C=CC(N)=CC=2)O1 MJZXFMSIHMJQBW-UHFFFAOYSA-N 0.000 description 1
- SOKDIHGREPWQCY-UHFFFAOYSA-N 4-[5-(4-aminophenyl)pentyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCCC1=CC=C(N)C=C1 SOKDIHGREPWQCY-UHFFFAOYSA-N 0.000 description 1
- LQLKUPAZZXUBTB-UHFFFAOYSA-N 4-[5-(methylamino)pentyl]aniline Chemical compound CNCCCCCC1=CC=C(N)C=C1 LQLKUPAZZXUBTB-UHFFFAOYSA-N 0.000 description 1
- XLKGPJIGDHZIMW-UHFFFAOYSA-N 4-[6-(4-aminophenyl)hexyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCCCC1=CC=C(N)C=C1 XLKGPJIGDHZIMW-UHFFFAOYSA-N 0.000 description 1
- JBXBSFFXAMVASC-UHFFFAOYSA-N 4-[7-(4-aminophenoxy)heptoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCCOC1=CC=C(N)C=C1 JBXBSFFXAMVASC-UHFFFAOYSA-N 0.000 description 1
- ZMWWYPZBEJOZDX-UHFFFAOYSA-N 4-hexadecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCCCCCOC1=CC=C(N)C=C1N ZMWWYPZBEJOZDX-UHFFFAOYSA-N 0.000 description 1
- VSHBABSXFHFTJN-UHFFFAOYSA-N 4-methoxymorpholine Chemical compound CON1CCOCC1 VSHBABSXFHFTJN-UHFFFAOYSA-N 0.000 description 1
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 1
- JYCTWJFSRDBYJX-UHFFFAOYSA-N 5-(2,5-dioxooxolan-3-yl)-3a,4,5,9b-tetrahydrobenzo[e][2]benzofuran-1,3-dione Chemical compound O=C1OC(=O)CC1C1C2=CC=CC=C2C(C(=O)OC2=O)C2C1 JYCTWJFSRDBYJX-UHFFFAOYSA-N 0.000 description 1
- TWKVCLRLFUIZLG-UHFFFAOYSA-N 5-(4-carboxyphenyl)cyclohexa-2,4-diene-1,1,2-tricarboxylic acid Chemical compound C1C(C(O)=O)(C(O)=O)C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)C=C1 TWKVCLRLFUIZLG-UHFFFAOYSA-N 0.000 description 1
- QQGYZOYWNCKGEK-UHFFFAOYSA-N 5-[(1,3-dioxo-2-benzofuran-5-yl)oxy]-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(OC=2C=C3C(=O)OC(C3=CC=2)=O)=C1 QQGYZOYWNCKGEK-UHFFFAOYSA-N 0.000 description 1
- KBZFDRWPMZESDI-UHFFFAOYSA-N 5-aminobenzene-1,3-dicarboxylic acid Chemical compound NC1=CC(C(O)=O)=CC(C(O)=O)=C1 KBZFDRWPMZESDI-UHFFFAOYSA-N 0.000 description 1
- PMZBHPUNQNKBOA-UHFFFAOYSA-N 5-methylbenzene-1,3-dicarboxylic acid Chemical compound CC1=CC(C(O)=O)=CC(C(O)=O)=C1 PMZBHPUNQNKBOA-UHFFFAOYSA-N 0.000 description 1
- BJLUCDZIWWSFIB-UHFFFAOYSA-N 5-tert-butylbenzene-1,3-dicarboxylic acid Chemical compound CC(C)(C)C1=CC(C(O)=O)=CC(C(O)=O)=C1 BJLUCDZIWWSFIB-UHFFFAOYSA-N 0.000 description 1
- LLQHSBBZNDXTIV-UHFFFAOYSA-N 6-[5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC1CC(=NO1)C1=CC2=C(NC(O2)=O)C=C1 LLQHSBBZNDXTIV-UHFFFAOYSA-N 0.000 description 1
- PKCOMQQWUXBKPO-UHFFFAOYSA-N 6-propan-2-yl-1h-triazine-2,4-diamine Chemical compound CC(C)C1=CC(N)=NN(N)N1 PKCOMQQWUXBKPO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- YCZUWQOJQGCZKG-UHFFFAOYSA-N 9h-carbazole-3,6-diamine Chemical compound C1=C(N)C=C2C3=CC(N)=CC=C3NC2=C1 YCZUWQOJQGCZKG-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OTXFGEHSBKFEAB-UHFFFAOYSA-N C(C)OC(=O)NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C)OC(=O)NCCCC(C(OC)(OC)OC)CCCCCCCC OTXFGEHSBKFEAB-UHFFFAOYSA-N 0.000 description 1
- SWUMRQQSIBCUPC-UHFFFAOYSA-N C(C)OC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C)OC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SWUMRQQSIBCUPC-UHFFFAOYSA-N 0.000 description 1
- PXUZMWOTICHNDV-UHFFFAOYSA-N C(C1=CC=CC=C1)NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C1=CC=CC=C1)NCCCC(C(OC)(OC)OC)CCCCCCCC PXUZMWOTICHNDV-UHFFFAOYSA-N 0.000 description 1
- SNPIERCLNKIBEM-UHFFFAOYSA-N C(C1=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SNPIERCLNKIBEM-UHFFFAOYSA-N 0.000 description 1
- YDEAAJZYBOCXIO-UHFFFAOYSA-N C1(=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C1(=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC YDEAAJZYBOCXIO-UHFFFAOYSA-N 0.000 description 1
- JGGREWWHFIUUGE-UHFFFAOYSA-N C1C=C2C(=C3C=CC(=N3)C=C4C=CC(=CC5=NC(=CC1(N2)C6=CC=C(C=C6)[N+](=O)[O-])C=C5)N4)[N+](=O)[O-] Chemical compound C1C=C2C(=C3C=CC(=N3)C=C4C=CC(=CC5=NC(=CC1(N2)C6=CC=C(C=C6)[N+](=O)[O-])C=C5)N4)[N+](=O)[O-] JGGREWWHFIUUGE-UHFFFAOYSA-N 0.000 description 1
- UFQPLVILOWQXNC-UHFFFAOYSA-N C1CC(OC(C1)N)N Chemical compound C1CC(OC(C1)N)N UFQPLVILOWQXNC-UHFFFAOYSA-N 0.000 description 1
- HJUBLEZFQVQJPQ-UHFFFAOYSA-N CC1C=C2C(=C3C=CC(=N3)C=C4C=CC(=CC5=NC(=CC1(N2)C6=CC=C(C=C6)[N+](=O)[O-])C=C5)N4)[N+](=O)[O-] Chemical compound CC1C=C2C(=C3C=CC(=N3)C=C4C=CC(=CC5=NC(=CC1(N2)C6=CC=C(C=C6)[N+](=O)[O-])C=C5)N4)[N+](=O)[O-] HJUBLEZFQVQJPQ-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 229920002160 Celluloid Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZPAKUZKMGJJMAA-UHFFFAOYSA-N Cyclohexane-1,2,4,5-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C(C(O)=O)CC1C(O)=O ZPAKUZKMGJJMAA-UHFFFAOYSA-N 0.000 description 1
- TXCDCPKCNAJMEE-UHFFFAOYSA-N Dibenzofuran Natural products C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N Dipicolinic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- UNVWJAYEKZVDDL-UHFFFAOYSA-N N(C(=O)N)CCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound N(C(=O)N)CCCC(C(OC)(OC)OC)CCCCCCCC UNVWJAYEKZVDDL-UHFFFAOYSA-N 0.000 description 1
- XEEHRQPQNJOFIQ-UHFFFAOYSA-N N(C1=CC=CC=C1)CCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound N(C1=CC=CC=C1)CCCC(C(OC)(OC)OC)CCCCCCCC XEEHRQPQNJOFIQ-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- HDJGANPLOWXKTM-UHFFFAOYSA-N NC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound NC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC HDJGANPLOWXKTM-UHFFFAOYSA-N 0.000 description 1
- AJOYCSBPBSZRHI-UHFFFAOYSA-N NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C Chemical compound NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C AJOYCSBPBSZRHI-UHFFFAOYSA-N 0.000 description 1
- IPSTVJHBBNUCRH-UHFFFAOYSA-N NC1=CC=C(OC2=CC=C(C=C2)C=2C3=CC=CC=C3C(=C3C=CC=CC23)C2=CC=C(C=C2)OC2=CC=C(C=C2)N)C=C1 Chemical compound NC1=CC=C(OC2=CC=C(C=C2)C=2C3=CC=CC=C3C(=C3C=CC=CC23)C2=CC=C(C=C2)OC2=CC=C(C=C2)N)C=C1 IPSTVJHBBNUCRH-UHFFFAOYSA-N 0.000 description 1
- SCECHYBTQMOHQK-UHFFFAOYSA-N NC=1C=C(OC2=CC=C(C=C2)C=2C3=CC=CC=C3C(=C3C=CC=CC23)C2=CC=C(C=C2)OC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OC2=CC=C(C=C2)C=2C3=CC=CC=C3C(=C3C=CC=CC23)C2=CC=C(C=C2)OC2=CC(=CC=C2)N)C=CC1 SCECHYBTQMOHQK-UHFFFAOYSA-N 0.000 description 1
- XJDCHDFUMGSEHD-UHFFFAOYSA-N NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCCC(C(OC)(OC)OC)CCCCCCCC XJDCHDFUMGSEHD-UHFFFAOYSA-N 0.000 description 1
- KTGXWDZUZLWXOF-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)C)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)C)CCCCCCCC KTGXWDZUZLWXOF-UHFFFAOYSA-N 0.000 description 1
- PEXBBTCNDBSFHT-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)OC)CCCCCCCC PEXBBTCNDBSFHT-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 101100074988 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nmp-1 gene Proteins 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 229910021603 Ruthenium iodide Inorganic materials 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 description 1
- KAKNDCFPIIVHLE-UHFFFAOYSA-N [Cl-].CO[NH+]1CCOCC1 Chemical compound [Cl-].CO[NH+]1CCOCC1 KAKNDCFPIIVHLE-UHFFFAOYSA-N 0.000 description 1
- PRMBCBUVSYYPJY-UHFFFAOYSA-N [N]1C2=CC=C1C=C(N1)C=C([N+](=O)[O-])C1=CC([N]1)=CC=C1C=C(N1)C=CC1=C2 Chemical class [N]1C2=CC=C1C=C(N1)C=C([N+](=O)[O-])C1=CC([N]1)=CC=C1C=C(N1)C=CC1=C2 PRMBCBUVSYYPJY-UHFFFAOYSA-N 0.000 description 1
- WZECUPJJEIXUKY-UHFFFAOYSA-N [O-2].[O-2].[O-2].[U+6] Chemical compound [O-2].[O-2].[O-2].[U+6] WZECUPJJEIXUKY-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- JIMXXGFJRDUSRO-UHFFFAOYSA-N adamantane-1-carboxylic acid Chemical compound C1C(C2)CC3CC2CC1(C(=O)O)C3 JIMXXGFJRDUSRO-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- UBADKKCCQHYPIX-UHFFFAOYSA-N aluminum oxygen(2-) ruthenium(3+) Chemical compound [O-2].[Al+3].[Ru+3].[O-2].[O-2] UBADKKCCQHYPIX-UHFFFAOYSA-N 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 238000007774 anilox coating Methods 0.000 description 1
- 150000004984 aromatic diamines Chemical class 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- DVWBKCSKPCZFDE-UHFFFAOYSA-N bicyclo[2.2.1]hept-2-ene-2,3-dicarboxylic acid Chemical compound C1CC2C(C(=O)O)=C(C(O)=O)C1C2 DVWBKCSKPCZFDE-UHFFFAOYSA-N 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- ZOIYKZIJKIJRCY-UHFFFAOYSA-N bis(4-aminophenyl) pentanedioate Chemical compound C1=CC(N)=CC=C1OC(=O)CCCC(=O)OC1=CC=C(N)C=C1 ZOIYKZIJKIJRCY-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- WKDNYTOXBCRNPV-UHFFFAOYSA-N bpda Chemical compound C1=C2C(=O)OC(=O)C2=CC(C=2C=C3C(=O)OC(C3=CC=2)=O)=C1 WKDNYTOXBCRNPV-UHFFFAOYSA-N 0.000 description 1
- NAJAZZSIKSSBGH-UHFFFAOYSA-N butane-1,1,1,2-tetracarboxylic acid Chemical compound CCC(C(O)=O)C(C(O)=O)(C(O)=O)C(O)=O NAJAZZSIKSSBGH-UHFFFAOYSA-N 0.000 description 1
- GGAUUQHSCNMCAU-UHFFFAOYSA-N butane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)CC(C(O)=O)C(C(O)=O)CC(O)=O GGAUUQHSCNMCAU-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- MUYSADWCWFFZKR-UHFFFAOYSA-N cinchomeronic acid Chemical compound OC(=O)C1=CC=NC=C1C(O)=O MUYSADWCWFFZKR-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- CURBACXRQKTCKZ-UHFFFAOYSA-N cyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1C(C(O)=O)C(C(O)=O)C1C(O)=O CURBACXRQKTCKZ-UHFFFAOYSA-N 0.000 description 1
- WYHYNUWZLKTEEY-UHFFFAOYSA-N cyclobutane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C1 WYHYNUWZLKTEEY-UHFFFAOYSA-N 0.000 description 1
- CFBGXYDUODCMNS-UHFFFAOYSA-N cyclobutene Chemical compound C1CC=C1 CFBGXYDUODCMNS-UHFFFAOYSA-N 0.000 description 1
- GEQHKFFSPGPGLN-UHFFFAOYSA-N cyclohexane-1,3-diamine Chemical compound NC1CCCC(N)C1 GEQHKFFSPGPGLN-UHFFFAOYSA-N 0.000 description 1
- XBZSBBLNHFMTEB-UHFFFAOYSA-N cyclohexane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCCC(C(O)=O)C1 XBZSBBLNHFMTEB-UHFFFAOYSA-N 0.000 description 1
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- YZFOGXKZTWZVFN-UHFFFAOYSA-N cyclopentane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCC1 YZFOGXKZTWZVFN-UHFFFAOYSA-N 0.000 description 1
- LNGJOYPCXLOTKL-UHFFFAOYSA-N cyclopentane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)C1 LNGJOYPCXLOTKL-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- FDKLLWKMYAMLIF-UHFFFAOYSA-N cyclopropane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CC1 FDKLLWKMYAMLIF-UHFFFAOYSA-N 0.000 description 1
- RLWFMZKPPHHHCB-UHFFFAOYSA-N cyclopropane-1,2-dicarboxylate;hydron Chemical compound OC(=O)C1CC1C(O)=O RLWFMZKPPHHHCB-UHFFFAOYSA-N 0.000 description 1
- OWEZJUPKTBEISC-UHFFFAOYSA-N decane-1,1-diamine Chemical compound CCCCCCCCCC(N)N OWEZJUPKTBEISC-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- OREAFAJWWJHCOT-UHFFFAOYSA-N dimethylmalonic acid Chemical compound OC(=O)C(C)(C)C(O)=O OREAFAJWWJHCOT-UHFFFAOYSA-N 0.000 description 1
- MPFLRYZEEAQMLQ-UHFFFAOYSA-N dinicotinic acid Chemical compound OC(=O)C1=CN=CC(C(O)=O)=C1 MPFLRYZEEAQMLQ-UHFFFAOYSA-N 0.000 description 1
- QTTMRISQQJEWFG-UHFFFAOYSA-N diphenylaluminum Chemical compound C=1C=CC=CC=1[Al]C1=CC=CC=C1 QTTMRISQQJEWFG-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical group CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 description 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- SYLAFCZSYRXBJF-UHFFFAOYSA-N furan-3,4-dicarboxylic acid Chemical compound OC(=O)C1=COC=C1C(O)=O SYLAFCZSYRXBJF-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid Chemical compound OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- IUVIZIXAUJLNMZ-UHFFFAOYSA-N hexadecane-3,4,10,11-tetracarboxylic acid Chemical compound CCCCC(C(O)=O)C(C(O)=O)CCCCCC(C(O)=O)C(C(O)=O)CCC IUVIZIXAUJLNMZ-UHFFFAOYSA-N 0.000 description 1
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- ZXIRTZXVKYMLKJ-UHFFFAOYSA-N hydrazine;phthalic acid Chemical compound NN.OC(=O)C1=CC=CC=C1C(O)=O ZXIRTZXVKYMLKJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- SZNYYWIUQFZLLT-UHFFFAOYSA-N isopropylmethyl ether Natural products CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- IPLONMMJNGTUAI-UHFFFAOYSA-M lithium;bromide;hydrate Chemical compound [Li+].O.[Br-] IPLONMMJNGTUAI-UHFFFAOYSA-M 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- MJIVRKPEXXHNJT-UHFFFAOYSA-N lutidinic acid Chemical compound OC(=O)C1=CC=NC(C(O)=O)=C1 MJIVRKPEXXHNJT-UHFFFAOYSA-N 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 1
- ANGDWNBGPBMQHW-UHFFFAOYSA-N methyl cyanoacetate Chemical compound COC(=O)CC#N ANGDWNBGPBMQHW-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- OXKUGIFNIUUKAW-UHFFFAOYSA-N n,n-dimethylformamide;hydrazine Chemical compound NN.CN(C)C=O OXKUGIFNIUUKAW-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 1
- ZKTLKYRAZWGBDB-UHFFFAOYSA-N n-methyl-n-propan-2-ylformamide Chemical compound CC(C)N(C)C=O ZKTLKYRAZWGBDB-UHFFFAOYSA-N 0.000 description 1
- KYTZHLUVELPASH-UHFFFAOYSA-N naphthalene-1,2-dicarboxylic acid Chemical compound C1=CC=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 KYTZHLUVELPASH-UHFFFAOYSA-N 0.000 description 1
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 1
- VAWFFNJAPKXVPH-UHFFFAOYSA-N naphthalene-1,6-dicarboxylic acid Chemical compound OC(=O)C1=CC=CC2=CC(C(=O)O)=CC=C21 VAWFFNJAPKXVPH-UHFFFAOYSA-N 0.000 description 1
- WPUMVKJOWWJPRK-UHFFFAOYSA-N naphthalene-2,7-dicarboxylic acid Chemical compound C1=CC(C(O)=O)=CC2=CC(C(=O)O)=CC=C21 WPUMVKJOWWJPRK-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- UFOIOXZLTXNHQH-UHFFFAOYSA-N oxolane-2,3,4,5-tetracarboxylic acid Chemical compound OC(=O)C1OC(C(O)=O)C(C(O)=O)C1C(O)=O UFOIOXZLTXNHQH-UHFFFAOYSA-N 0.000 description 1
- NWZKSMUXWGUELC-UHFFFAOYSA-N pentane-1,1,1,5-tetramine Chemical compound NCCCCC(N)(N)N NWZKSMUXWGUELC-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical group NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004597 plastic additive Substances 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ZADZFVKVTLMTEH-UHFFFAOYSA-N propane-1,1,2,3-tetramine Chemical compound NCC(N)C(N)N ZADZFVKVTLMTEH-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940032159 propylene carbonate Drugs 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 150000004060 quinone imines Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- LJZVDOUZSMHXJH-UHFFFAOYSA-K ruthenium(3+);triiodide Chemical compound [Ru+3].[I-].[I-].[I-] LJZVDOUZSMHXJH-UHFFFAOYSA-K 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- JQZAKMJZYGPUFD-UHFFFAOYSA-N spiro[3.3]heptane-2,6-dicarboxylic acid Chemical compound C1C(C(=O)O)CC21CC(C(O)=O)C2 JQZAKMJZYGPUFD-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- MFPWEWYKQYMWRO-UHFFFAOYSA-N tert-butyl carboxy carbonate Chemical compound CC(C)(C)OC(=O)OC(O)=O MFPWEWYKQYMWRO-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- GZZOYMCNZSCLDW-UHFFFAOYSA-N tert-butyl n-(1,2,3,4-tetrahydroquinolin-6-yl)carbamate Chemical compound N1CCCC2=CC(NC(=O)OC(C)(C)C)=CC=C21 GZZOYMCNZSCLDW-UHFFFAOYSA-N 0.000 description 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 229910000439 uranium oxide Inorganic materials 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Nonlinear Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mathematical Physics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Liquid Crystal (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Description
201226390 六、發明說明 【發明所屬之技術領域】 本發明爲關於一種新穎之二胺、聚醯亞胺前驅物及聚 醯亞胺、使用於液晶表示元件之液晶配向劑、液晶配向膜 以及液晶表示元件。 【先前技術】 在液晶表示元件中,液晶配向膜爲擔任所謂的使液晶 配向於一定之方向之角色》現在,工業上被利用之主要的 液晶配向膜,係將由聚醯亞胺前驅物之聚醯胺酸(亦稱爲 聚醯胺酸)、聚醯胺酸酯、或聚醯亞胺之溶液所成的聚醯 亞胺系液晶配向劑塗佈於基板,並藉由進行成膜而製作。 又,使液晶平行配向或傾斜配向於基板面時,成膜後,更 藉由磨擦(rubbing)來進行表面延伸處理。又,作爲取代磨 擦處理者,亦有提案著使用藉由偏光紫外線照射等異向性 光化學反應之方法,近年正朝向工業化進行檢討。 爲了提昇如此般之液晶表示元件之表示特性,藉由變 更聚醯胺酸、聚醯胺酸酯或聚醯亞胺之構造;摻合特性相 異的聚醯胺酸、聚醯胺酸酯或聚醯亞胺;或添加添加劑等 之手段,正進行著液晶配向性或電氣特性等之改善、或預 傾角之控制等。例如,用來得到高的電壓保持率,藉由使 用具有特定重複構造之聚醯亞胺樹脂(參考專利文獻1)、 或除了醯亞胺基以外使用具有氮原子之可溶性聚醯亞胺, 來縮短至殘像消除爲止之時間(參考專利文獻2),又,藉 -5- 201226390 由將1-苯基吲哚構造導入於聚醯胺酸之原料之二胺,一 邊保持高的電壓保持率一邊使殘留DC降低(參考專利文 獻3)等,已有各式各樣的技術被提案著。 然而,隨著液晶表示元件之高性能化、大面積化、表 示裝置之省電力化等之進展,除此之外,變得使用於各式 各樣之環境下,對於液晶配向膜所要求之特性亦變得嚴 苛》特別是,因爲將液晶配向劑塗佈於基板之際之工站時 間之變長,因析出或分離而產生的印刷不良、或因儲存電 荷(RDC)的燒附等問題已成爲課題,使用以往之技術難以 同時解決此兩者之問題。 [先前技術文獻] [專利文獻] [專利文獻1]特開平2-287324號公報 [專利文獻2]特開平1 0-1 04633號公報 [專利文獻3]特開20 1 0-70537號公報 【發明內容】 [發明所欲解決的課題] 本發明之課題係以解決上述以往技術之問題點,以提 供一可得到印刷性良好之液晶配向劑,且可得到儲存電荷 少、已儲存電荷之緩和快之液晶配向膜的二胺、聚醯亞胺 前驅物及聚醯亞胺、使用此等之液晶配向劑、液晶配向膜 以及液晶表示元件。 201226390 [解決課題之手段] 本發明人經深入硏究之結果,發現作爲二胺成分,使 用下述式[1]所示特定之二胺之含有聚醯亞胺前驅物或聚 醯亞胺之液晶配向劑’對於用來達成上述目的極爲有效, 遂而完成本發明。尙,下述式[1]所示二胺化合物爲未有 文獻記載之新穎化合物。 解決前述課題之本發明之新穎二胺,一種下述式[1] 所示之二胺, [化1]201226390 VI. TECHNOLOGICAL FIELD The present invention relates to a novel diamine, a polyimide precursor and a polyimide, a liquid crystal alignment agent for a liquid crystal display element, a liquid crystal alignment film, and a liquid crystal representation. element. [Prior Art] In the liquid crystal display element, the liquid crystal alignment film functions as a so-called alignment of the liquid crystal in a certain direction. Now, the main liquid crystal alignment film which is industrially utilized is a polyelectron imide precursor. A polyimine-based liquid crystal alignment agent prepared from a solution of proline (also known as polyglycolic acid), polyphthalate or polyimine is applied to a substrate and formed by film formation. . Further, when the liquid crystal is aligned in the parallel direction or obliquely to the substrate surface, the surface extension treatment is performed by rubbing after the film formation. In addition, as a method of replacing the rubbing, a method of using an anisotropic photochemical reaction such as polarized ultraviolet ray irradiation has been proposed, and in recent years, industrialization has been reviewed. In order to enhance the representational characteristics of such liquid crystal display elements, by changing the structure of polylysine, polyphthalate or polyimine; polyamine or polylysine having different blending characteristics or Polyimine or an additive or the like is being improved in liquid crystal alignment, electrical properties, etc., or pretilt angle control. For example, to obtain a high voltage holding ratio, by using a polyimine resin having a specific repeating structure (refer to Patent Document 1), or using a soluble polyimine having a nitrogen atom in addition to the quinone imine group, The time until the afterimage is removed (refer to Patent Document 2), and the high voltage retention rate is maintained by the introduction of the 1-phenylfluorene structure into the diamine of the poly-plycine raw material by -5 to 201226390. Various techniques have been proposed while reducing the residual DC (refer to Patent Document 3). However, as the liquid crystal display element is improved in performance, large in area, and power saving of the device, etc., it has been used in a wide variety of environments, and is required for a liquid crystal alignment film. The characteristics are also severe. In particular, the station time when the liquid crystal alignment agent is applied to the substrate is prolonged, printing failure due to precipitation or separation, or burning due to stored charge (RDC). The problem has become a problem, and it is difficult to solve both problems at the same time using the prior art. [PRIOR ART DOCUMENT] [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei. No. Hei. No. Hei. No. Hei. Disclosure of the Invention [Problems to be Solved by the Invention] The problem of the present invention is to solve the above problems of the prior art, and to provide a liquid crystal alignment agent which is excellent in printability, and which has a low storage charge and a mitigation of stored charge. A fast liquid crystal alignment film of a diamine, a polyimide precursor and a polyimide, a liquid crystal alignment agent using the liquid crystal alignment film, and a liquid crystal display element. 201226390 [Means for Solving the Problem] As a result of intensive research, the present inventors have found that a diamine component containing a polydiimide precursor or a polyimine which is a specific diamine represented by the following formula [1] is used as the diamine component. The liquid crystal alignment agent 'is extremely effective for achieving the above object, and the present invention has been completed. The diamine compound represented by the following formula [1] is a novel compound not described in the literature. A novel diamine of the present invention which solves the aforementioned problems, a diamine represented by the following formula [1], [Chemical Formula 1]
ReRe
(式[1]中,Ri〜R9中之二個爲1級胺基’殘餘爲氫原子或 胺基以外之一價有機基,可分別爲相同或相異。n爲1或 2,形成環之飽和烴部位之氫原子可被鹵素原子或胺基以 外之一價有機基所取代)。 又,上述二胺,較佳如下述式[2 ]所不’ [化2] 201226390 (式[2]中,p示爲0〜3之整數,R1Q示爲胺基以外之一價 有機基,-(R1())P示爲具有P個取代基R1(),並可分別爲相 同或相異。q示爲〇〜4之整數,Ru示爲胺基以外之一價 有機基,-(R^h示爲具有q個取代基Rh,並可分別爲相 同或相異。η爲1或2,形成環之飽和烴部位之氫原子可 被鹵素原子或胺基以外之有機基所取代)。 更,上述二胺,較佳如下述式[3]所示, [化3] /严2 (R12(In the formula [1], two of Ri to R9 are a 1-stage amine group', and the residue is a hydrogen atom or a monovalent organic group other than the amine group, which may be the same or different, and n is 1 or 2, forming a ring. The hydrogen atom of the saturated hydrocarbon moiety may be substituted by a halogen atom or a monovalent organic group other than the amine group). Further, the diamine is preferably not represented by the following formula [2]. [Chemical Formula 2] 201226390 (In the formula [2], p is an integer of 0 to 3, and R1Q is a monovalent organic group other than the amine group. -(R1())P is shown as having P substituents R1(), and may be the same or different, respectively. q is shown as an integer of 〇~4, and Ru is a one-valent organic group other than an amine group, -( R^h is shown as having q substituents Rh and may be the same or different. η is 1 or 2, and a hydrogen atom forming a saturated hydrocarbon moiety of the ring may be substituted by an organic group other than a halogen atom or an amine group) Further, the above diamine is preferably represented by the following formula [3], [Chemical 3] / Yan 2 (R12)
NH2 -0 [3] (式[3]中’ η爲1或2,m爲〇〜2(n+l)之整數,R12示爲 氟原子或胺基以外之一價有機基,_(R12)m示爲具有m個 取代基R1 2,並可分別爲相同或相異)。 又,前述Rl2較佳爲碳數1〜6之烴基,更佳爲Rl2 爲甲基。 其中,較佳爲n= 1。 又,可爲下述式[4_a]〜[4-d]所示之二胺,NH2 -0 [3] (In the formula [3], 'η is 1 or 2, m is an integer of 〇~2(n+l), and R12 is a fluorine atom or an amine group other than the amine group, _(R12 m is shown to have m substituents R1 2 and may be the same or different, respectively. Further, the above R12 is preferably a hydrocarbon group having 1 to 6 carbon atoms, and more preferably R1 is a methyl group. Among them, n = 1 is preferred. Further, it may be a diamine represented by the following formula [4_a] to [4-d],
-8- 201226390 [化4]-8- 201226390 [化4]
nh2 本發明之聚醯亞胺前驅物,係使由四羧酸及該衍生物 所選出之至少一種與含有上述二胺之二胺成分產生反應而 得到。 在上述聚醯亞胺前驅物中,將四羧酸及該衍生物之總 莫耳量定爲100莫耳%時,上述二胺較佳爲5〜95莫耳 %。 又,本發明之聚醯亞胺,係將上述聚醯亞胺前驅物醯 亞胺化而得到》 接著,本發明之液晶配向劑,係含有由上述聚醯亞胺 前驅物、及上述聚醯亞胺所選出之至少一種。 本發明之液晶配向膜,係將上述液晶配向劑塗佈、鍛 燒於基板而得到。 本發明之液晶表示元件,係具備有上述液晶配向膜。 [發明之效果] 藉由本發明,可提供一種新穎之二胺,其係可得到印 刷性良好之液晶配向劑,且可得到儲存電荷少、已儲存電 荷之緩和快之液晶配向膜。然後,藉由使用此二胺,可成 -9 - 201226390 爲印刷性良好之液晶配向劑。又,藉由使用此液晶配向 劑’由於可得到儲存電荷少且已儲存之電荷之緩和快之液 晶配向膜’故具有該液晶配向膜之液晶表示元件不易產生 對比降低或燒附’可得到表示特性優異之效果。 [實施發明的最佳型態] 以下’對於本發明予以詳細說明。 本發明之二胺,係下述式[1 ]所示者。 [化5]Nh2 The polyimine precursor of the present invention is obtained by reacting at least one selected from a tetracarboxylic acid and the derivative with a diamine component containing the above diamine. In the above polyimine precursor, when the total molar amount of the tetracarboxylic acid and the derivative is 100 mol%, the diamine is preferably 5 to 95 mol%. Further, the polyimine of the present invention is obtained by imidating the above-mentioned polyimine precursor ruthenium. Next, the liquid crystal alignment agent of the present invention contains the above-mentioned polyimine precursor and the above-mentioned polyfluorene At least one of the imines is selected. The liquid crystal alignment film of the present invention is obtained by applying and forging the above liquid crystal alignment agent onto a substrate. The liquid crystal display element of the present invention is provided with the above liquid crystal alignment film. [Effects of the Invention] According to the present invention, it is possible to provide a novel diamine which is capable of obtaining a liquid crystal alignment agent having good printing properties, and which can provide a liquid crystal alignment film which has a small storage charge and a fast relaxation of a stored charge. Then, by using this diamine, it is possible to form a liquid crystal alignment agent having good printability from -9 to 201226390. Further, by using the liquid crystal alignment agent, since a liquid crystal alignment film having a small storage charge and a fast relaxation of the stored charge can be obtained, the liquid crystal display element having the liquid crystal alignment film is less likely to cause contrast reduction or burning. Excellent performance. [Best Mode of Carrying Out the Invention] Hereinafter, the present invention will be described in detail. The diamine of the present invention is represented by the following formula [1]. [Chemical 5]
ReRe
(式[1]中’ 1〜119中之二個爲i級胺基,殘餘爲氫原子或 胺基以外之一價有機基,可分別爲相同或相異。η爲1或 2’形成環之飽和烴部位之氫原子可被鹵素原子或胺基以 外之一價有機基所取代)。 在式[1]中,作爲鹵素原子,舉例如氟原子等。又, 在式[1 ]中,作爲胺基以外之—價有機基,舉例如烴基、 經基 '羧基、羥基、硫醇基、或含有羧基之烴基;藉由醚 鍵結' 酯鍵結 '醯胺鍵結等之鍵結基所連結之烴基;含有 砂原子之烴基、鹵素化烴基等。又,作爲胺基以外之一價 有機基’亦可舉例如胺基爲藉由例如t-丁氧基羰基等胺甲(In the formula [1], two of the '1 to 119' are i-group amine groups, and the residue is a hydrogen atom or a monovalent organic group other than the amine group, which may be the same or different, respectively. η is 1 or 2' to form a ring. The hydrogen atom of the saturated hydrocarbon moiety may be substituted by a halogen atom or a monovalent organic group other than the amine group). In the formula [1], examples of the halogen atom include a fluorine atom and the like. Further, in the formula [1], as the valent organic group other than the amine group, for example, a hydrocarbon group, a terminal group 'carboxy group, a hydroxyl group, a thiol group, or a hydrocarbon group having a carboxyl group; by an ether linkage 'ester linkage' a hydrocarbon group to which a bonding group such as a guanamine bond is bonded; a hydrocarbon group containing a sand atom, a halogenated hydrocarbon group, or the like. Further, as the monovalent organic group other than the amine group, for example, the amine group may be an amine group such as t-butoxycarbonyl group.
-10- 201226390 酸酯系之保護基所保護的惰性之基等。 又,在式[1]中,胺基之位置未特別限定,只要是二 胺即可未特別限定,但就液晶配向性或合成之容易性之觀 點,較佳爲下述式[2]所示之位置。 [化6]-10- 201226390 An inert base protected by a protecting group of an acid ester. In the formula [1], the position of the amine group is not particularly limited, and the diamine is not particularly limited. From the viewpoint of liquid crystal alignment or ease of synthesis, it is preferably the following formula [2]. Show location. [Chemical 6]
(式[2]中,p示爲0〜3之整數,R1G示爲胺基以外之一價 有機基,_(R1())P示爲具有p個取代基R1Q,並可分別爲相 同或相異。q示爲0〜4之整數,Rh示爲胺基以外之一價 有機基,爲具有q個取代基Rm,並可分別爲相 同或相異。η爲1或2,形成環之飽和烴部位之氫原子可 被鹵素原子或胺基以外之有機基所取代)。 又,如上述式[2]所示般,具有胺基之苯環之氫原 子,可被胺基以外之一價有機基之R1()或Rh所取代,可 依試劑之取得性等予以各種之選擇。尙,在式[2]中,作 爲胺基以外之一價有機基R1G、R! !,舉例如烴基、羧基、 羥基、硫醇基、或具有此等之烴基;藉由醚鍵結、酯鍵 結、醯胺鍵結等之鍵結基所連結之烴基;含有矽原子之烴 基、鹵素化烴基等。又,作爲R, G或R! i,亦可舉例如胺 基爲藉由例如t-丁氧基羰基等胺甲酸酯系之保護基所保護 的惰性之基等。然而,就試劑之取得性'或合成之容易性之 -11 - 201226390 觀點而言’具有胺基之苯環之氫原子較佳爲未取代者。 更’具體之構造例如下述式[3]所示。 [化7] nh2 (R12(In the formula [2], p is an integer of 0 to 3, R1G is a one-valent organic group other than the amine group, and _(R1())P is represented as having p substituents R1Q, and may be the same or Different, q is shown as an integer from 0 to 4, and Rh is a monovalent organic group other than an amine group, having q substituents Rm, and may be the same or different, respectively, and η is 1 or 2, forming a ring. The hydrogen atom of the saturated hydrocarbon moiety may be substituted by a halogen atom or an organic group other than the amine group). In addition, as shown in the above formula (2), the hydrogen atom of the benzene ring having an amine group may be substituted by R1 () or Rh of a monovalent organic group other than the amine group, and various kinds of reagents may be used depending on the availability of the reagent. Choice. In the formula [2], as the monovalent organic group R1G, R!, other than the amine group, for example, a hydrocarbon group, a carboxyl group, a hydroxyl group, a thiol group, or a hydrocarbon group having the same; by an ether bond, an ester a hydrocarbon group to which a bonding group such as a bond or a hydrazine bond is bonded; a hydrocarbon group containing a halogen atom; a halogenated hydrocarbon group; Further, as R, G or R! i, for example, the amine group is an inert group which is protected by a urethane-based protecting group such as t-butoxycarbonyl group. However, in view of the availability of the reagent or the ease of synthesis, the hydrogen atom of the benzene ring having an amine group is preferably unsubstituted. More specifically, the configuration is as shown in the following formula [3]. [n7] nh2 (R12
nh2 【31 (式[3]中’ η爲1或2,m爲0〜2(n+l)之整數,R12示爲 氟原子或胺基以外之一價有機基,-(R12)m示爲具有m個 取代基R12,並可分別爲相同或相異)。 在式[1]〜[3]中,n=l時,係成爲具有吲哚啉構造之 二胺,n = 2時,係成爲具有四氫喹啉構造之二胺。雖皆爲 具有形成環之飽和烴部位,但此飽和烴部位之碳之氫原 子,可被氟原子等之鹵素原子、胺基以外之一價有機基所 取代。尙,在式[3]中,取代飽和烴部位之氫原子之取代 基爲R, 2 »作爲取代飽和烴部位之氫原子之胺基以外之一 價有機基,舉例如烴基、羥基、羧基等。在此的烴基,可 爲直鏈、分支 '環狀中任一者,又,可爲飽和烴或不飽和 烴,其中,烴基之氫原子之一部份可被羧基、羥基、硫醇 基、或矽原子或鹵素原子等取代,亦可藉由醚鍵結、酯鍵 結、醯胺鍵結等之鍵結基所連結。另一方面’就合成之容 易性或試劑之取得性之點而言,R|2較佳爲僅由碳原子與 氫原子所構成之烴基。Nh2 [31 (in the formula [3], η is 1 or 2, m is an integer of 0 to 2 (n+1), and R12 is a fluorine atom or a monovalent organic group other than the amine group, -(R12)m is shown It has m substituents R12 and may be the same or different, respectively. In the formulas [1] to [3], when n = 1, it is a diamine having a porphyrin structure, and when n = 2, it is a diamine having a tetrahydroquinoline structure. Although they are all saturated hydrocarbon sites forming a ring, the hydrogen hydrogen atom of the saturated hydrocarbon moiety may be substituted by a halogen atom such as a fluorine atom or a monovalent organic group other than the amine group. In the formula [3], the substituent of the hydrogen atom replacing the saturated hydrocarbon moiety is R, 2» is a monovalent organic group other than the amine group of the hydrogen atom substituted for the saturated hydrocarbon moiety, and examples thereof include a hydrocarbon group, a hydroxyl group, a carboxyl group, and the like. . The hydrocarbon group herein may be any of a linear or branched 'ring, and may be a saturated hydrocarbon or an unsaturated hydrocarbon, wherein a part of a hydrogen atom of the hydrocarbon group may be a carboxyl group, a hydroxyl group, a thiol group, Alternatively, it may be substituted by a halogen atom, a halogen atom or the like, or may be bonded by a bonding group such as an ether bond, an ester bond or a guanamine bond. On the other hand, R|2 is preferably a hydrocarbon group composed only of a carbon atom and a hydrogen atom in terms of the ease of synthesis or the availability of a reagent.
-12- 201226390 取代飽和烴部位之碳之氫原子之取代基’較佳爲碳數. 1〜6之烴基。使用本發明之二胺之聚醯胺酸等之聚醯亞 胺前驅物或聚醯亞胺,由於對於溶媒之溶解性高,故印刷 性良好,但如果是飽和烴部·位之氫原子爲被碳數1〜6之 烴基所取代之二胺時,聚醯胺酸等之聚醯亞胺前驅物或聚 醯亞胺之對於有機溶媒之溶解性會更爲提高,因此印刷性 變得更良好。又,因聚醯胺酸等之聚醯亞胺前驅物或聚醯 亞胺之對於溶媒之溶解性變高,與其他的聚合物之相溶性 優異,使用本發明之二胺之聚醯亞胺前驅物或聚醯亞胺, 即使是與其他之聚合物混合使用時,亦不易產生分離或析 出,印刷性優異。作爲碳數1〜6之烴基之具體例,舉例 如甲基、乙基、丙基'丁基、t-丁基、己基、環戊基、環 己基、乙烯基、烯丙基、1-丙烯基、2-丙烯基、異丙烯 基、1-甲基-2-丙烯基、1或2或3-丁烯基、己烯基、苯基 等,但不限定於此。 飽和烴部位之氫原子若以此等之取代時,取代位置或 數量無特別限定,可依合成之容易性或試劑之取得性予以 各種之選擇。特佳之構造爲飽和烴部位之氫原子爲甲基所 取代者。又,就合成之容易性之觀點,較佳爲飽和烴部位 之氫原子爲未被取代者。以下爲示例本發明之二胺之較佳 具體例,但不於此。 201226390-12- 201226390 The substituent of the hydrogen atom replacing the carbon of the saturated hydrocarbon moiety is preferably a hydrocarbon group having a carbon number of from 1 to 6. The polyimine precursor or the polyimine which uses the polyamine of the diamine of the present invention has high solubility in a solvent, so that the printability is good, but if the hydrogen atom of the saturated hydrocarbon moiety is When a diamine substituted with a hydrocarbon group having 1 to 6 carbon atoms is substituted, the solubility of the polyamidene precursor such as polyglycine or the polyimine is more improved in the organic solvent, so that the printability is further improved. good. Further, the polyamidene precursor such as polylysine or the polyimine has high solubility in a solvent, and is excellent in compatibility with other polymers, and the polyamine imide of the present invention is used. The precursor or polyimine is not easily separated or precipitated when used in combination with other polymers, and is excellent in printability. Specific examples of the hydrocarbon group having 1 to 6 carbon atoms include, for example, a methyl group, an ethyl group, a propyl 'butyl group, a t-butyl group, a hexyl group, a cyclopentyl group, a cyclohexyl group, a vinyl group, an allyl group, and a 1-propene group. The group is a 2-propenyl group, an isopropenyl group, a 1-methyl-2-propenyl group, a 1 or 2 or a 3-butenyl group, a hexenyl group, a phenyl group or the like, but is not limited thereto. When the hydrogen atom of the saturated hydrocarbon moiety is substituted by this or the like, the position or amount of substitution is not particularly limited, and various options can be selected depending on the ease of synthesis or the availability of the reagent. A particularly preferred structure is that the hydrogen atom of the saturated hydrocarbon moiety is replaced by a methyl group. Further, from the viewpoint of easiness of synthesis, it is preferred that the hydrogen atom in the saturated hydrocarbon portion is unsubstituted. The following is a preferred specific example of the diamine of the present invention, but it is not. 201226390
-14 201226390 [化9]-14 201226390 [化9]
ρΝΗ2 h2nΝΗ2 h2n
[4-24】[4-24]
H2NH2N
[4-26] [4-27] [4-28] [化 10][4-26] [4-27] [4-28] [Chem. 10]
本發明之特佳之二胺如同以下 -15- 201226390 [化 11]The particularly preferred diamine of the present invention is as follows -15- 201226390 [Chemical 11]
t-WJ 如此般地,將上述式[1]所示本發明之二胺作爲原料 之聚醯胺酸或聚醯胺酸醋等之聚醯亞胺前驅物或聚醯亞 胺,由於對於有機溶媒之溶解性良好,在形成液晶配向膜 之際不會產生針孔之形成或邊緣部等之膜厚不均勻,故可 得到印刷性良好之液晶配向劑。又,使用此液晶配向劑 時,由於可得到不易產生電荷儲存,且已儲存之電荷之消 除快之液晶配向膜,故具有該液晶配向膜之液晶表示元件 不易產生對比降低或燒附,可得到表示特性優異之效果。 又,亦可抑制因長期間使用之離子密度之增加。更,液晶 配向性亦爲良好。 如此般之效果,係因本發明之二胺爲含有具有作用爲 立體阻礙之部位之二苯胺構造及飽和烴部位,能以保持二 苯胺之電氣性質之狀態而提昇溶解性或提昇聚合物之相溶 性,推測因而能展現出如上述般之特性。另一方面,專利 文獻3之二胺,其構造在位置於本發明之二胺之飽和烴部 位爲具有雙鍵’但不具有飽和烴部位;使用如專利文獻3 之二胺時’如同後述比較例所示般,無法得到如使用本發t-WJ is a polyimine imine precursor or polyimine which is a polyamine or a polyamidamide of the present invention having the diamine of the present invention represented by the above formula [1] as a raw material, since The solubility of the solvent is good, and the formation of pinholes or the uneven thickness of the edge portion or the like is not formed when the liquid crystal alignment film is formed, so that a liquid crystal alignment agent having good printability can be obtained. Moreover, when the liquid crystal alignment agent is used, since a liquid crystal alignment film which is less likely to generate charge storage and which has a fast elimination of stored charges can be obtained, the liquid crystal display element having the liquid crystal alignment film is less likely to be reduced in contrast or burned. Indicates the effect of excellent characteristics. Further, it is also possible to suppress an increase in ion density used for a long period of time. Furthermore, the liquid crystal alignment is also good. The effect of the present invention is that the diamine of the present invention contains a diphenylamine structure and a saturated hydrocarbon moiety having a site which acts as a steric hindrance, and can enhance the solubility or enhance the phase of the polymer by maintaining the electrical properties of the diphenylamine. Solubility, it is speculated that it can exhibit the characteristics as described above. On the other hand, the diamine of Patent Document 3 is constructed such that the saturated hydrocarbon site at the position of the diamine of the present invention has a double bond but does not have a saturated hydrocarbon moiety; when using a diamine such as Patent Document 3, it is compared as described later. As shown in the example, it is not possible to get the same as using this hair.
-16- 201226390 苯基吲哚骨架之故。 明之二胺時之儲存電荷少、 配向膜,又,液晶配向性亦 之聚醯亞胺之溶解性或相溶 利文獻3之二胺爲富含有平 二苯胺爲相異之電子狀態之 對於如此般之本發明之 尙,以下所說明之方法爲合 本發明之二胺,如下述 物還原後,藉由將硝基變換 反應式中,係將苯環及飽和 等鹵素原子或胺基以外之一 來予以記載。 [化 12] 已儲存電荷之緩和爲快之液晶 會變差,然後,對於有機溶劑 性亦得到不佳之結果。此爲專 面性,又,推測爲具有採取與 二胺之主要合成法進行說明。 成例,並不限定於此。 反應式所示般,將二硝基化合 爲胺基而可得到。尙,在下述 烴部位之氫原子爲未被氟原子 價有機基所取代之二胺作爲例-16- 201226390 The reason of the phenyl hydrazine skeleton. In the case of the diamine, the storage charge is small, the alignment film, and the liquid crystal alignment property is also soluble or compatible. The diamine of the literature 3 is rich in the dimorphic electronic state of the diphenylamine. In the case of the present invention, the method described below is a diamine of the present invention, and after the reduction of the following, the nitro group is converted into a benzene ring and a halogen atom or an amine group other than the amine group. One is to be recorded. [Chem. 12] The liquid crystal which has a moderate relaxation of the stored charge is deteriorated, and then, the organic solvent property is also poorly obtained. This is specific and is presumed to have been described as the main synthesis method with diamine. The example is not limited to this. As shown in the reaction formula, a dinitro group is obtained as an amine group.尙, as a case where the hydrogen atom of the hydrocarbon moiety is a diamine which is not substituted with a fluorine atomic valent organic group
nh2 將二硝基化合物還原 鈀-碳、氧化鈾、雷氏鎳 作爲觸媒使用,在乙酸乙 醇系等之溶媒中,藉由氫氣 法。視必要性,亦可在使月 方法未特別限制,可示例如將 珀黒、铑-氧化鋁、硫化鉑碳等 、甲苯、四氫呋喃、二噁烷、 、肼、氯化氫等進行還原之方 蒸壓鍋等之加壓下進行。另一 方面,若取代苯環或飽和Μ部位之氫原子之取代基之構造 爲含有不飽和鍵結部位時 使用鈀碳或鉑碳等時,此不飽 和鍵結部位會被還原,因彳ί變成飽和鍵結之虞,故較佳爲 -17- 201226390 使用還原鐵或錫、氧化錫等之過渡金屬作爲觸媒之還原條 件。 在二硝基化合物之合成中,如下述反應式所示般,藉 由使市售的硝基吲哚啉衍生物或硝基四氫嗤啉衍生物與經 鹵素等之脫離基X所取代之硝基苯產生反應,可得到該 二硝基化合物。作爲較佳的脫離基X,舉例如氟原子、氯 原子、溴原子、碘原子、甲苯磺酸酯(-OTs)、meSylate(- OMs)等。 [化 13]Nh2 Reduction of dinitro compound Palladium-carbon, uranium oxide, and Raney nickel are used as a catalyst, and a hydrogen method is used in a solvent such as an acetic acid acetate. Depending on the necessity, the monthly method is not particularly limited, and examples thereof include autoclaving such as ruthenium, ruthenium-aluminum oxide, ruthenium sulfide carbon, toluene, tetrahydrofuran, dioxane, hydrazine, hydrogen chloride, and the like. It is carried out under pressure from a pot or the like. On the other hand, when the structure of the substituent of the hydrogen atom replacing the benzene ring or the saturated fluorene moiety is such that palladium carbon or platinum carbon is used when the unsaturated bond site is contained, the unsaturated bond site is reduced because 彳ί Since it becomes a saturated bond, it is preferable to use -17-201226390 as a reducing condition for using a transition metal such as reduced iron or tin or tin oxide as a catalyst. In the synthesis of the dinitro compound, as shown in the following reaction formula, the commercially available nitroporphyrin derivative or the nitrotetrahydroporphyrin derivative is substituted with a leaving group X such as a halogen. The nitrobenzene is reacted to obtain the dinitro compound. Preferred examples of the leaving group X include a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a tosylate (-OTs), and a meSylate (-OMs). [Chem. 13]
上述反應,可在鹼存在下進行。所使用的鹼只要是能 合成即可,無特別限定,舉例如碳酸鉀、碳酸鈉、碳酸 铯、烷氧化鈉、烷氧化鉀、氫氧化鈉、氫氧化鉀、氫化鈉 等之無機鹼 '吡啶、二甲基胺基吡啶、三甲基胺、三乙基 胺、三丁基胺等之有機鹼等。又,視情況,若倂用如二亞 苄基丙酮鈀或二苯基鱗二茂鐵鈀之鈀觸媒或銅觸媒等時, 可使收率提昇。就合成之容易性之觀點,較佳爲如下述反 應式所不般,使用氫化鈉等之驗,將存在於硝基Π引哄啉衍 生物或硝基四氫喹啉衍生物之-NH-之氫予以取出,使與 4 -硝基氟苯產生反應之方法,由於除此方法以外亦能合 成,故合成法無特別限定。 -18- 201226390 [化 14]The above reaction can be carried out in the presence of a base. The base to be used is not particularly limited as long as it can be synthesized, and examples thereof include an inorganic base 'pyridine" such as potassium carbonate, sodium carbonate, cesium carbonate, sodium alkoxide, potassium alkoxide, sodium hydroxide, potassium hydroxide or sodium hydride. An organic base such as dimethylaminopyridine, trimethylamine, triethylamine or tributylamine. Further, depending on the case, when a palladium catalyst such as dibenzylideneacetone palladium or diphenylaluminum ferrocene palladium or a copper catalyst is used, the yield can be improved. From the viewpoint of easiness of synthesis, it is preferred to use the sodium hydride or the like, and the -NH- which is present in the nitroguanidine porphyrin derivative or the nitrotetrahydroquinoline derivative, as in the following reaction formula. The method in which the hydrogen is taken out and reacted with 4-nitrofluorobenzene can be synthesized in addition to the method, and the synthesis method is not particularly limited. -18- 201226390 [Chem. 14]
本發明之二胺,藉由與由四羧酸及四羧酸衍生物所選 出之至少一種產生反應,可得到本發明之聚醯胺酸或聚醯 胺酸酯等之聚醯亞胺前驅钉。用來得到此聚醯亞胺前驅 物,使本發明之二胺與四羧酸及該衍生物產生反應之比例 未特別限定,例如,將四羧酸及該衍生物之總莫耳量定爲 1 0 0莫耳%時,本發明之二Φ較佳爲5〜9 5莫耳%。 作爲四羧酸衍生物,舉 二酐、四羧酸二酯二氯化物 使四羧酸二鹵化物、四羧酸 含有本發明之二胺之二胺 酸。又,藉由使四羧酸二i 之二胺成分之反應,或使E 之二胺成分,在適當之縮 例如四羧酸二鹵化物、四羧酸 四羧酸二酯等。例如,藉由 二酐等四羧酸或該衍生物,與 丨交分產生反應,可得到聚醯胺 二氯化物與含有本發明之二胺 羧酸二酯與含有本發明之二胺 劑或鹼之存在下等產生反應, 可得到聚醯胺酸酯。尙,本說明書中,所謂的二胺成分, 係用來得到聚醯亞胺前驅物或聚醯亞胺,而與由四羧酸及 四羧酸衍生物所選出之至少一種產生反應之二胺,本發明 之二胺亦可單獨或與其他之二胺倂用。 接著,將此聚醯亞胺前驅物進行醯亞胺化,具體爲使 聚醯胺酸脫水閉環,或以萵溫將聚醯胺酸酯加熱,並藉由 促使脫醇而使閉環,可得到本發明之聚醯亞胺。 -19- 201226390 關於本發明之聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前 驅物、聚醯亞胺,以下爲更予以詳細敘述。在用來藉由與 由上述四羧酸二酐等四羧酸及四羧酸衍生物所選出之至少 一種來產生反應而得到聚醯胺酸等之聚醯亞胺前驅物之二 胺成分中,本發明之二胺之含有比例無限制。使用本發明 之聚醯亞胺前驅物或已將此醯亞胺化之聚醯亞胺所得到的 液晶配向膜,上述所示本發明之二胺之含有比例越多時, 越可得到儲存電荷少、已儲存電荷之緩和快之液晶配向 膜。 以加速緩和已儲存之電荷作爲目的時,較佳爲二胺成 分之1莫耳%以上爲本發明之二胺。另一方面,若考量液 晶配向性、預傾角特性等其他之特性時,聚合時所使用的 二胺成分中,本發明之二胺成分之含有比例較佳爲20〜 90莫耳%、特佳爲30〜80莫耳。 在上述二胺成分中,若式[1]所示二胺之使用爲未滿 1 00莫耳%時’式[1 ]所示二胺以外之其他二胺並未特別限 定。若要舉例該具體例時,如同下述。 作爲脂環式二胺類之例,舉例如1,4_二胺基環己烷、 1,3-二胺基環己烷、4,4’-二胺基二環己基甲烷' 4,4,-二胺 基-3,3’-二甲基二環己基胺、異佛酮二胺等。 作爲芳香族二胺類之例,舉例如〇-苯二胺、m_苯二 胺、P-苯二胺、2,4-二胺基甲苯' 2,5-二胺基甲苯、3,5-二 胺基甲苯、1,4-二胺基-2_甲氧基苯、2,5-二胺基-P-二甲 苯、1,3-二胺基-4-氯苯、3,5 -二胺基安息香酸、ι,4 -二胺 -20- 201226390 基-2,5-二氯苯、4,4’-二胺基-1,2-二苯基乙烷、4,4’-二胺 基-2,2’-二甲基聯苄、4,4’-二胺基二苯基甲烷、3,3’-二胺 基二苯基甲烷、3,4’-二胺基二苯基甲烷、4,4’-二胺基-3,3’-二甲基二苯基甲烷、2,2’-二胺基芪、4,4’-二胺基 芪、4,4’-二胺基二苯基醚、3,4’-二胺基二苯基醚、4,4’-二胺基二苯基硫化物、4,4’-二胺基二苯基颯、3,3’-二胺 基二苯基碾、4,4’-二胺基二苯基酮、1,3-雙(3-胺基苯氧基) 苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯氧基)苯、 3,5-雙(4-胺基苯氧基)安息香酸、4,4’-雙(4-胺基苯氧基) 聯苄、2,2-雙[(4-胺基苯氧基)甲基]丙烷、2,2-雙[4-(4-胺 基苯氧基)苯基]六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基] 丙烷、雙[4-(3-胺基苯氧基)苯基]颯、雙[4-(4-胺基苯氧基) 苯基]颯、1,1-雙(4-胺基苯基)環己烷、α、α’-雙(4-胺基苯 基)-1,4-二異丙基苯、9,9-雙(4-胺基苯基)芴、2,2-雙(3-胺 基苯基)六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、4,4’-二 胺基二苯胺、2,4-二胺基二苯胺、1,8-二胺基萘、1,5-二 胺基萘、1,5-二胺基蔥肽、1,3-二胺基芘、1,6-二胺基 芘、1,8-二胺基芘' 2,7-二胺基芴、1,3-雙(4-胺基苯基)四 甲基二矽氧烷、聯苯胺、2,2’-二甲基聯苯胺、1,2-雙(4-胺 基苯基)乙烷、1,3-雙(4-胺基苯基)丙烷、1,4-雙(4-胺基苯 基)丁烷、1,5-雙(4-胺基苯基)戊烷、1,6-雙(4-胺基苯基) 己烷、1,7-雙(4-胺基苯基)庚烷、1,8-雙(4-胺基苯基)辛 烷、1,9-雙(4_胺基苯基)壬烷、1,10-雙(4-胺基苯基)癸 烷、1,3-雙(4-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁 -21 - 201226390 烷、1,5-雙(4-胺基苯氧基)戊烷、ι,6_雙(4_胺基苯氧基)己 烷、1,7-雙(4-胺基苯氧基)庚烷、ι,8-雙(4 -胺基苯氧基)辛 烷、1,9-雙(4_胺基苯氧基)壬烷、ι,1〇_雙(“胺基苯氧基) 癸烷、二(4-胺基苯基)丙烷-1,3-二酸酯(dioate)、二(4-胺 基苯基)丁烷-1,4-二酸酯、二(4-胺基苯基)戊烷-is二酸 酯、二(4-胺基苯基)己烷-l,6-二酸酯、二(4-胺基苯基)庚 院-1,7 -二酸醋、二(4 -胺基苯基)辛院-1,8 -二酸醋、二(4-胺基苯基)壬烷-1,9-二酸酯、二(4-胺基苯基)癸烷_ι,ι〇-二 酸酯、1,3-雙[4-(4-胺基苯氧基)苯氧基]丙烷、14-雙ΜΗ-胺基苯 氧基)苯 氧基]丁烷、 1,5-雙 [4-(4-胺基苯 氧基) 苯 氧基]戊烷、1,6-雙[4-(4-胺基苯氧基)苯氧基]己烷、1>7_ 雙[4-(4-胺基苯氧基)苯氧基]庚烷、1>8-雙[4_(4_胺基苯氧 基)苯氧基]辛烷、1,9 -雙[4-(4 -胺基苯氧基)苯氧基]壬烷、 1,10-雙[4-(4-胺基苯氧基)苯氧基]癸烷等。 作爲芳香族-脂肪族二胺之例,舉例如3 -胺基苄基 胺、4-胺基苄基胺、3-胺基-N-甲基苄基胺、4-胺基-N-甲 基苄基胺、3-胺基苯乙基胺、4-胺基苯乙基胺、3-胺基-N-甲基苯乙基胺、4-胺基-N-甲基苯乙基胺、3-(3-胺基丙基) 苯胺、4-(3-胺基丙基)苯胺、3-(3-甲基胺基丙基)苯胺、4-(3-甲基胺基丙基)苯胺、3-(4-胺基丁基)苯胺、4-(4-胺基 丁基)苯胺、3-(4-甲基胺基丁基)苯胺、4-(4-甲基胺基丁基) 苯胺、3-(5-胺基戊基)苯胺、4-(5-胺基戊基)苯胺、3-(5-甲基胺基戊基)苯胺、4-(5-甲基胺基戊基)苯胺、2-(6-胺基 萘基)甲基胺、3-(6-胺基萘基)甲基胺、2-(6-胺基萘基)乙 22- 201226390 基胺、3-(6-胺基萘基)乙基胺等。 作爲雜環式二胺類之例,舉例如2,6-二胺基 2,4 -二胺基吡啶、2,4 -二胺基-1,3,5 -三吖畊、2,7 -二 苯并呋喃、3,6-二胺基咔唑、2,4-二胺基-6-異丙基 三吖哄、2,5-雙(4-胺基苯基)-1,3,4-噚二唑等。 作爲脂肪族二胺類之例,舉例如1,2-二胺基 1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊燒 二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、 胺基壬烷、1,1〇-二胺基癸烷、1,3-二胺基-2,2-二 烷、1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-烷、1,9-二胺基_5_甲基庚烷、1,12-二胺基十二烷 二胺基十八烷、1,2-雙(3-胺基丙氧基)乙烷等^ 又,作爲其他二胺,可舉例如於側鏈具有烷基 烷基、芳香環、脂肪族環、雜環、以及由此等所成 狀取代物之二胺化合物。具體可示例如下述式[DA· [DA-30]所示之二胺。 吡啶、 胺基二 -1,3,5 - 乙烷、 ;' 1,6-1,9-二 甲基丙 二甲基 甲基庚 ' 1,18- 、含氟 的大環 .1 ]〜式 -23- 201226390 [化 15]The diamine of the present invention can be obtained by reacting at least one selected from the group consisting of a tetracarboxylic acid and a tetracarboxylic acid derivative to obtain a polyimine precursor precursor of the polyglycolic acid or polyphthalate of the present invention. . The ratio of the diamine of the present invention to the tetracarboxylic acid and the derivative is not particularly limited, and the total molar amount of the tetracarboxylic acid and the derivative is determined as In the case of 1% by mole, the second Φ of the present invention is preferably 5 to 9 5 mol%. As the tetracarboxylic acid derivative, a dianhydride or a tetracarboxylic acid diester dichloride is used to make the tetracarboxylic acid dihalide or the tetracarboxylic acid contain the diamine of the present invention. Further, by reacting the diamine component of the tetracarboxylic acid di-i or the diamine component of E, for example, a tetracarboxylic acid dihalide or a tetracarboxylic acid tetracarboxylic acid diester is appropriately condensed. For example, by reacting a tetracarboxylic acid such as a dianhydride or the derivative with a hydrazine moiety, a polyamine amine dichloride and a diamine carboxylic acid diester containing the present invention and a diamine agent of the present invention or A reaction occurs in the presence of a base to obtain a polyphthalate.尙, in the present specification, the so-called diamine component is used to obtain a polyimine precursor or a polyimine, and a diamine which reacts with at least one selected from a tetracarboxylic acid and a tetracarboxylic acid derivative. The diamine of the present invention may also be used alone or in combination with other diamines. Next, the polyamidiamine precursor is subjected to hydrazine imidization, specifically, the polyglycine is dehydrated and closed, or the polyglycolate is heated by the lettuce, and the ring closure is obtained by promoting the dealcoholization. The polyimine of the present invention. -19-201226390 The polyimine precursors and polyimines of polyglycines and polyphthalates of the present invention are described in more detail below. It is used in a diamine component which is obtained by reacting at least one selected from a tetracarboxylic acid and a tetracarboxylic acid derivative such as the above tetracarboxylic dianhydride to obtain a polyamidene precursor such as polylysine. The content ratio of the diamine of the present invention is not limited. When the polyimine precursor of the present invention or the liquid crystal alignment film obtained by the imidization of the ruthenium iodide is used, the more the content ratio of the diamine of the present invention shown above, the more the storage charge can be obtained. A liquid crystal alignment film that has a low relaxation and a fast charge. In order to accelerate the relaxation of the stored charge, it is preferred that the diamine component is 1 mol% or more of the diamine of the present invention. On the other hand, when other characteristics such as liquid crystal alignment property and pretilt angle characteristics are considered, the content of the diamine component of the present invention in the diamine component used in the polymerization is preferably from 20 to 90 mol%, which is particularly preferable. For 30 to 80 moles. In the above diamine component, when the use of the diamine represented by the formula [1] is less than 100% by mole, the other diamines other than the diamine represented by the formula [1] are not particularly limited. To exemplify the specific example, it is as follows. Examples of the alicyclic diamines include 1,4-diaminocyclohexane, 1,3-diaminocyclohexane, and 4,4'-diaminodicyclohexylmethane 4,4. , -Diamino-3,3'-dimethyldicyclohexylamine, isophorone diamine, and the like. Examples of the aromatic diamines include quinone-phenylenediamine, m-phenylenediamine, P-phenylenediamine, 2,4-diaminotoluene' 2,5-diaminotoluene, and 3,5. -diaminotoluene, 1,4-diamino-2-methoxybenzene, 2,5-diamino-P-xylene, 1,3-diamino-4-chlorobenzene, 3,5 -diamine benzoic acid, iota, 4-diamine-20- 201226390, base-2,5-dichlorobenzene, 4,4'-diamino-1,2-diphenylethane, 4,4' -diamino-2,2'-dimethylbibenzyl, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-diamino Diphenylmethane, 4,4'-diamino-3,3'-dimethyldiphenylmethane, 2,2'-diaminopurine, 4,4'-diaminopurine, 4,4 '-Diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenyl sulfide, 4,4'-diaminodiphenylanthracene, 3,3'-diaminodiphenyl milling, 4,4'-diaminodiphenyl ketone, 1,3-bis(3-aminophenoxy)benzene, 1,3-bis(4- Aminophenoxy)benzene, 1,4-bis(4-aminophenoxy)benzene, 3,5-bis(4-aminophenoxy)benzoic acid, 4,4'-bis (4- Aminophenoxy)bibenzyl, 2,2 - bis[(4-aminophenoxy)methyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-( 4-aminophenoxy)phenyl]propane, bis[4-(3-aminophenoxy)phenyl]anthracene, bis[4-(4-aminophenoxy)phenyl]anthracene, 1 , 1-bis(4-aminophenyl)cyclohexane, α,α'-bis(4-aminophenyl)-1,4-diisopropylbenzene, 9,9-bis(4-amine Phenyl, fluorene, 2,2-bis(3-aminophenyl)hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-diaminodiphenylamine , 2,4-diaminodiphenylamine, 1,8-diaminonaphthalene, 1,5-diaminonaphthalene, 1,5-diamino onion peptide, 1,3-diaminopurine, 1, 6-Diaminoguanidine, 1,8-diaminoguanidine 2,7-diaminoguanidine, 1,3-bis(4-aminophenyl)tetramethyldioxane, benzidine, 2 , 2'-dimethylbenzidine, 1,2-bis(4-aminophenyl)ethane, 1,3-bis(4-aminophenyl)propane, 1,4-bis(4-amine Phenyl)butane, 1,5-bis(4-aminophenyl)pentane, 1,6-bis(4-aminophenyl)hexane, 1,7-bis(4-aminobenzene) Heptane, 1,8-bis(4-aminophenyl)octane 1,9-bis(4-aminophenyl)decane, 1,10-bis(4-aminophenyl)decane, 1,3-bis(4-aminophenoxy)propane, 1 ,4-bis(4-aminophenoxy)butan-21 - 201226390 alkane, 1,5-bis(4-aminophenoxy)pentane, iota, 6-bis(4-aminophenoxy) Hexane, 1,7-bis(4-aminophenoxy)heptane, iota, 8-bis(4-aminophenoxy)octane, 1,9-bis(4-aminophenoxy) Base) decane, ι, 1 〇 _ bis ("aminophenoxy" decane, bis(4-aminophenyl)propane-1,3-dicarboxylate (dioate), di(4-amino) Phenyl)butane-1,4-diester, bis(4-aminophenyl)pentane-is diester, bis(4-aminophenyl)hexane-l,6-dicarboxylate , bis(4-aminophenyl)glycine-1,7-diacid vinegar, bis(4-aminophenyl) xinyuan-1,8-diacid vinegar, bis(4-aminophenyl) Decane-1,9-diester, bis(4-aminophenyl)decane_ι,ι〇-diester, 1,3-bis[4-(4-aminophenoxy)benzene Oxy]propane, 14-bisindole-aminophenoxy)phenoxy]butane, 1,5-bis[4-(4-aminophenoxy)phenoxy]pentane, 1,6 - bis[4-(4-amine Phenoxy)phenoxy]hexane, 1>7_bis[4-(4-aminophenoxy)phenoxy]heptane, 1>8-bis[4_(4-aminophenoxy) Phenoxy]octane, 1,9-bis[4-(4-aminophenoxy)phenoxy]decane, 1,10-bis[4-(4-aminophenoxy)benzene Oxy] decane and the like. As an example of the aromatic-aliphatic diamine, for example, 3-aminobenzylamine, 4-aminobenzylamine, 3-amino-N-methylbenzylamine, 4-amino-N-methyl Benzylamine, 3-aminophenethylamine, 4-aminophenethylamine, 3-amino-N-methylphenethylamine, 4-amino-N-methylphenethylamine , 3-(3-Aminopropyl) aniline, 4-(3-aminopropyl)aniline, 3-(3-methylaminopropyl)aniline, 4-(3-methylaminopropyl) Aniline, 3-(4-aminobutyl)aniline, 4-(4-aminobutyl)aniline, 3-(4-methylaminobutyl)aniline, 4-(4-methylamino group Butyl) aniline, 3-(5-aminopentyl)aniline, 4-(5-aminopentyl)aniline, 3-(5-methylaminopentyl)aniline, 4-(5-methyl Aminopentyl)aniline, 2-(6-aminonaphthyl)methylamine, 3-(6-aminonaphthyl)methylamine, 2-(6-aminonaphthyl)ethyl 22-201226390 Amine, 3-(6-aminonaphthyl)ethylamine, and the like. As examples of the heterocyclic diamines, for example, 2,6-diamino 2,4-diaminopyridine, 2,4-diamino-1,3,5-triterpene, 2,7- Dibenzofuran, 3,6-diaminocarbazole, 2,4-diamino-6-isopropyltriazine, 2,5-bis(4-aminophenyl)-1,3, 4-oxadiazole and the like. Examples of the aliphatic diamines include 1,2-diamino1,3-diaminopropane, 1,4-diaminobutane, and 1,5-diaminopentanediamine. Alkane, 1,7-diaminoheptane, 1,8-diaminooctane, aminodecane, 1,1 -diaminodecane, 1,3-diamino-2,2- Dioxane, 1,6-diamino-2,5-dimethylhexane, 1,7-diamino-2,5-heptane, 1,7-diamino-4,4-dimethyl Heptane, 1,7-diamino-3-alkane, 1,9-diamino-5-methylheptane, 1,12-diaminododecanediamine octadecane, 1, 2-bis(3-aminopropoxy)ethane, etc. Further, examples of the other diamine include an alkylalkyl group, an aromatic ring, an aliphatic ring, a heterocyclic ring, and the like in the side chain. A diamine compound of a substituted substituent. Specifically, a diamine represented by the following formula [DA·[DA-30] can be exemplified. Pyridine, aminodi-1,3,5-ethane, '1,6-1,9-dimethylpropanemethylglycolide 1,18-, fluorine-containing macrocycle.1]~ -23- 201226390 [Chem. 15]
(式中,Rl3示爲碳數1〜22之烷基或含氟烷基,S5示爲 -COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-0-、-CO-、 或-NH-)。 [化 16](wherein Rl3 is represented by an alkyl group having 1 to 22 carbon atoms or a fluorine-containing alkyl group, and S5 is represented by -COO-, -OCO-, -CONH-, -NHCO-, -CH2-, -0-, -CO -, or -NH-). [Chemistry 16]
(式中,s6 示爲-0-、-OCH2-、-CH20-、-COOCH2-、或 -CH2OCO-,R14示爲碳數1〜22之烷基、烷氧基、含氟烷 基或含氟烷氧基)。 [化 17](wherein s6 is represented by -0-, -OCH2-, -CH20-, -COOCH2-, or -CH2OCO-, and R14 is represented by an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a Fluoroalkoxy). [Chem. 17]
-24- 201226390 (式中,s7 示爲-COO-、-OCO-、-CONH-、-NHCO-、 -COOCH2-、-CH2OCO-、-CH20-、-OCH2-、或-CH2-,R15 示爲碳數1〜22之烷基、烷氧基、含氟烷基或含氟烷氧 基)。 [化 18]-24- 201226390 (wherein s7 is shown as -COO-, -OCO-, -CONH-, -NHCO-, -COOCH2-, -CH2OCO-, -CH20-, -OCH2-, or -CH2-, R15 It is an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group). [Chem. 18]
(式中 ’ s8 示爲-COO-、-OCO-、-CONH-、-NHCO-、 -COOCH2- ' -CH2OCO- ' -CH2O- ' -OCH2- ' -CH2- ' -ο- ' 或- NH-,R16示爲氟基、氰基、三氟甲烷基、硝基、偶氮 基、甲醯基、乙醯基、乙醯氧基、或羥基)。 [化 19](where 's8 is shown as -COO-, -OCO-, -CONH-, -NHCO-, -COOCH2- '-CH2OCO- ' -CH2O- ' -OCH2- ' -CH2- ' -ο- ' or - NH -, R16 is represented by a fluoro group, a cyano group, a trifluoromethyl group, a nitro group, an azo group, a decyl group, an ethyl group, an ethoxy group, or a hydroxy group). [Chem. 19]
(式中,R17示爲碳數3〜12之烷基,1,4-伸環己基之順-反 異構性分別爲反體)。 -25- 201226390 [化 20](wherein R17 is represented by an alkyl group having 3 to 12 carbon atoms, and the cis-trans isomerism of 1,4-cyclohexylene is a trans group, respectively). -25- 201226390 [化 20]
在以光進行配向處理時,藉由使上述式Π ]之二胺與 上述[DA-1]〜[DA-30]之二胺併用,可得到更安定之預 傾。作爲倂用的二胺,較佳爲式[DA-10]〜[DA-30],更佳 爲[DA-l〇]〜[DA-l6]之二胺。此等二胺之較佳含有量未特 -26- 201226390 別限定,相對於二胺成分全量,較佳爲5〜50莫耳%,就 印刷性之觀點’較佳爲5〜3 0莫耳%。 又,作爲其他二胺,亦可舉例如以下之二胺。 [化 21]When the alignment treatment with light is carried out, a more stable pretilt can be obtained by using the above-mentioned diamine of the formula [?] with the above-mentioned [DA-1] to [DA-30] diamine. As the diamine to be used, a compound of the formula [DA-10] to [DA-30] is preferred, and a diamine of [DA-l〇]~[DA-l6] is more preferred. The preferred content of such diamines is not limited to -26-201226390, and is preferably 5 to 50 mol% based on the total amount of the diamine component, and is preferably 5 to 30 m from the viewpoint of printability. %. Further, examples of the other diamine include the following diamines. [Chem. 21]
-〇< [DA-31] ' η2Ν Γη2Ν-〇< [DA-31] ' η2Ν Γη2Ν
νη2 [DA-35]Ηη2 [DA-35]
NH2NH2
[DA-38] (式中,i爲0〜3之整數,j爲i〜5之整數)。 藉由導入[DA-31]或[DA-32],可使電壓保持率(VHR) 提昇’又’ [DA-33]〜[DA-38]可使儲存電荷降低。 又’亦可舉例如下述式[DA_ 3 9]所示般之二胺基矽氧 烷等。 -27- 201226390 [化 22] / 9H3\ ?«3 H2N-<CH2h卜甲-0卜-甲-(CH2)3-NH2 (η4 \ CHa/h CH3 [DA'39] (式中,k爲1〜10之整數)。 如此般地,因應在製成液晶配向膜之際之液晶配向 性、電壓保持特性、儲存電荷等之特性,亦可混合1種或 2種以上的其他二胺化合物來使用。 用來得到本發明之聚醯胺酸等之聚醯亞胺前驅物而使 與二胺成分產生反應之四羧酸二酐等四羧酸及該衍生物, 未特別限定。以下舉例該具體例。 作爲具有脂環式構造或脂肪族構造之四羧酸二酐,舉 例如1,2,3,4-環丁烷四羧酸二酐、1,2_二甲基-1,2,3,4-環丁 烷四羧酸二酐、1,3 -二甲基-1,2,3,4_環丁烷四羧酸二酐、 1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊 烷四羧酸二酐、2,3,4,5-四氫呋喃四羧酸二酐、1,2,4,5-環 己烷四羧酸二酐、3,4-二羧基-1 -環己基琥珀酸二酐、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二酐、1,2,3,4-丁烷四羧 酸二酐、雙環[3,3,0]辛烷-2,4,6,8-四羧酸二酐、3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基乙酸二酐、順· 3,7-二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二酐、三環 [4.2.1.02’5]壬烷-3,4,7,8-四羧酸-3,4 : 7,8-二酐、六環 [6.6.0.12’7·03,6.19,14.01()’13]十六烷·4,5,11,12-四羧酸- 4,5 : 11,12-二酐、4-(2,5-二氧代四氫呋喃-3-基)-1,2,3,4-四氫 萘-1,2-二羧酸酐等。[DA-38] (where i is an integer of 0 to 3, and j is an integer of i to 5). By introducing [DA-31] or [DA-32], the voltage holding ratio (VHR) can be increased by 'and' [DA-33]~[DA-38] to lower the stored charge. Further, for example, a diamine oxane or the like as shown by the following formula [DA_39] may be mentioned. -27- 201226390 [化22] / 9H3\ ?«3 H2N-<CH2hb--0------------------ It is an integer of 1 to 10). In this way, one or two or more kinds of other diamine compounds may be mixed in accordance with characteristics such as liquid crystal alignment property, voltage holding property, and storage charge when the liquid crystal alignment film is formed. A tetracarboxylic acid such as a tetracarboxylic dianhydride which is obtained by reacting a polyimine precursor such as polyglycine of the present invention with a diamine component, and the derivative are not particularly limited. Specific examples of the tetracarboxylic dianhydride having an alicyclic structure or an aliphatic structure include, for example, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1, 2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3 -dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetra 1,2-,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,4-dicarboxy-1 -cyclohexyl succinic dianhydride, 3,4-dicarboxy-1,2,3,4-tetra Hydrogen-1-naphthalene succinic dianhydride 1,2,3,4-butane tetracarboxylic dianhydride, bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic dianhydride, 3,3',4,4' -dicyclohexyltetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, cis,3,7-dibutylcyclooctane-1,5-diene-1,2,5, 6-tetracarboxylic dianhydride, tricyclo[4.2.1.02'5]nonane-3,4,7,8-tetracarboxylic acid-3,4: 7,8-dianhydride, hexacyclo[6.6.0.12' 7·03, 6.19, 14.01()'13]hexadecane·4,5,11,12-tetracarboxylic acid-4,5: 11,12-dianhydride, 4-(2,5-dioxotetrahydrofuran -3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic anhydride and the like.
-28- 201226390 更,除了具有上述脂環式構造或脂肪族構造之四羧酸 二酐以外,若使用芳香族四羧酸二酐時,液晶配向性可提 昇,且可使液晶晶胞之儲存電荷降低,故宜。作爲芳香族 四羧酸二酐,舉例如焦蜜石酸二酐、3,3’,4,4’-聯苯基四 羧酸二酐、2,2’,3,3’-聯苯基四羧酸二酐、2,3,3’,4-聯苯基 四羧酸二酐' 3,3’,4,4’-二苯基酮四羧酸二酐、2,3,3’,4-二 苯基酮四羧酸二酐 '雙(3,4-二羧基苯基)醚二酐、雙(3,4-二羧基苯基)颯二酐、1,2,5,6-萘四羧酸二酐、2,3,6,7-萘 四羧酸二酐等。 用來得到本發明之聚醯胺酸酯,而使與二胺成分產生 反應之四羧酸二烷基酯亦未特別限定。以下舉例該具體 例。 作爲脂肪族四羧酸二酯之具體例,舉例如1,2,3,4-環 丁烷四羧酸二烷基酯、1,2-二甲基-1,2,3,4_環丁烷四羧酸 二烷基酯、1,3-二甲基-1,2,3,4-環丁烷四羧酸二烷基酯、 1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二烷基酯、1,2,3,4-環戊烷四羧酸二烷基酯、2,3,4,5-四氫呋喃四羧酸二烷基 酯、1,2,4,5-環己烷四羧酸二烷基酯、3,4-二羧基-1-環己 基琥珀酸二烷基酯、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸 二烷基酯、1,2,3,4-丁烷四羧酸二烷基酯、雙環[3,3,0]辛 烷-2,4,6,8-四羧酸二烷基酯、3,3’,4,4’-二環己基四羧酸二 烷基酯、2,3,5-三羧基環戊基乙酸二烷基酯、順-3,7-二丁 基環辛-1,5-二烯-1,2,5,6-四羧酸二烷基酯、三環 [4.2.1.02’5]壬烷-3,4,7,8-四羧酸-3,4:7,8-二烷基酯、六環 -29- 201226390 [6.6·0.12,7·03’6·19’14·〇1ΰ’13]十六烷 _4,5,11,12-四羧酸-4,5: 11,12-二烷基酯、4-(2,5-二氧代四氫呋喃-3·基)-丨^^,4_四 氫萘-1,2-二殘酸二院基酯等。 作爲芳香族四羧酸二烷基酯,舉例如焦蜜石酸二烷基 酯、3,3,,4,4’ -聯苯基四羧酸二烷基酯、2,2,,3,3’-聯苯基 四羧酸二烷基酯、2,3,3’,4-聯苯基四羧酸二烷基酯、 3,3’,4,4’-二苯基酮四羧酸二烷基酯、2,3,3,,4-二苯基酮四 羧酸二烷基酯、雙(3,4-二羧基苯基)醚二烷基酯、雙(3,4-二羧基苯基)颯二烷基酯、1,2,5,6-萘四羧酸二烷基酯、 2,3,6,7-萘四羧酸二烷基酯等。 尙,藉由使本發明之二胺等之二胺成分與二羧酸產生 反應,亦可合成聚醯胺。用來得到聚醯胺而使與二胺成分 產生反應之二羧酸未特別限定。以下舉例該具體例。 作爲二羧酸或該衍生物之脂肪族二羧酸之具體例,可 舉例如丙二酸、草酸、二甲基丙二酸、琥珀酸、福馬酸、 戊二酸、已二酸、黏康酸、2-甲基已二酸、三甲基已二 酸、庚二酸、2,2-二甲基戊二酸、3 ,3-二乙基琥珀酸、壬 二酸、癸二酸及辛二酸等之二羧酸。 作爲脂環式系之二羧酸,可舉例如1,1-環丙烷二羧 酸、1,2-環丙烷二羧酸、丨,1_環丁烷二羧酸、ι,2-環丁烷 二羧酸、1,3-環丁烷二羧酸、3,4-二苯基-1,2-環丁烷二羧 酸、2,4-二苯基·ι,3_環丁烷二羧酸、1-環丁烯-12—二羧 酸、1-環丁烯·3,4-二羧酸、1,1-環戊烷二羧酸、ΐ,2-環戊 烷二羧酸、1,3-環戊烷二羧酸、1,1-環己烷二羧酸、丨,2_ -30- 201226390 環己垸二羧酸、1,3-環己烷二羧酸、1‘環己烷二羧酸、 1,4-(2-降冰片烯)二羧酸、降冰片烯_2,3_二羧酸、雙環 [2.2.2]辛烷-1,4-二羧酸'雙環[2 2 2]辛烷_2,3_二羧酸、 2,5_二氧代- I,4-雙環[2.2.2]辛烷二羧酸、丨,3·金剛烷二羧 酸、4,8·二氧代_1,3 -金剛烷二羧酸、2,6•螺[3.3]庚烷二羧 酸、1,3-金剛烷二乙酸、樟腦二酸等。 作爲芳香族二羧酸,可舉例如〇_鄰苯二甲酸、異鄰 苯二甲酸、對苯二甲酸、5 -甲基異鄰苯二甲酸、5-tert-丁 基異鄰苯二甲酸、5-胺基異鄰苯二甲酸、5-羥異鄰苯二甲 酸、2,5-二甲基對苯二甲酸、四甲基對苯二甲酸、ι,4-萘 二羧酸、2,5-萘二羧酸、2,6-萘二羧酸、2,7-萘二羧酸、 1,4-蔥二羧酸、l,4-蔥肽二羧酸、2,5_聯苯基二羧酸、 4,4’-聯苯基二羧酸、i,5-伸聯苯基二羧酸、4,4"-聯三苯二 羧酸、4,4’-二苯基甲烷二羧酸、4,4,_二苯基乙烷二羧 酸、4,4’-二苯基丙烷二羧酸、4,4’_二苯基六氟丙烷二羧 酸、4,4’·二苯基醚二羧酸、4,4,-聯苄二羧酸、4,4,-芪二 羧酸、4,4’-二苯乙炔二羧酸、4,4,-羰基二安息香酸、 4,4 ’ -碾基二安息香酸' 4,4 ’ -二硫代二安息香酸、p _伸苯基 二乙酸、3,3’-p -伸苯基二丙酸、4_羧基桂皮酸、p_伸苯基 二丙嫌酸、3,3,-[4,4,-(亞甲基二-卩_伸苯基)]二丙酸、4,4,_ [4,4’_(氧二 _p_ 伸苯基)]二丙酸、4,4,_[4,4,_(·:·ρ^φ* 基)]二丁酸、(異丙烯二-Ρ-伸苯基二氧)二丁酸、雙(ρ_羧基 苯基)二甲基矽烷等之二羧酸。 作爲含有雜環之二羧酸’可舉例如1,5-(9 -芴酮)二羧 • 31 - 201226390 酸、3,4 -呋喃二羧酸、4,5 -噻唑二羧酸、2 -苯基-4,5 -噻唑 二羧酸、1,2,5-噻二唑-3,4-二羧酸、1,2,5-噚二唑-3,4-二 羧酸、2,3-吡啶二羧酸、2,4-吡啶二羧酸、2,5-吡啶二羧 酸、2,6-吡啶二羧酸、3,4-吡啶二羧酸、3,5-吡啶二羧酸 等。 上述的各種二羧酸可爲酸二鹵化物或酐之構造者。此 等之二羧酸類,爲了保持液晶分子之配向性,較佳爲能賦 予直線構造之聚醯胺之二羧酸類。此等之中,又較佳爲對 苯二甲酸、異對苯二甲酸、1,4-環己烷二羧酸、4,4’-聯苯 基二羧酸、4,4’-二苯基甲烷二羧酸、4,4’-二苯基乙烷二 羧酸、4,4’-二苯基丙烷二羧酸、4,4’-二苯基六氟丙烷二 羧酸、2,2-雙(苯基)丙烷二羧酸、4,4"-聯三苯二羧酸、 2,6-萘二羧酸、2,5-吡啶二羧酸或此等之酸二鹵化物等。 此等之化合物中亦有存在著異構性體者,亦可爲含有該等 之混合物。又,可倂用2種以上之化合物。尙,使用於本 發明之二羧酸類,並不限定於上述示例之化合物。. 上述四羧酸二酐等之四羧酸或該衍生物,因應在製成 液晶配向膜之際之液晶配向性、電壓保持特性、儲存電荷 等之特性,可倂用1種或2種以上。 作爲使二胺成分與由四羧酸及四羧酸衍生物所選出之 至少一種產生反應,而得到聚醯胺酸等聚醯亞胺前驅物之 方法,可使用習知的合成手段。 例如’作爲藉由四羧酸二酐與二胺成分之反應,而得 到本發明之聚醯胺酸之方法,舉例如使四羧酸二酐與二胺 -32- 201226390 成分在有機溶媒中產生反應之方法。四羧酸二酐與二胺之 反應,在有機溶媒中相對地較易進行,且在不會產生副生 成物此點爲有利的。 作爲使用於四羧酸二酐與二胺之反應之有機溶媒,只 要是已生成的聚醯胺酸爲溶解者即可,未特別限定。作爲 具體例,舉例如N,N-二甲基甲醯胺、N,N-二甲基乙醯 胺、N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、N-甲基己 內醯胺、二甲亞颯、四甲基尿素、吡啶、二甲基颯、六甲 亞楓、γ-丁內酯 '異丙醇、甲氧基甲基戊醇、二戊烯、乙 基戊基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、甲 基異丙基酮、甲基賽璐蘇 '乙基賽璐蘇、甲基賽璐蘇乙酸 酯、乙基賽璐蘇乙酸酯、丁基卡必醇、乙基卡必醇、乙二 醇、乙二醇單乙酸酯、乙二醇單異丙基醚、乙二醇單丁基 醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲基醚、丙二 醇-tert· 丁基醚、二丙二醇單甲基醚、二乙二醇、二乙二 醇單乙酸酯、二乙二醇二甲基醚、二丙二醇單乙酸酯單甲 基醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二醇 單乙酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單乙酸 酯單丙基醚、3-甲基-3-甲氧基丁基乙酸酯、三丙二醇甲 基醚、3-甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基 醚、二異丁烯、乙酸戊酯、丁酸丁酯、丁基醚、二異丁基 酮、甲基環己烯、丙基醚、二己基醚、二噁烷'η-己烷、 η-戊烷、η-辛烷 '二乙基醚、環已酮、碳酸乙烯酯、碳酸 丙烯酯、乳酸甲酯、乳酸乙酯、乙酸甲酯 '乙酸乙酯、乙 -33- 201226390 酸正丁酯、乙酸丙二醇單乙基醚、丙酮酸甲酯、丙酮酸乙 酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧 基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙 酸丙酯、3-甲氧基丙酸丁酯、二甘二甲醚、4-羥-4-甲基-2-戊酮、3-甲氧基-N,N-二甲基丙烷醯胺、3-乙氧基-N,N-二甲基丙烷醯胺、3-丁氧基-N,N-二甲基丙烷醯胺等。此 等可單獨使用,亦可混合使用。更,即使是無法溶解聚醯 胺酸之溶媒,只要是已生成的聚醯胺酸爲不會析出之範 圍,亦可混合於上述溶媒中使用。又,有機溶媒中之水分 會妨礙聚合反應,進而成爲使已生成的聚醯胺酸水解之原 因,有機溶媒較佳爲使用已盡可能脫水乾燥者。 使四羧酸二酐與二胺成分在有機溶媒中反應之際,可 舉例如使有機溶媒中爲已分散或溶解有二胺成分之溶液攪 拌,將四羧酸二酐成分原樣地添加、或使四羧酸二酐成分 分散或溶解於有機溶媒中再予以添加之方法,相反地,可 舉例如將二胺成分添加於有機溶媒中爲已分散或溶解有四 羧酸二酐成分之溶液之方法、將四羧酸二酐成分與二胺成 分交互地添加之方法等,可使用此等方法之任一。又,若 四羧酸二酐成分或二胺成分爲由複數種之化合物所成時, 能使用已事先混合之狀態使產生反應,或使個別依序產生 反應,更,亦可使已個別反應之低分子量體予以混合反 應,以成爲高分子量體。 此時之縮聚合溫度,可選擇-20〜150°C之任意溫度, 較佳爲-5〜100 °C之範圍。又,縮聚合反應雖然可在任意 -34- 201226390 之濃度下進行’但濃度過低時,會變得難以得到 之聚合物;濃度過高時’反應液之黏性會變得過 之攪拌變得困難,故在反應溶液中四羧酸二酐與 之合s十濃度較佳爲1〜5 〇質量%、更佳爲5〜3 0 反應初期爲以商濃度進行,之後,可追加有機溶 在聚醯胺酸之聚合反應中,四羧酸二酐之合 與二胺成分之合計莫耳數之比(四羧酸二酐之合f 二胺成分之合計莫耳數),較佳爲Oja〗.?。與 聚合反應相同地’此莫耳比越接近1.0時,生成 酸之分子量變得越大。 又’聚醯胺酸酯,將如上述般之四羧酸二酯 與二胺成分之反應、或四羧酸二酯與二胺成分, 當之縮合劑、鹼之存在下使產生反應而可得到。 上述之方法事先合成聚醯胺酸,並利用高分子反 將醯胺酸中之羧酸進行酯化,亦可得到。 具體爲,例如,將四羧酸二酯二氯化物與二 在鹼與有機溶劑之存在下,藉由以-20〜150°C、 〜5 0°C中,使反應30分鐘〜24小時、較佳爲1〜 可合成聚醯胺酸酯。 鹼方面,可使用吡啶、三乙基胺、4-二甲 啶,爲了穩定地進行反應,較佳爲吡啶。鹼之添 容易除去之量,且容易得到高分子量體等觀點而 於四羧酸二酯二氯化物,較佳爲2〜4莫耳倍。 又,在縮合劑之存在下將四羧酸二酯與二胺 高分子量 高,均勻 二胺成分 質量%。 媒。 計莫耳數 十莫耳數/ 通常的縮 的聚醯胺 二氯化物 藉由在適 或,使用 應,藉由 胺化合物 較佳爲〇 • 4小時, 基胺基吡 加量,就 言,相對 成分進行 -35- 201226390 縮聚合反應時,作爲鹼,可使用三苯基亞磷酸酯、二環己 基碳二醯亞胺、1-乙基-3-(3-二甲基胺基丙基)碳二醯亞胺 鹽酸鹽、N,N’-羰基二咪唑、二甲氧基-1,3,5-三畊基甲基 嗎福啉、〇-(苯并三唑-1-基)-N,N,N’,N’-四甲基脲四氟硼 酸酯、0-(苯并三唑-1-基)-Ν,Ν,Ν’,Ν’-四甲基脲六氟磷酸 酯、(2,3-二氫-2-硫基-3-苯并噚唑基)膦酸二苯基、4-(4,6-二甲氧基-1,3,5-三吖哄-2-基)4-甲氧基嗎福啉氯化物-η-水 合物等。 又,在使用上述縮合劑之方法中,藉由添加路易斯酸 作爲添加劑,反應會有效率地進行。作爲路易斯酸,較佳 爲氯化鋰、溴化鋰等之鹵素化鋰。路易斯酸之添加量,相 對於使產生反應之二胺或四羧酸二酯,較佳爲〇」〜1.0 莫耳倍之量。 使用於上述反應之溶媒,可使用與上述所示於合成聚 醯胺酸之際所使用之溶媒爲相同之溶媒,就單體及聚合物 之溶解性而言,較佳爲Ν-甲基-2-吡咯啶酮、γ-丁內酯 等,此等能以1種或混合2種以上使用。合成時之濃度, 就聚合物不易產生析出,且容易得到高分子量體之觀點而 言,在反應溶液中四羧酸二酯二氯化物或四羧酸二酯等之 四羧酸衍生物與二胺成分之合計濃度,較佳爲1〜30質量 %、更佳爲5〜20質量%。又,爲防止四羧酸二酯二氯化 物之水解,使用於聚醯胺酸酯之合成之溶媒,以盡可能爲 已脫水者爲宜,較佳爲在氮氣氛中,以防止外部氣體之混 入。-28- 201226390 Further, in addition to the tetracarboxylic dianhydride having the above alicyclic structure or aliphatic structure, when an aromatic tetracarboxylic dianhydride is used, liquid crystal alignment property can be improved, and liquid crystal cell storage can be performed. The charge is reduced, so it is appropriate. Examples of the aromatic tetracarboxylic dianhydride include pyromellitic dianhydride, 3,3', 4,4'-biphenyltetracarboxylic dianhydride, and 2,2',3,3'-biphenyl. Tetracarboxylic dianhydride, 2,3,3',4-biphenyltetracarboxylic dianhydride '3,3',4,4'-diphenyl ketone tetracarboxylic dianhydride, 2,3,3' , 4-diphenyl ketone tetracarboxylic dianhydride 'bis(3,4-dicarboxyphenyl)ether dianhydride, bis(3,4-dicarboxyphenyl)ruthenic anhydride, 1,2,5,6 - naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, and the like. The polycarboxylic acid ester of the present invention is also used, and the dialkyl tetracarboxylic acid which reacts with the diamine component is also not particularly limited. The specific example is exemplified below. Specific examples of the aliphatic tetracarboxylic acid diester include, for example, 1,2,3,4-cyclobutanetetracarboxylic acid dialkyl ester, 1,2-dimethyl-1,2,3,4-ring. Dialkyl butane tetracarboxylate, dialkyl 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylate, 1,2,3,4-tetramethyl-1 , 2,3,4-cyclobutane tetracarboxylic acid dialkyl ester, 1,2,3,4-cyclopentane tetracarboxylic acid dialkyl ester, 2,3,4,5-tetrahydrofuran tetracarboxylic acid Alkyl ester, dialkyl 1,2,4,5-cyclohexanetetracarboxylate, dialkyl 3,4-dicarboxy-1-cyclohexyl succinate, 3,4-dicarboxy-1, Dialkyl 2,3,4-tetrahydro-1-naphthalene succinate, dialkyl 1,2,3,4-butanetetracarboxylate, bicyclo[3,3,0]octane-2, Dialkyl 4,6,8-tetracarboxylate, dialkyl 3,3',4,4'-dicyclohexyltetracarboxylate, dialkyl 2,3,5-tricarboxycyclopentylacetate Ester, cis-3,7-dibutylcyclooctane-1,5-diene-1,2,5,6-tetracarboxylic acid dialkyl ester, tricyclo[4.2.1.02'5]nonane-3 ,4,7,8-tetracarboxylic acid-3,4:7,8-dialkyl ester,hexacyclic-29- 201226390 [6.6·0.12,7·03'6·19'14·〇1ΰ'13] Hexadecane-4,5,11,12-tetracarboxylic acid-4,5:11,12-dialkyl ester, 4-(2,5-dioxotetrahydrofuran -3-3·yl)-丨^^, 4_tetrahydronaphthalene-1,2-di-residual acid, di-linyl ester, and the like. As the aromatic dicarboxylic acid dialkyl ester, for example, dialkyl pyrethinate, 3,3,4,4'-biphenyltetracarboxylic acid dialkyl ester, 2, 2, 3, Dialkyl 3'-biphenyltetracarboxylate, dialkyl 2,3,3',4-biphenyltetracarboxylate, 3,3',4,4'-diphenyl ketone tetracarboxylate Dialkyl acid ester, dialkyl 2,3,3,4-diphenyl ketone tetracarboxylate, bis(3,4-dicarboxyphenyl)ether dialkyl ester, bis(3,4- Dicarboxyphenyl) decyl dialkyl ester, 1,2,5,6-naphthalene tetracarboxylic acid dialkyl ester, 2,3,6,7-naphthalene tetracarboxylic acid dialkyl ester, and the like. Further, polyamine can be synthesized by reacting a diamine component such as a diamine of the present invention with a dicarboxylic acid. The dicarboxylic acid used to obtain the polyamine to react with the diamine component is not particularly limited. This specific example is exemplified below. Specific examples of the dicarboxylic acid or the aliphatic dicarboxylic acid of the derivative include malonic acid, oxalic acid, dimethylmalonic acid, succinic acid, fumaric acid, glutaric acid, adipic acid, and bismuth. Acid, 2-methyl adipic acid, trimethyl adipic acid, pimelic acid, 2,2-dimethylglutaric acid, 3,3-diethyl succinic acid, azelaic acid, sebacic acid and Dicarboxylic acid such as suberic acid. Examples of the alicyclic dicarboxylic acid include 1,1-cyclopropanedicarboxylic acid, 1,2-cyclopropanedicarboxylic acid, hydrazine, 1-cyclobutanedicarboxylic acid, and ι,2-cyclobutylene. Alkanedicarboxylic acid, 1,3-cyclobutanedicarboxylic acid, 3,4-diphenyl-1,2-cyclobutanedicarboxylic acid, 2,4-diphenyl·ι, 3-cyclobutane Dicarboxylic acid, 1-cyclobutene-12-dicarboxylic acid, 1-cyclobutene·3,4-dicarboxylic acid, 1,1-cyclopentanedicarboxylic acid, anthracene, 2-cyclopentanedicarboxylate Acid, 1,3-cyclopentanedicarboxylic acid, 1,1-cyclohexanedicarboxylic acid, hydrazine, 2_ -30- 201226390 cyclohexyl dicarboxylic acid, 1,3-cyclohexane dicarboxylic acid, 1 'Cyclohexanedicarboxylic acid, 1,4-(2-norbornene) dicarboxylic acid, norbornene 2,3-dicarboxylic acid, bicyclo[2.2.2]octane-1,4-dicarboxyl Acid 'bicyclo[2 2 2]octane-2,3-dicarboxylic acid, 2,5-dioxo-I,4-bicyclo[2.2.2]octanedicarboxylic acid, anthracene, 3·adamantane Carboxylic acid, 4,8-dioxo-1,3-adamantane dicarboxylic acid, 2,6-spiro[3.3]heptane dicarboxylic acid, 1,3-adamantane diacetic acid, camphoric acid, and the like. Examples of the aromatic dicarboxylic acid include hydrazine phthalic acid, isophthalic acid, terephthalic acid, 5-methylisophthalic acid, and 5-tert-butyl isophthalic acid. 5-aminoisophthalic acid, 5-hydroxyisophthalic acid, 2,5-dimethylterephthalic acid, tetramethylterephthalic acid, iota, naphthalene dicarboxylic acid, 2, 5-naphthalene dicarboxylic acid, 2,6-naphthalene dicarboxylic acid, 2,7-naphthalene dicarboxylic acid, 1,4- onion dicarboxylic acid, 1,4- onion peptide dicarboxylic acid, 2,5-biphenyl Dicarboxylic acid, 4,4'-biphenyldicarboxylic acid, i,5-extended biphenyl dicarboxylic acid, 4,4"-biphenyldicarboxylic acid, 4,4'-diphenylmethane Dicarboxylic acid, 4,4,-diphenylethane dicarboxylic acid, 4,4'-diphenylpropane dicarboxylic acid, 4,4'-diphenylhexafluoropropane dicarboxylic acid, 4,4' Diphenyl ether dicarboxylic acid, 4,4,-bibenzyldicarboxylic acid, 4,4,-indole dicarboxylic acid, 4,4'-diphenylacetylene dicarboxylic acid, 4,4,-carbonyl dibenzoin Acid, 4,4 '-millyl dibenzoic acid '4,4 '-dithiodibenzoic acid, p _phenylenediacetic acid, 3,3'-p-phenylenedipropionic acid, 4-carboxyl Cinnamic acid, p_phenylene dipropylene acid, 3,3,-[4,4 -(methylenedi-fluorene-phenylene)]dipropionic acid, 4,4,_[4,4'-(oxydi-p_phenylene)dipropionic acid, 4,4,_[4 , 4, _(·:·ρ^φ* base)]dibutyric acid, (isopropene di-fluorene-phenylene dioxy)dibutyric acid, bis(ρ-carboxyphenyl)dimethyl decane, etc. Dicarboxylic acid. The dicarboxylic acid containing a heterocyclic ring may, for example, be 1,5-(9-fluorenone)dicarboxyl 31 - 201226390 acid, 3,4-furan dicarboxylic acid, 4,5-thiazole dicarboxylic acid, 2 - Phenyl-4,5-thiazole dicarboxylic acid, 1,2,5-thiadiazole-3,4-dicarboxylic acid, 1,2,5-oxadiazole-3,4-dicarboxylic acid, 2, 3-pyridinedicarboxylic acid, 2,4-pyridinedicarboxylic acid, 2,5-pyridinedicarboxylic acid, 2,6-pyridinedicarboxylic acid, 3,4-pyridinedicarboxylic acid, 3,5-pyridinedicarboxylic acid Acid, etc. The various dicarboxylic acids described above may be the construct of an acid dihalide or anhydride. In order to maintain the alignment property of the liquid crystal molecules, these dicarboxylic acids are preferably dicarboxylic acids of a polyamine which can impart a linear structure. Among these, terephthalic acid, isoterephthalic acid, 1,4-cyclohexanedicarboxylic acid, 4,4'-biphenyldicarboxylic acid, 4,4'-diphenyl are preferred. Methane dicarboxylic acid, 4,4'-diphenylethane dicarboxylic acid, 4,4'-diphenylpropane dicarboxylic acid, 4,4'-diphenylhexafluoropropane dicarboxylic acid, 2, 2-bis(phenyl)propane dicarboxylic acid, 4,4"-biphenyldicarboxylic acid, 2,6-naphthalenedicarboxylic acid, 2,5-pyridinedicarboxylic acid or such acid dihalides . There are also isomers present in such compounds, and mixtures containing such may also be present. Further, two or more kinds of compounds can be used. The dicarboxylic acid used in the present invention is not limited to the above-exemplified compounds. The tetracarboxylic acid or the like of the above-mentioned tetracarboxylic dianhydride or the like may be one or more selected from the group consisting of liquid crystal alignment properties, voltage retention characteristics, and storage charges when the liquid crystal alignment film is formed. . A conventional synthesis means can be used as a method of reacting a diamine component with at least one selected from a tetracarboxylic acid and a tetracarboxylic acid derivative to obtain a polyimine precursor such as polyglycine. For example, as a method for obtaining the polyproline of the present invention by a reaction of a tetracarboxylic dianhydride with a diamine component, for example, a tetracarboxylic dianhydride and a diamine-32-201226390 component are produced in an organic solvent. The method of reaction. The reaction of tetracarboxylic dianhydride with a diamine is relatively easy to carry out in an organic solvent, and it is advantageous in that no by-products are produced. The organic solvent used for the reaction of the tetracarboxylic dianhydride and the diamine is not particularly limited as long as the produced polyamic acid is dissolved. Specific examples include N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, and N-ethyl-2-pyrrolidone. N-methyl caprolactam, dimethyl hydrazine, tetramethyl urea, pyridine, dimethyl hydrazine, hexamethine, γ-butyrolactone 'isopropanol, methoxymethylpentanol, dipentane Alkene, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, methyl cytosine 'ethyl acesulfame, methyl ace Subacetate, ethyl cyproterone acetate, butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol Monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol-tert. butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethyl Glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, Dipropylene glycol monoacetate monopropyl ether, 3-methyl 3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, pentane acetate Ester, butyl butyrate, butyl ether, diisobutyl ketone, methyl cyclohexene, propyl ether, dihexyl ether, dioxane 'η-hexane, η-pentane, η-octane' Diethyl ether, cyclohexanone, ethylene carbonate, propylene carbonate, methyl lactate, ethyl lactate, methyl acetate 'ethyl acetate, B-33-201226390 n-butyl acid acetate, propylene glycol monoethyl ether, Methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, diglyme, 4-hydroxy-4-methyl-2-pentanone, 3- Methoxy-N,N-dimethylpropane decylamine, 3-ethoxy-N,N-dimethylpropane decylamine, 3-butoxy-N,N-dimethylpropane decylamine, and the like. These can be used alone or in combination. Further, even if the solvent of the polyamine acid cannot be dissolved, it may be used in the above solvent as long as it is a range in which the produced polyamic acid does not precipitate. Further, the water in the organic solvent hinders the polymerization reaction and further causes hydrolysis of the produced polylysine, and the organic solvent is preferably dried as far as possible. When the tetracarboxylic dianhydride and the diamine component are reacted in an organic solvent, for example, a solution in which the diamine component is dispersed or dissolved in the organic solvent is stirred, and the tetracarboxylic dianhydride component is added as it is, or A method in which a tetracarboxylic dianhydride component is dispersed or dissolved in an organic solvent, and a method of adding a diamine component to an organic solvent as a solution in which a tetracarboxylic dianhydride component has been dispersed or dissolved is exemplified. As a method, a method of adding a tetracarboxylic dianhydride component and a diamine component alternately, etc., any of these methods can be used. Further, when the tetracarboxylic dianhydride component or the diamine component is formed of a plurality of compounds, the reaction can be carried out in a state of being mixed beforehand, or the reaction can be carried out in an individual order, or the individual reaction can be carried out. The low molecular weight body is subjected to a mixing reaction to become a high molecular weight body. The polycondensation temperature at this time may be any temperature of from -20 to 150 ° C, preferably from -5 to 100 ° C. Further, the polycondensation reaction can be carried out at any concentration of -34 to 201226390, but when the concentration is too low, the polymer becomes difficult to obtain; when the concentration is too high, the viscosity of the reaction solution becomes excessively agitated. If it is difficult, the tetracarboxylic dianhydride and the s ten concentration in the reaction solution are preferably 1 to 5 〇 mass%, more preferably 5 to 3 0. The initial stage of the reaction is carried out at a commercial concentration, and then an organic solvent may be added. In the polymerization reaction of polyamic acid, the ratio of the total number of moles of the combination of the tetracarboxylic dianhydride and the diamine component (the total number of moles of the diamine component of the tetracarboxylic dianhydride and the diamine component) is preferably Oja〗.? . The same as the polymerization reaction, the closer the molar ratio is to 1.0, the larger the molecular weight of the acid produced becomes. Further, a polyglycolate is a reaction between a tetracarboxylic acid diester and a diamine component as described above, or a tetracarboxylic acid diester and a diamine component, and a reaction is carried out in the presence of a condensing agent or a base. get. The above method can also be obtained by synthesizing polylysine in advance and esterifying the carboxylic acid in valeric acid with a polymer. Specifically, for example, the reaction of the tetracarboxylic acid diester dichloride with two in the presence of a base and an organic solvent is carried out at -20 to 150 ° C to 405 ° C for 30 minutes to 24 hours. Preferably, it is a 1~ synthesizable polyphthalate. As the base, pyridine, triethylamine or 4-dimethylpyridine can be used, and in order to carry out the reaction stably, pyridine is preferred. The addition of the base is easy to remove, and it is easy to obtain a high molecular weight body or the like, and the tetracarboxylic acid diester dichloride is preferably 2 to 4 moles. Further, the tetracarboxylic acid diester and the diamine have a high molecular weight and a uniform diamine component mass% in the presence of a condensing agent. Media. Counting moles of tens of moles / usually shrinking polyamine dichloride by means of appropriate or suitable, by means of the amine compound preferably 〇 4 hours, the amount of amide is added, in other words, When the relative component is -35- 201226390, in the polycondensation reaction, as the base, triphenylphosphite, dicyclohexylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl) can be used. Carboximide hydrochloride, N,N'-carbonyldiimidazole, dimethoxy-1,3,5-tri-n-methyl-m-propofolin, 〇-(benzotriazol-1-yl) )-N,N,N',N'-tetramethylurea tetrafluoroborate, 0-(benzotriazol-1-yl)-oxime, hydrazine, Ν', Ν'-tetramethylurea Fluorophosphate, diphenyl (2,3-dihydro-2-thio-3-benzoxazolyl)phosphonic acid, 4-(4,6-dimethoxy-1,3,5-tri Ind-2-yl) 4-methoxymorpholine chloride-η-hydrate and the like. Further, in the method of using the above condensing agent, the reaction proceeds efficiently by adding a Lewis acid as an additive. The Lewis acid is preferably lithium halide such as lithium chloride or lithium bromide. The amount of the Lewis acid to be added is preferably 〇" to 1.0 mol" relative to the diamine or tetracarboxylic acid diester which causes the reaction. The solvent used in the above reaction may be the same solvent as that used in the above-mentioned synthesis of polyamic acid. The solubility of the monomer and the polymer is preferably Ν-methyl- 2-pyrrolidone, γ-butyrolactone, and the like, and these may be used alone or in combination of two or more. The concentration at the time of synthesis is a tetracarboxylic acid derivative such as a tetracarboxylic acid diester dichloride or a tetracarboxylic acid diester and a second in the reaction solution insofar as the polymer is less likely to be precipitated and a high molecular weight body is easily obtained. The total concentration of the amine component is preferably from 1 to 30% by mass, more preferably from 5 to 20% by mass. Further, in order to prevent hydrolysis of the tetracarboxylic acid diester dichloride, it is preferred to use a solvent for the synthesis of the polyphthalate to be dehydrated as much as possible, preferably in a nitrogen atmosphere to prevent external gases. Mix in.
36- 201226390 本發明之聚醯亞胺,係藉由使上述聚醯胺酸脫水閉環 而得到。在本發明之聚醯亞胺中,醯胺酸基之脫水閉環率 (醯亞胺化率)並非一定要1 00%,因應用途或目的可任意 進行調整。 作爲使聚醯胺酸醯亞胺化之方法,舉例如將聚醯胺酸 之溶液依原樣地進行加熱之熱醯亞胺化、將觸媒添加於聚 醯胺酸之溶液之觸媒醯亞胺化。 使聚醯胺酸在溶液中進行熱醯亞胺化時之溫度爲1 00 〜400t、較佳爲120〜250°c,將因醯亞胺化反應所生成 的水一邊排除至系外一邊予以進行之方法爲宜。 聚醯胺酸之觸媒醯亞胺化,可將鹼性觸媒與酸酐添加 於聚醯胺酸之溶液中,並藉由-2 0〜25(TC、較佳爲0〜 1 8 0°C之攪拌來予以進行》鹼性觸媒之量,爲醯胺酸基之 0.5〜30莫耳倍、較佳爲2〜20莫耳倍;酸酐之量,爲醯 胺酸基之1〜5 0莫耳倍、較佳爲3〜3 0莫耳倍。作爲鹼性 觸媒,可舉例如吡啶、三乙基胺、三甲基胺、三丁基胺、 三辛基胺等,之中又以吡啶,因爲具有使反應進行之適度 鹼性,故宜。作爲酸酐,可舉例如乙酸酐、偏苯三酸酐、 焦蜜石酸酐等,之中有以使用乙酸酐時,因爲反應結束後 之純化變得容易,故宜。藉由觸媒醯亞胺化之醯亞胺化 率,可藉由調節觸媒量、反應溫度、反應時間而予以控 制。 又,如上述般,藉由將聚醯胺酸酯以高溫進行加熱’ 並促使脫醇使閉環,亦可得到聚醯亞胺。 -37- 201226390 尙,由聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、 或聚醯亞胺之反應溶液,將生成的聚醯胺酸、聚醯胺酸 酯、聚醯亞胺等回收時,只要將反應溶液投入於弱溶劑中 使沈澱即可。作爲使用於沈澱之弱溶劑,可舉例如甲醇、 丙酮、己烷、丁基賽璐蘇、庚烷、甲基乙基酮、甲基異丁 基酮、乙醇、甲苯、苯、水等。投入於弱溶劑中使沈澱的 聚醯亞胺前驅物或聚醯亞胺,在進行過濾回收後,於常壓 或減壓下,能以常溫或加熱予以乾燥。又,將沈澱回收後 的聚醯亞胺前驅物或聚醯亞胺重覆2〜10次之使再溶解於 有機溶媒中並進行再沈澱回收之操作時,可減少聚合物中 之雜質。作爲此時的弱溶劑,例如,舉例如醇類、酮類、 烴等,若使用由此等之中所選出的3種以上之弱溶劑時, 因爲純化之效率會更進一步之提昇,故宜。 本發明之液晶配向劑中所含有的聚醯胺酸、聚醯胺酸 酯等之聚醯亞胺前驅物或聚醯亞胺之分子量,若考量所得 到塗膜之強度、塗膜形成時之作業性、及塗膜之均勻性 時,以 GPC(Gel Permeation Chromatography)法所測定的 重量平均分子量,較佳爲 5,000〜1,〇〇〇,〇〇〇、更佳爲 1 0,000 〜1 50,000 ° 本發明之上述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前 驅物及聚醯亞胺,可與溶媒共同使用而製成液晶配向劑。 所謂的液晶配向劑係用來形成液晶配向膜之溶液,爲將用 來形成液晶配向膜之聚合物成分分散或溶解於有機溶媒中 之溶液。尙,所謂的液晶配向膜,係用來使液晶配向於指36-201226390 The polyimine of the present invention is obtained by dehydrating and ring-closing the above polyamic acid. In the polyimine of the present invention, the dehydration ring closure ratio of the valine group is not necessarily 100%, and can be arbitrarily adjusted depending on the purpose or purpose. As a method for imidizing polyphosphonium amide, for example, a solution in which a solution of polyproline is heated as it is is imidized, and a catalyst is added to a solution of polylysine. Amination. The temperature at which the polyaminic acid is thermally imidized in the solution is from 100 to 400 t, preferably from 120 to 250 ° C, and the water formed by the imidization reaction is removed to the outside of the system. The method carried out is suitable. The catalyst of the polyaminic acid is imidized, and the basic catalyst and the acid anhydride are added to the solution of the poly-proline, and the ratio is -2 0 to 25 (TC, preferably 0 to 180 °) The amount of the alkaline catalyst is 0.5 to 30 moles, preferably 2 to 20 moles, of the prolyl group; the amount of the anhydride is 1 to 5 of the amidate group. 0 moles, preferably 3 to 30 moles. Examples of the basic catalyst include pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine, and the like. Further, pyridine is preferred because it has a moderate basicity for carrying out the reaction. Examples of the acid anhydride include acetic anhydride, trimellitic anhydride, and pyrogallic anhydride. Among them, when acetic anhydride is used, purification after completion of the reaction is changed. It is easy to use, and it is preferable to control the imidization ratio of the imidization of the catalyst by adjusting the amount of the catalyst, the reaction temperature, and the reaction time. Further, as described above, by using polyamine The acid ester is heated at a high temperature' and promotes the dealcoholization to close the ring, and the polyimine is also obtained. -37- 201226390 尙, agglomerated by poly-proline, polylysine, etc. When the reaction solution of the imine precursor or the polyimine is recovered by collecting the produced polyamine, polyphthalate, polyimine or the like, the reaction solution may be placed in a weak solvent to precipitate. Examples of the weak solvent used for precipitation include methanol, acetone, hexane, butyl cyanisol, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water, and the like. The precipitated polyimide precursor or polyimine in a weak solvent can be dried at room temperature or under normal pressure or reduced pressure after being subjected to filtration and recovery, and the precipitated polycondensate is recovered. When the imine precursor or the polyimine is repeated for 2 to 10 times to be redissolved in an organic solvent and subjected to reprecipitation recovery, impurities in the polymer can be reduced. As a weak solvent at this time, for example, for example When three or more kinds of weak solvents selected from the above are used, such as alcohols, ketones, hydrocarbons, etc., since the efficiency of purification is further improved, it is preferably contained in the liquid crystal alignment agent of the present invention. Polyimine, polyamidomate, etc. The molecular weight of the precursor or the polyimine, and the weight average molecular weight measured by the GPC (Gel Permeation Chromatography) method, in consideration of the strength of the coating film obtained, the workability at the time of formation of the coating film, and the uniformity of the coating film. Preferably, it is 5,000 〜1, 〇〇〇, 〇〇〇, more preferably 10,000 〜1 50,000 ° The polyimine precursor of the above polylysine, polyphthalate, etc. of the present invention and poly phthalate The amine can be used together with a solvent to form a liquid crystal alignment agent. The so-called liquid crystal alignment agent is a solution for forming a liquid crystal alignment film, and is a solution for dispersing or dissolving a polymer component for forming a liquid crystal alignment film in an organic solvent.尙, the so-called liquid crystal alignment film, used to make the liquid crystal alignment
•38- 201226390 定方向之膜。然後,在本發明中,作爲上述聚合物成分, 含有由本發明之上述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺 前驅物及聚醯亞胺所選出之至少一種》 在本發明之液晶配向劑中,所含有的聚合物成分可全 數爲本發明之上述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前 驅物或聚醯亞胺,又,亦可混合其他聚合物於本發明之上 述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物或聚醯亞胺 中。作爲聚合物成分若爲含有其他聚合物時,聚合物成分 全量之其他聚合物之含有量爲0.5質量%〜50質量%、較 佳爲1質量%〜30質量%。藉由成爲複數種聚合物之混合 物,可使液晶配向劑或液晶配向膜之特性提昇。 作爲如此般之其他聚合物,例如,作爲使與四羧酸二 酐成分產生反應之二胺成分,舉例如使用本發明之上述式 [1 ]所示二胺以外之二胺所得到的聚醯胺酸、聚醯胺酸酯 或聚醯亞胺等。 在液晶配向劑中,由本發明之上述聚醯胺酸、聚醯胺 酸酯等之聚醯亞胺前驅物及聚醯亞胺所選出之至少一種, 及視必要性所進行混合之其他聚合物之含有比例,就聚合 物成分全量較佳爲1質量%〜20質量%、更佳爲3質量% 〜1 5質量%、特佳爲3〜1 0質量%。 使用於本發明之液晶配向劑之溶媒,只要是使聚合物 成分溶解之有機溶媒即可,無特別限定。作爲該具體例, 舉例如Ν,Ν-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2 -吡咯啶酮、N -甲基己內醯胺、2 -吡咯啶酮、N -乙基吡咯•38- 201226390 Directional film. Then, in the present invention, at least one selected from the above-mentioned polymer component, the polyimine precursor such as polylysine or polylysine of the present invention, and polyimine is selected in the present invention. In the liquid crystal alignment agent, all of the polymer components contained in the present invention may be the polyimine precursors such as polylysine or polylysine of the present invention or polyimine, or may be mixed with other polymerizations. The present invention is used in the polyimine precursor or polyimine of the above polylysine, polyphthalate or the like of the present invention. When the polymer component contains another polymer, the content of the other polymer in the total amount of the polymer component is from 0.5% by mass to 50% by mass, preferably from 1% by mass to 30% by mass. By forming a mixture of a plurality of polymers, the characteristics of the liquid crystal alignment agent or the liquid crystal alignment film can be improved. As such a polymer, for example, a diamine component which reacts with a tetracarboxylic dianhydride component, for example, a polyamine obtained by using a diamine other than the diamine represented by the above formula [1] of the present invention. Amine acid, polyphthalate or polyimine. In the liquid crystal alignment agent, at least one selected from the above-mentioned polyamidamine precursors such as polylysine, polylysine, and polyimine, and other polymers which are mixed as necessary. The content of the polymer component is preferably from 1% by mass to 20% by mass, more preferably from 3% by mass to 15% by mass, even more preferably from 3 to 10% by mass, based on the total amount of the polymer component. The solvent to be used in the liquid crystal alignment agent of the present invention is not particularly limited as long as it is an organic solvent that dissolves the polymer component. As such a specific example, for example, hydrazine, dimethyl-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, 2 -pyrrolidone, N-ethylpyrrole
S -39- 201226390 啶酮、N-乙烯基吡咯啶酮 '二甲亞颯、四甲基尿素、吡 啶、二甲基颯、六甲亞楓、γ-丁內酯、3 -甲氧基-N,N -二 甲基丙烷醯胺、3-乙氧基-N,N-二甲基丙烷醯胺、3-丁氧 基-N,N-二甲基丙烷醯胺、1,3-二甲基-咪唑啶酮、乙基戊 基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、甲基異 丙基酮、環已酮、碳酸乙烯酯、碳酸丙烯酯、二甘二甲 醚、4-羥-4-甲基-2-戊酮等。此等能以單獨使用,或混合 後使用。 本發明之液晶配向劑,亦可含有上述以外之成分。作 爲該例,有將液晶配向劑塗佈之際,使膜厚均勻性或表面 平滑性提昇之溶媒或化合物、使液晶配向膜與基板之密著 性提昇之化合物等。 作爲使膜厚之均勻性或表面平滑性提昇之溶媒(弱溶 劑)之具體例,例如,異丙醇、甲氧基甲基戊醇、甲基賽 璐蘇、乙基賽璐蘇、丁基賽璐蘇、甲基賽璐蘇乙酸酯、乙 基賽璐蘇乙酸酯、丁基卡必醇、乙基卡必醇、乙基卡必醇 乙酸酯、乙二醇、乙二醇單乙酸酯、乙二醇單異丙基醚、 乙二醇單丁基醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲 基醚、丙二醇-tert-丁基醚、二丙二醇單甲基醚、二乙二 醇、二乙二醇單乙酸酯、二乙二醇二甲基醚、二丙二醇單 乙酸酯單甲基醚、二丙二醇單甲基醚、二丙二醇單乙基 醚、二丙二醇單乙酸酯單乙基醚、二丙二醇單丙基醚、二 丙二醇單乙酸酯單丙基醚、3 -甲基-3 -甲氧基丁基乙酸 酯、三丙二醇甲基醚、3 -甲基-3-甲氧基丁醇、二異丙基 -40- 201226390 醚、乙基異丁基醚、二異丁烯、乙酸戊酯、丁酸丁酯、丁 基醚、二異丁基酮、甲基環己烯、丙基醚、二己基醚、1-己醇、η-己烷、η-戊烷、η-辛烷、二乙基醚、乳酸甲酯、 乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙酸丙二 醇單乙基醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲 酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧 基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙 酸丁酯、1-甲氧基-2-丙醇、1-乙氧基-2-丙醇、1-丁氧基-2-丙醇、1-苯氧基-2-丙醇、丙二醇單乙酸酯、丙二醇二乙 酸酯、丙二醇-1-單甲基醚-2-乙酸酯、丙二醇-1-單乙基 醚-2-乙酸酯、二丙二醇、2-(2-乙氧基丙氧基)丙醇、乳酸 甲基酯、乳酸乙基酯、乳酸η-丙基酯、乳酸η-丁基酯、 乳酸異戊基酯等具有低表面張力之溶媒等。 此等弱溶劑,能以1種或混合複數種予以使用。使用 如上述之溶媒時,較佳爲液晶配向處理劑中所含有全體溶 媒之5〜80質量%、更佳爲20〜60質量%。 作爲使膜厚之均勻性或表面平滑性提昇之化合物,舉 例如氟系界面活性劑、聚矽氧系界面活性劑、非離子系界 面活性劑等。更具體地,例如,舉例如 F - Τ ο p E F 3 0 1、 EF3 03、EF352(Tokem Products 公司製)、MEGAFACE F171、F173、R-30(DIC 公司製)、Fluorad FC43 0、 FC431(住友 3M 公司製)、AashiGuard AG710、Surflon S-3 8 2、SC101、SC 102 ' SC 103 ' SC104、SC105、SC106(旭 硝子公司製)等。此等界面活性劑之使用比例,相對於液 -41 - 201226390 晶配向劑中所含有樹脂成分之100質量份,較佳爲0.01〜 2質量份、更佳爲0.01〜1質量份。 作爲使液晶配向膜與基板之密著性提昇之化合物之具 體例,例如,舉例如3 -胺基丙基三甲氧基矽烷、3 -胺基丙 基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基 三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽 烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲 基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧 基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基 丙基三乙氧基矽烷、N-三乙氧基矽基丙基三乙烯三胺、N-三甲氧基矽基丙基三乙烯三胺、10-三甲氧基矽基-1,4,7-三吖癸烷、10-三乙氧基矽基-1,4,7-三吖癸烷、9-三甲氧 基矽基-3,6-二吖壬基乙酸酯、9-三乙氧基矽基-3,6-二吖壬 基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N-苄基- 3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽 烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧乙烯)-3· 胺基丙基三甲氧基矽烷、N-雙(氧乙烯)-3-胺基丙基三乙氧 基矽烷、乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、 丙二醇二縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇 二縮水甘油醚、新戊二醇二縮水甘油醚、1,6-己二醇二縮 水甘油醚、甘油二縮水甘油醚、2,2·二溴新戊二醇二縮水 甘油醚、1,3,5,6-四縮水甘油基-2,4-己二醇、1^,1^,:^,,>^’-四縮水甘油基-m-二甲苯二胺、1,3-雙(N,N-二縮水甘油胺 基甲基)環己烷、义:^:^’々’-四縮水甘油基-4,4’-二胺基二 -42- 201226390 本基甲院等之含有官㈤性砂院之化合物或含有環氧基之化 合物等。 更,除了基板與膜之密著性提昇外,以防止因背光之 電氣特性之降低等目的’液晶配向處理劑中亦可含有如以 下之酚醛塑料(phenoplast)系添加劑。具體的酚醛塑料系 添加劑如以下所示,但不限定於此構造。 [化 23]S -39- 201226390 ketone, N-vinylpyrrolidone 'dimethyl hydrazine, tetramethyl urea, pyridine, dimethyl hydrazine, hexamethine, γ-butyrolactone, 3-methoxy-N , N-dimethylpropane decylamine, 3-ethoxy-N,N-dimethylpropane decylamine, 3-butoxy-N,N-dimethylpropane decylamine, 1,3-dimethyl Base-imidazolidinone, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, propylene carbonate, Diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These can be used alone or in combination. The liquid crystal alignment agent of the present invention may contain components other than the above. In this case, there is a solvent or a compound which improves film thickness uniformity or surface smoothness when a liquid crystal alignment agent is applied, and a compound which improves the adhesion between the liquid crystal alignment film and the substrate. Specific examples of the solvent (weak solvent) for improving the uniformity of the film thickness or the smoothness of the surface, for example, isopropyl alcohol, methoxymethylpentanol, methyl ceramide, ethyl ceramide, butyl Celluloid, methyl cyanoacetate, ethyl cyproterone acetate, butyl carbitol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol Monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol-tert-butyl ether, dipropylene glycol monomethyl ether , diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, two Propylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl-40- 201226390 ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, butyl ether, diiso Ketone, methylcyclohexene, propyl ether, dihexyl ether, 1-hexanol, η-hexane, η-pentane, η-octane, diethyl ether, methyl lactate, ethyl lactate, Methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether acetate, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, methyl 3-ethoxypropionate Ester, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, 1- Methoxy-2-propanol, 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-phenoxy-2-propanol, propylene glycol monoacetate, propylene glycol II Acetate, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2-acetate, dipropylene glycol, 2-(2-ethoxypropoxy)propane A solvent having a low surface tension, such as an alcohol, methyl lactate, ethyl lactate, η-propyl lactate, η-butyl lactate or isoamyl lactate. These weak solvents can be used in one type or in a mixture of plural kinds. When the solvent is used, it is preferably 5 to 80% by mass, more preferably 20 to 60% by mass based on the total amount of the solvent contained in the liquid crystal alignment agent. The compound which improves the uniformity of the film thickness or the surface smoothness is, for example, a fluorine-based surfactant, a polyfluorene-based surfactant, or a nonionic surfactant. More specifically, for example, F - Τ ο p EF 3 0 1 , EF3 03, EF352 (manufactured by Tokem Products Co., Ltd.), MEGAFACE F171, F173, R-30 (manufactured by DIC Corporation), Fluorad FC43 0, FC431 (Sumitomo 3M Company), AashiGuard AG710, Surflon S-3 8 2, SC101, SC 102 'SC 103 'SC104, SC105, SC106 (made by Asahi Glass Co., Ltd.). The ratio of use of the surfactant is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass, per 100 parts by mass of the resin component contained in the liquid-41-201226390 crystal alignment agent. Specific examples of the compound which enhances the adhesion between the liquid crystal alignment film and the substrate include, for example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, and 2-aminopropyl. Trimethoxy decane, 2-aminopropyltriethoxy decane, N-(2-aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl) 3-aminopropylmethyldimethoxydecane, 3-ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyl Trimethoxy decane, N-ethoxycarbonyl-3-aminopropyltriethoxy decane, N-triethoxymercaptopropyltriethylenetriamine, N-trimethoxydecylpropyltri Ethylene triamine, 10-trimethoxydecyl-1,4,7-trioxane, 10-triethoxyindolyl-1,4,7-trioxane, 9-trimethoxyindenyl -3,6-dimercaptoacetate, 9-triethoxyindolyl-3,6-dimercaptoacetate, N-benzyl-3-aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane, N-double (oxyethylene)-3·Aminopropyltrimethoxydecane, N-bis(oxyethylene)-3-aminopropyltriethoxydecane, ethylene glycol diglycidyl ether, polyethylene glycol diminish Glycerol ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2·dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, 1^,1^,:^,,>^' -tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, meaning: ^:^'々'-tetraglycidyl-4 , 4'-Diaminodi-42-201226390 The compound of the genus (5) sex sand chamber or the compound containing an epoxy group. Further, in addition to the adhesion between the substrate and the film, it is possible to prevent the deterioration of the electrical characteristics of the backlight. The liquid crystal alignment treatment agent may further contain a phenoplast-based additive as described below. The specific phenolic plastic additive is as follows, but is not limited to this configuration. [Chem. 23]
(式中,Me示爲甲基)。 使用提昇與基板之密著性之化合物時,該使用量,相 對於液晶配向處理劑中所含有聚合物成分之100質量份, 較佳爲〇·1〜30質量份、更佳爲1〜20質量份。使用量若 未滿〇·1質量份時,無法期待密著性提昇之效果;若變得 較30質量份爲多時,液晶之配向性會有變差之情形。 本發明之液晶配向處理劑中,除了上述以外,只要是 在不會損及本發明效果之範圍,就使液晶配向膜之介電常 數或導電性等之電氣特性變化之目的,可添加介電質或導 -43- 201226390 電物質,更,就提高製做成液晶配向膜之際之膜之硬度或 緻密度爲目的,可添加交聯性化合物。 本發明之液晶配向劑,在基板上予以塗佈、锻燒後, 以磨擦處理或光照射等進行配向處理,或在垂直配向用途 等時,可作爲無配向處理之液晶配向膜來使用。如此般之 本發明之液晶配向膜,因爲含有使用本發明之二胺所形成 的聚醯亞胺前驅物或聚醯亞胺,故不會有針孔形成或邊緣 部等膜厚之不均勻,又,不易產生電荷之儲存,且已儲存 之電荷之消除亦快。 作爲基板,只要是透明性高者即可,無特別限定,可 使用玻璃基板、或丙烯酸基板或聚碳酸酯基板等之塑膠基 板等。又,使用已形成有用來驅動液晶之ITO電極等之基 板,就程序之簡便化之觀點而言爲宜。又,就反射型液晶 表示元件而言,若僅爲單側之基板時,亦可使用矽晶圓等 之不透明物,此情形之電極亦可使用鋁等將光反射之材 料。又,如TFT型元件之高機能元件中,可使用在用來 驅動液晶之電極與基板之間形成有如電晶體之元件者。 雖然液晶配向劑之塗佈方法無特別限定,但就工業性 而言,一般有進行網板印刷、平板印刷、快乾印刷、注入 等之方法。作爲其他的塗佈方法,亦有浸漬、輥塗佈機、 隙縫(slit)塗佈機、旋塗機等,因應目的亦可使用此等。 將液晶配向劑塗佈於基板後之鍛燒,藉由加熱板、熱 風循環爐、紅外線爐等之加熱手段以50〜3 0(TC、較佳爲 80〜250°C予以進行,使溶媒蒸發,可形成塗膜。於鍛燒 -44- 201226390 後所形成塗膜之厚度,若過厚時,在液晶表示元件之消耗 電力方面爲不利,又,若過薄時,因爲會有液晶表示元件 之信賴性降低之情形,較佳爲5〜3 0 0 n m、更佳爲1 0〜 1 OOnm。使液晶水平配向或傾斜配向時,將锻燒後之塗膜 以磨擦或偏光紫外線照射等進行處理。 本發明之液晶表示元件,爲在以上述之手段由本發明 之液晶配向劑得到附著有液晶配向膜之基板後,使用習知 的方法來製作液晶晶胞,而製成液晶表示元件。若舉例一 例時,係具備有以對向般所配置的2片基板、設置於基板 間之液晶層、及於基板與液晶層之間所設置具有藉由本發 明之液晶配向劑所形成的上述液晶配向膜之液晶晶胞之液 晶表示元件。 作爲使用於本發明之液晶表示元件之基板,只要是透 明性高之基板即可,無特別限定,通常爲基板上已形成有 用來驅動液晶之透明電極之基板。作爲具體例,可舉例與 上述液晶配向膜所記載之基板爲相同者。 又,液晶配向膜,係將本發明之液晶配向劑塗佈於此 基板上後,藉由進行锻燒所形成者,詳細如同上述。 構成本發明之液晶表示元件之液晶層之液晶材料未特 別限定,可使用在以往的垂直配向方式所使用的液晶材 料’例如莫克公司製 MLC-2003、MLC-6608、MLC-6609 等。 若舉例液晶晶胞製作之一例時,可示例如準備1對已 形成有液晶配向膜之基板,將珠粒等之間隔物(spacer)散 -45- 201226390 布於單方基板之液晶配向膜上,並使液晶配向膜面以成爲 內側地將另一方之基板貼合,將液晶減壓注入後予以封止 之方法,或,於已散佈有間隔物之液晶配向膜面上將液晶 滴下後,將基板貼合、予以封止之方法等。此時間隔物之 厚度,較佳爲1〜30μιη、更佳爲2〜ΙΟμπι。 如以上般,使用本發明之液晶配向劑所製作的液晶表 示元件,爲信賴性優異者,可適當地使用於大畫面、高精 細之液晶電視等。 【實施方式】 [實施例] 以下,根據實施例更詳細進行說明,惟,本發明並不 受限於此實施例。 [二胺之合成] 下述所使用之簡稱如同以下。 DMF: Ν,Ν -二甲基甲醯胺 THF :四氫呋喃 RT :室溫(25t) (合成實施例1)下述式所不1-(4_胺基苯基)'5_胺基D引 哚啉[Diamine-1 ]之合成 201226390 [化 24] NH2(In the formula, Me is shown as a methyl group). When the compound is used to improve the adhesion to the substrate, the amount of use is preferably from 1 to 30 parts by mass, more preferably from 1 to 20 parts by weight based on 100 parts by mass of the polymer component contained in the liquid crystal alignment agent. Parts by mass. When the amount of use is less than 1 part by mass, the effect of improving the adhesion cannot be expected; if it is more than 30 parts by mass, the alignment of the liquid crystal may be deteriorated. In the liquid crystal alignment treatment agent of the present invention, in addition to the above, the dielectric properties of the liquid crystal alignment film may be changed so as not to impair the effects of the present invention, and dielectric properties may be added.质质-43-201226390 Electrical substances, in addition, for the purpose of improving the hardness or density of the film formed into a liquid crystal alignment film, crosslinkable compounds can be added. The liquid crystal alignment agent of the present invention can be used as a liquid crystal alignment film which is not subjected to alignment treatment when it is applied onto a substrate, calcined, and then subjected to alignment treatment by rubbing treatment or light irradiation, or when it is used for vertical alignment or the like. Since the liquid crystal alignment film of the present invention contains the polyimine precursor or polyimine formed using the diamine of the present invention, there is no pinhole formation or unevenness of the film thickness at the edge portion. Moreover, the storage of electric charges is not easy to occur, and the stored charge is eliminated quickly. The substrate is not particularly limited as long as it has high transparency, and a glass substrate or a plastic substrate such as an acrylic substrate or a polycarbonate substrate can be used. Further, it is preferable to use a substrate on which an ITO electrode or the like for driving a liquid crystal is formed, from the viewpoint of simplification of the procedure. Further, in the case of the reflective liquid crystal display element, if it is only a single-sided substrate, an opaque material such as a germanium wafer or the like may be used. In this case, a material such as aluminum or the like may be used. Further, in a high functional element such as a TFT type element, an element such as a transistor formed between an electrode for driving a liquid crystal and a substrate can be used. The coating method of the liquid crystal alignment agent is not particularly limited, but industrially, there are generally methods such as screen printing, lithography, quick-drying printing, and injection. As another coating method, there are also a dipping, a roll coater, a slit coater, a spin coater, etc., and these may be used depending on the purpose. The liquid crystal alignment agent is applied to the substrate and calcined, and is heated by a heating means such as a hot plate, a hot air circulation furnace or an infrared furnace at 50 to 30 (TC, preferably 80 to 250 ° C to evaporate the solvent). A film can be formed. The thickness of the coating film formed after calcining -44 - 201226390 is too unfavorable in terms of power consumption of the liquid crystal display element, and if it is too thin, there is a liquid crystal display element. In the case where the reliability is lowered, it is preferably 5 to 300 nm, more preferably 10 to 100 nm. When the liquid crystal is horizontally aligned or tilted, the film after calcination is irradiated by rubbing or polarized ultraviolet rays. In the liquid crystal display element of the present invention, a liquid crystal cell is produced by a known method using a liquid crystal alignment film of the present invention, and a liquid crystal display element is produced. For example, the liquid crystal layer provided in the opposite direction, the liquid crystal layer disposed between the substrates, and the liquid crystal alignment layer formed by the liquid crystal alignment agent of the present invention are provided between the substrate and the liquid crystal layer. The liquid crystal display element of the liquid crystal cell of the film is not particularly limited as long as it is a substrate having high transparency, and a transparent electrode for driving liquid crystal is usually formed on the substrate. The substrate is, for example, the same as the substrate described in the above liquid crystal alignment film. Further, the liquid crystal alignment film is formed by applying calcination by applying the liquid crystal alignment agent of the present invention to the substrate. The liquid crystal material constituting the liquid crystal layer of the liquid crystal display element of the present invention is not particularly limited, and a liquid crystal material used in a conventional vertical alignment method can be used, for example, MLC-2003, MLC-6608 manufactured by Mok Corporation. MLC-6609, etc. When an example of liquid crystal cell fabrication is exemplified, one pair of substrates on which a liquid crystal alignment film has been formed may be prepared, and a spacer such as beads may be dispersed on a single substrate. a liquid crystal alignment film, and the liquid crystal alignment film surface is bonded to the inside to bond the other substrate, and the liquid crystal is injected under reduced pressure to be sealed, or The liquid crystal alignment film surface on which the spacer has been dispersed is a method in which the liquid crystal is dropped, and the substrate is bonded and sealed. The thickness of the spacer is preferably 1 to 30 μm, more preferably 2 to ΙΟμπι. In the above, the liquid crystal display element produced by using the liquid crystal alignment agent of the present invention is excellent in reliability, and can be suitably used for a large-screen, high-definition liquid crystal television, etc. [Embodiment] [Embodiment] The examples are described in more detail, but the present invention is not limited to the examples. [Synthesis of Diamine] The abbreviations used below are as follows. DMF: hydrazine, hydrazine - dimethylformamide THF: tetrahydrofuran RT : room temperature (25t) (Synthesis Example 1) Synthesis of 1-(4-aminophenyl) '5-amino D porphyrin [Diamine-1] of the following formula 201226390 [Chem. 24] NH2
h2N^nXXh2N^nXX
[Dlamlne-1] (第一步驟)1-(4-硝基苯基)-5-硝基吲哚啉之合成 [化 25] N〇2[Dlamlne-1] (first step) Synthesis of 1-(4-nitrophenyl)-5-nitroporphyrin [Chem. 25] N〇2
DMF RTDMF RT
_ - 0jNiJO 將氫化鈉(純度 55%)9.30g(213mmol)、脫水 DMF 100 mL加入於500mL二頸燒瓶中,於氮氣氛下,一邊進行攪 拌一邊將5-硝基吲哚啉之DMF溶液(5-硝基吲哚啉: 35.0g(213mmol)、DMF: 100mL)以不超過 30°C 般地進行滴 下。滴下結束後以室溫攪拌2小時》將4-氟硝基苯之 DMF 溶液(4-氟硝基苯:33.0g(234.5mmol)、DMF: lOOmL) 滴下於此反應溶液中,於氮氣氛下以室溫攪拌6小時。 反應結束後,一邊攪拌反應溶液一邊緩慢注入純水 lOOmL,使固體析出,將析出的固體過濾並使再度溶解於 DMF中,注入於純水500mL中使再沈澱,再次將固體過 濾回收。將所得到的固體使用甲醇、η-己烷進行分散洗 淨,並藉由真空乾燥而得到橙色的固體 54.7g(收率 9 0%) ° (第二步驟)Diamine-Ι之合成 -47- 201226390 [化 26]_ - 0jNiJO Sodium hydride (purity 55%) 9.30 g (213 mmol) and dehydrated DMF 100 mL were placed in a 500 mL two-necked flask, and a 5-nitroporphyrin DMF solution was stirred while stirring under a nitrogen atmosphere ( 5-Nitroporphyrin: 35.0 g (213 mmol), DMF: 100 mL) was dripped at not more than 30 °C. After the completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours. A solution of 4-fluoronitrobenzene in DMF (4-fluoronitrobenzene: 33.0 g (234.5 mmol), DMF: 100 mL) was added dropwise to the reaction solution under a nitrogen atmosphere. Stir at room temperature for 6 hours. After the completion of the reaction, the reaction solution was stirred while slowly injecting 100 mL of pure water to precipitate a solid. The precipitated solid was filtered and dissolved again in DMF, and poured into 500 mL of pure water to reprecipitate, and the solid was again filtered and recovered. The obtained solid was dispersed and washed with methanol and η-hexane, and dried in vacuo to obtain an orange solid 54.7 g (yield: 90%). (Second step) Diamine-indole synthesis-47- 201226390 [化26]
N〇2 ό Pd/c h2 EtOHRT NH2 [Diamine-1] 於300mL四頸燒瓶中秤取於第一步驟所得到的i_(4_ 硝基苯基)-5 -硝基卩引晚啉15.0g(52.6mmol)及i〇質量 碳1 _50g,加入乙醇1 5 OmL ’以氮充分地取代後,使成爲 氫氣體氣氛,以室溫激烈攪拌。 反應結束後,將鈀碳使用玻璃濾器進行過濾,濾液使 甩旋轉蒸發器將溶媒除去。使所得的殘渣溶解於丙酮中, 加入活性碳暫時地攪拌,過濾活性碳,並使用旋轉蒸發器 除去丙酮後,以η-己烷與乙酸乙酯之混合溶液(2: 3質量 比)進行再結晶,得到目的之二胺(Diamine-1)之微紫色的 固體10.5g(收率:89%)。該構造利用分子內氫原子之核磁 共振光譜之1 H-NMR光譜進行確認。測定數據如下所示。 1 H NMR(400MHz,[D6]-DMSO)5 : 6.8 7 - 6.2 3 (Arom at i c-H、7H)、4.77-4.68(s-br、2H)、4.39-4.38(s-br、2H)、 3,62-3,5 8 (t、2H)、2.8 9-2.8 7(t、2H) (合成實施例2)下述式所示^(4-胺基苯基)-2-甲基-5-月女基Π引噪咐[Diamine-2]之合成(外消旋混合) -48 - 201226390 [化 27]N〇2 ό Pd/c h2 EtOHRT NH2 [Diamine-1] 15.0 g of i_(4_nitrophenyl)-5-nitroindole derived from the first step was weighed in a 300 mL four-necked flask ( 52.6 mmol) and i〇 mass carbon 1 _50 g, and 1 5 OmL of ethanol was added. After being sufficiently substituted with nitrogen, a hydrogen gas atmosphere was obtained, and the mixture was vigorously stirred at room temperature. After completion of the reaction, palladium carbon was filtered using a glass filter, and the filtrate was passed through a rotary evaporator to remove the solvent. The obtained residue was dissolved in acetone, and the activated carbon was temporarily stirred, and the activated carbon was filtered, and acetone was removed by a rotary evaporator, followed by a mixed solution of η-hexane and ethyl acetate (2:3 by mass). Crystallization gave 10.5 g of a pale purple solid of the desired diamine (diamine-1) (yield: 89%). This structure was confirmed by 1 H-NMR spectrum of the nuclear magnetic resonance spectrum of the intramolecular hydrogen atom. The measurement data is as follows. 1 H NMR (400 MHz, [D6]-DMSO) 5 : 6.8 7 - 6.2 3 (Arom at i cH, 7H), 4.77-4.68 (s-br, 2H), 4.39-4.38 (s-br, 2H), 3,62-3,5 8 (t, 2H), 2.8 9-2.8 7 (t, 2H) (Synthesis Example 2) ^(4-Aminophenyl)-2-methyl- represented by the following formula Synthesis of 5-month female based Π[Diamine-2] (racemic mixing) -48 - 201226390 [化27]
(第一步驟)1-(4 -硝基苯基)-2 -甲基-5-硝基吲哚啉之合 成 [化 28](First step) Synthesis of 1-(4-nitrophenyl)-2-methyl-5-nitroporphyrin [Chem. 28]
將氫化鈉(純度 55%)2.45g(56.1mmol)、脫水 DMF 100 mL加入於500mL二頸燒瓶中,於氮氣氛下,一邊進行攪 拌一邊將2 -甲基-5 -硝基吲哚啉之D M F溶液(2 -甲基-5 -硝 基吲哚啉:l〇.〇g(56.1mmol)、DMF: 50mL)以不超過 30°C 般地進行滴下。滴下結束後以室溫攪拌2小時。將4 -氟 硝基苯之 DMF溶液(4-氟硝基苯:8.7g(61 .7mmol)、 DMF : 5 OmL)滴下於此反應溶液中,於氮氣氛下以室溫攪 拌6小時。 反應結束後’一邊攪拌反應溶液一邊緩慢注入純水 100mL ’使固體析出,將析出的固體過濾並使再度溶解於 DMF中,注入於純水500mL中使再沈澱,再次將固體過 濾回收。將所得到的固體使用甲醇、n_己烷進行分散洗 淨’並藉由真空乾燥而得到橙色的固體14.4g(收率: -49- 201226390 8 6%))。 (第二步驟)Diamine-2之合成 [化 29] no2 0 J〇>- [Diamine-2] ή2. Sodium hydride (purity 55%) 2.45 g (56.1 mmol) and dehydrated DMF 100 mL were placed in a 500 mL two-necked flask, and 2-methyl-5-nitroporphyrin was stirred while stirring under a nitrogen atmosphere. The DMF solution (2-methyl-5-nitroporphyrin: l〇.〇g (56.1 mmol), DMF: 50 mL) was dropped at a temperature not exceeding 30 °C. After the completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours. A DMF solution of 4-fluoronitrobenzene (4-fluoronitrobenzene: 8.7 g (61.7 mmol), DMF: 5 OmL) was added dropwise to the reaction solution, and the mixture was stirred at room temperature for 6 hours under a nitrogen atmosphere. After the completion of the reaction, while stirring the reaction solution, 100 mL of pure water was slowly injected to precipitate a solid, and the precipitated solid was filtered and dissolved again in DMF, and poured into 500 mL of pure water to reprecipitate, and the solid was again filtered and recovered. The obtained solid was subjected to dispersion washing with methanol and n-hexane, and dried in vacuo to give 14.4 g of an orange solid (yield: -49 - 201226390 8 6%). (Second step) Synthesis of Diamine-2 [Chem. 29] no2 0 J〇>- [Diamine-2] ή
Pd/c h2Pd/c h2
EtOH.RTEtOH.RT
H2N 於3〇OmL四頸燒瓶中秤取於第一步驟所得到的i_(4_ 硝基苯基)-2 -甲基-5-硝基卩引哄咐l〇.〇g(56.1mmol)及10質 量%鈀碳1 . 〇 〇 g ’加入乙醇1 5 Om L,以氮充分地取代後, 使成爲氫氣體氣氛,以室溫激烈攪拌。 反應結束後,將鈀碳使用玻璃濾器進行過濾,濾液使 用旋轉蒸發器將溶媒除去。使所得的殘渣溶解於丙酮中, 加入活性碳暫時地攪拌,過濾活性碳,並使用旋轉蒸發器 除去丙酮後,以η-己烷與乙酸乙酯之混合溶液(2: 3質量 比)進行再結晶,得到目的之二胺(Diamine-2)之微粉紅色 的固體7.03g(收率:89%)。該構造利用1H-NMR光譜進行 確認。測定數據如下所示。 1H NMR (400 MHz,[D6]-DMSO)5 : 6.86-6.84(d、 2H)、6.5 6-6.22 (Aromatic-H、7 Η)、4.7 7 - 4.6 8 (s - b r、2H)、 4.39-4.3 8(s-br、2H)、4.83-4.81(m、1H)、3,42-3,3 8(dd、 1H)、2.89-2.87(dd、1 H) 1 · 4 8 -1 · 4 7 (s、3H) (合成實施例3)1-(4-胺基苯基)-2,3,3-三甲基-5-胺基 -50- 201226390 口引哄琳[Diamine-3]之合成(外消旋混合) [化 30]H2N was weighed in a 3 〇OmL four-necked flask to obtain i_(4_nitrophenyl)-2-methyl-5-nitroindole 哄咐l〇.〇g (56.1 mmol) obtained in the first step and 10% by mass of palladium carbon 1. 〇〇g 'Isoethanol was added to 1 5 Om L, and it was sufficiently substituted with nitrogen to form a hydrogen gas atmosphere, and the mixture was vigorously stirred at room temperature. After completion of the reaction, palladium carbon was filtered using a glass filter, and the filtrate was removed by a rotary evaporator. The obtained residue was dissolved in acetone, and the activated carbon was temporarily stirred, and the activated carbon was filtered, and acetone was removed by a rotary evaporator, followed by a mixed solution of η-hexane and ethyl acetate (2:3 by mass). Crystallization gave 7.03 g of a slightly pink solid of the desired diamine (diamine-2) (yield: 89%). This structure was confirmed by 1H-NMR spectroscopy. The measurement data is as follows. 1H NMR (400 MHz, [D6]-DMSO) 5: 6.86-6.84 (d, 2H), 6.5 6-6.22 (Aromatic-H, 7 Η), 4.7 7 - 4.6 8 (s - br, 2H), 4.39 -4.3 8(s-br, 2H), 4.83-4.81 (m, 1H), 3, 42-3, 3 8 (dd, 1H), 2.89-2.87 (dd, 1 H) 1 · 4 8 -1 · 4 7 (s, 3H) (Synthesis Example 3) 1-(4-Aminophenyl)-2,3,3-trimethyl-5-amino-50-201226390 哄引哄琳[Diamine-3 Synthesis (racemic mixing) [Chem. 30]
(第一步驟)1-(4-硝基苯基)_2,3,3-三甲基-5-硝基吲哚 啉之合成 [化 31](First step) Synthesis of 1-(4-nitrophenyl)_2,3,3-trimethyl-5-nitroporphyrin [Chem. 31]
將氫化鈉(純度 55%)2.16g(48.5mmol)、脫水 DMF 100 mL加入於50OmL二頸燒瓶中,於氮氣氛下,一邊進行攪 拌一邊將2,3,3 -三甲基-5 -硝基吲哚啉之D M F溶液(2,3,3 -三甲基-5-硝基吲哚啉:10.0g(48.5mmol)、DMF: 50mL)以 不超過3 0 °C般地進行滴下。滴下結束後以室溫攪拌2小 時。將 4-氟硝基苯之 DMF溶液(4-氟硝基苯: 7.52g(53.3mmol)、DMF: 50mL)滴下於此反應溶液中,於 氮氣氛下以室溫攪拌6小時。 反應結束後,一邊攪拌反應溶液一邊緩慢注入純水 100mL,使固體析出,將析出的固體過濾並使再度溶解於 DMF中,注入於純水5 00mL中使再沈澱,再次將固體過 濾回收。將所得到的固體使用甲醇、η-己烷進行分散洗 -51 - 201226390 淨,並藉由真空乾燥而得到橙色的固體13.5g(收率: 8 5%) 〇 (第二步驟)Diamine-3之合成 [化 32]2.61 g (48.5 mmol) of sodium hydride (purity 55%) and 100 mL of dehydrated DMF were placed in a 50 mL two-necked flask, and 2,3,3-trimethyl-5-nitrate was stirred while stirring under a nitrogen atmosphere. The porphyrin-containing DMF solution (2,3,3-trimethyl-5-nitroporphyrin: 10.0 g (48.5 mmol), DMF: 50 mL) was dropped at a temperature of not more than 30 °C. After the completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours. A 4-fluoronitrobenzene-containing DMF solution (4-fluoronitrobenzene: 7.52 g (53.3 mmol), DMF: 50 mL) was added dropwise to the reaction mixture, and the mixture was stirred at room temperature for 6 hours under a nitrogen atmosphere. After the completion of the reaction, 100 mL of pure water was slowly poured while stirring the reaction solution to precipitate a solid. The precipitated solid was filtered and dissolved again in DMF, and poured into 500 mL of pure water to reprecipitate, and the solid was again filtered and recovered. The obtained solid was dispersed and washed with methanol and η-hexane -51 - 201226390, and dried in vacuo to give an orange solid 13.5 g (yield: 8 5%) 〇 (second step) Diamine-3 Synthesis [32]
於300mL四頸燒瓶中秤取於第一步驟所得到的1-(4-硝基苯基)·2,3,3-二甲基-5-硝基吲哚啉10.0g(30.5mmol)及 10質量%鈀碳1 .〇〇g,加入乙醇150mL,以氮充分地取代 後,使成爲氫氣體氣氛,以室溫激烈攪拌。 反應結束後,將鈀碳使用玻璃濾器進行過濾,濾液使 用旋轉蒸發器將溶媒除去。使所得的殘渣溶解於丙酮中, 加入活性碳暫時地攪拌,過濾活性碳,並使用旋轉蒸發器 除去丙酮後,以η-己烷與乙酸乙酯之混合溶液(2 : 3質量 比)進行再結晶,得到目的之二胺(Diamine-3)之微紫色的 固體7.50g(收率:92%)。該構造利用iH-NMR光譜進行確 認。測定數據如下所示。 'H NMR(400MHz,[D6]-DMSO)5 : 6.8 6 - 6.2 2 ( Aromat i c-H、7H)、4.74-4_66(s-br、2H)、4.41-4.39(s-br、2H)、 4.23-4.21(m、1H)、1.48-1.14(s、9H) -52- 201226390 (合成實施例4)下述式所示1-(4-胺基苯基)-6-胺基· 1,2,3,4-四氫喹琳[Diamine-4]之合成 [化 33]10.0 g (30.5 mmol) of 1-(4-nitrophenyl)·2,3,3-dimethyl-5-nitroporphyrin obtained in the first step was weighed in a 300 mL four-necked flask and 10% by mass of palladium carbon 1 〇〇g, 150 mL of ethanol was added thereto, and after sufficiently substituted with nitrogen, a hydrogen gas atmosphere was obtained, and the mixture was vigorously stirred at room temperature. After completion of the reaction, palladium carbon was filtered using a glass filter, and the filtrate was removed by a rotary evaporator. The obtained residue was dissolved in acetone, and the activated carbon was temporarily stirred, and the activated carbon was filtered, and acetone was removed by a rotary evaporator, followed by a mixed solution of η-hexane and ethyl acetate (2:3 by mass). Crystallization gave 7.50 g (yield: 92%) of a pale purple solid of the desired diamine. This structure was confirmed by iH-NMR spectroscopy. The measurement data is as follows. 'H NMR (400 MHz, [D6]-DMSO) 5 : 6.8 6 - 6.2 2 (Aromat i cH, 7H), 4.74-4_66 (s-br, 2H), 4.41-4.39 (s-br, 2H), 4.23 -4.21 (m, 1H), 1.48-1.14 (s, 9H) -52 - 201226390 (Synthesis Example 4) 1-(4-aminophenyl)-6-amino group 1,2 represented by the following formula Synthesis of 3,4-tetrahydroquinoline [Diamine-4] [Chem. 33]
(第一步驟)6-(tert-丁氧基羰基)胺基喹啉之合成 [化 34](First step) Synthesis of 6-(tert-butoxycarbonyl)aminoquinoline [Chem. 34]
在20 0mL四頸燒瓶中,使6·脖基喹啉5.00g(34.7 mmol)溶解於 THFlOOmL中,並加入二碳酸 tert-丁酯 7.5 7g(3 4.7mmol),於氮氣氛下迴流20小時。 反應結束後,藉由旋轉蒸發器將THF除去,加入乙 酸乙酯,並以純水、飽和食鹽水進行洗淨,使用無水硫酸 鎂使乾燥。以過濾將無水硫酸鎂除去後,使用旋轉蒸發器 將溶媒除去,並將殘渣以乙酸乙酯與η-己烷之混合溶媒 (1 : 4體積比)進行再結晶,得到白色的固體7.29g(86%)。 (第二步驟)6-(tert-丁氧基羰基)胺基-1,2,3,4-四氫喹啉 之合成 -53- 201226390 [化 35]rV,Pd/C.H〜CrS B〇C Boc 於100mL二頸燒瓶中秤取第一步驟所得到的6-(tert-丁氧基羰基)胺基喹啉5.00g(20.4mm〇l)及10質量%鈀碳 〇.50g,力Π入甲醇50mL,以氮充分地取代後,使成爲氫氣 體氣氛,以60°C激烈攪拌。 反應結束後,將鈀碳使用玻璃濾器進行過濾,濾液使 用旋轉蒸發器將溶媒除去。使所得的殘渣溶解於丙酮中, 加入活性碳暫時地攪拌,過濾活性碳,並使用旋轉蒸發器 除去丙酮後,以η-己烷與乙酸乙酯之混合溶液(2 : 3質量 比)進行再結晶,得到白色的玻璃狀固體3.65g(收率: 72%) » (第二步驟)1-(4_硝基苯基)-6-胺基-1,2,3,4-四氫喹啉 之合成 [化 36]ΗΝΧ» I Boc Y=58%In a 20 mL four-necked flask, 5.00 g (34.7 mmol) of 6-n-quinoline was dissolved in THF 100 mL, and 7.5 7 g (3 4.7 mmol) of tert-butyl dicarbonate was added thereto, and the mixture was refluxed for 20 hours under a nitrogen atmosphere. After completion of the reaction, THF was removed by a rotary evaporator, ethyl acetate was added, and the mixture was washed with purified water and saturated brine, and dried with anhydrous magnesium sulfate. After removing anhydrous magnesium sulfate by filtration, the solvent was removed using a rotary evaporator, and the residue was recrystallized from a mixed solvent of ethyl acetate and hexane-hexane (1: 4 by volume) to give white solid 7.29 g ( 86%). (Second step) Synthesis of 6-(tert-butoxycarbonyl)amino-1,2,3,4-tetrahydroquinoline-53- 201226390 [Chem. 35] rV, Pd/CH~CrS B〇C Boc was taken in a 100 mL two-necked flask to obtain 5.00 g (20.4 mm 〇l) of 6-(tert-butoxycarbonyl)aminoquinoline obtained in the first step and 10% by mass of palladium carbon ruthenium. After 50 mL of methanol was sufficiently substituted with nitrogen, it was allowed to stand in a hydrogen gas atmosphere and vigorously stirred at 60 °C. After completion of the reaction, palladium carbon was filtered using a glass filter, and the filtrate was removed by a rotary evaporator. The obtained residue was dissolved in acetone, and the activated carbon was temporarily stirred, and the activated carbon was filtered, and acetone was removed by a rotary evaporator, followed by a mixed solution of η-hexane and ethyl acetate (2:3 by mass). Crystallization gave 3.65 g of a white glassy solid (yield: 72%) » (Second step) 1-(4-nitrophenyl)-6-amino-1,2,3,4-tetrahydroquine Synthesis of porphyrins [Chem. 36] ΗΝΧ» I Boc Y=58%
NaH 〇2N 〇fNaH 〇2N 〇f
HCJHCJ
DMF RT RT 20h 將氫化鈉(純度 55%)〇.615g(i4.immol)、脫水 DMF 20 mL加入於1 OOmL二頸燒瓶中,於氮氣氛下,—邊進行攪 拌一邊將第二步驟所得到的6-(tert-丁氧基羰基)胺基- 1,2,3,4-四氫喹啉之DMF溶液(6-(tert-丁氧基羰基)胺基- -54 - 201226390 1,2,3,4-四氫喹啉:3.50g(14.1mmol)、DMF: 20mL)以不 超過30°C般地進行滴下。滴下結束後攪拌2小時。將4-氟硝基苯之DMF溶液(4-氟硝基苯:2.19g(15.5mmol)、 DMF : 2 0mL)滴下於此反應溶液中,於氮氣氛下以室溫攪 拌2 0小時。 反應結束後,一邊攪拌反應溶液一邊緩慢注入純水 3 OmL,使固體析出,將析出的固體過濾並使再度溶解於 DMF中,注入於純水lOOmL中使再沈澱,再次將固體過 濾回收。使用η-己烷進行分散洗淨,並藉由真空乾燥而 得到黃色的固體。將4Ν鹽酸-乙酸乙酯溶液加入於此固 體,以40°C使攪拌2小時。反應溶液中加入純水,將水層 回收,並使用碳酸氫鈉進行中和,加入乙酸乙酯進行萃 取,並以水、飽和食鹽水進行洗淨,使用無水硫酸鎂使乾 燥》以過濾將無水硫酸鎂除去後,使用旋轉蒸發器將溶媒 除去,並將殘渣進行管柱層析法(乙酸乙酯與二氯乙烷之 混合溶媒1 : 1體積比),得到黃色的固體2.2〇g(收率: 5 8%) 〇 (第四步驟)1-(4-胺基苯基)-6-胺基-1,2,3,4-四氫喹啉 [Diamine-4]之合成 [化 37]DMF RT RT 20h Sodium hydride (purity 55%) 615.615g (i4.immol), dehydrated DMF 20 mL was added to a 100 mL two-necked flask, and the mixture was stirred under a nitrogen atmosphere. 6-(tert-butoxycarbonyl)amino-1,2,3,4-tetrahydroquinoline in DMF (6-(tert-butoxycarbonyl)amino--54 - 201226390 1,2 3,4-tetrahydroquinoline: 3.50 g (14.1 mmol), DMF: 20 mL) was dripped at not more than 30 °C. After the completion of the dropwise addition, the mixture was stirred for 2 hours. 4-Fluoronitrobenzene in DMF solution (4-fluoronitrobenzene: 2.19 g (15.5 mmol), DMF: 20 mL) was added dropwise to the reaction solution, and the mixture was stirred at room temperature for 20 hours under a nitrogen atmosphere. After the completion of the reaction, the reaction solution was stirred while slowly injecting 3 mL of pure water to precipitate a solid. The precipitated solid was filtered and dissolved again in DMF, poured into 100 mL of pure water to reprecipitate, and the solid was again filtered and recovered. Dispersion washing was carried out using η-hexane, and dried in vacuo to give a yellow solid. A 4 Ν hydrochloric acid-ethyl acetate solution was added to the solid, and the mixture was stirred at 40 ° C for 2 hours. Pure water was added to the reaction solution, the aqueous layer was recovered, neutralized with sodium hydrogencarbonate, extracted with ethyl acetate, and washed with water and saturated brine, dried over anhydrous magnesium sulfate. After removing the magnesium sulfate, the solvent was removed using a rotary evaporator, and the residue was subjected to column chromatography (1:1 volume ratio of ethyl acetate and dichloroethane) to obtain a yellow solid of 2.2 g. Rate: 5 8%) Synthesis of hydrazine (fourth step) 1-(4-aminophenyl)-6-amino-1,2,3,4-tetrahydroquinoline [Diamine-4] ]
NH2NH2
Pd/C, H2Pd/C, H2
EtOHEtOH
RT 於500mL四頸燒瓶中秤取於第三步驟所得到的l-(4· -55- 201226390 硝基苯基)-6-胺基-1,2,3,4-四氫喹啉 10.0g(37.1mmol)、l〇 質量%鈀碳l.〇〇g,加入乙醇300mL,以氮充分地取代 後,使成爲氫氣體氣氛,以室溫激烈攪拌》 反應結束後,將鈀碳使用玻璃濾器進行過濾,濾液使 用旋轉蒸發器將溶媒除去。使所得的殘渣溶解於丙酮中, 加入活性碳暫時地攪拌,過濾活性碳,並使用旋轉蒸發器 除去丙酮後,以η-己烷與乙酸乙酯之混合溶液(5: 1質量 比)進行再結晶,得到目的之二胺(Diamine-4)之微紫色的 固體7.30g(收率:82%)。該構造利用1H-NMR光譜進行確 認。測定數據如下所示。 *H N M R (4 0 0 Μ H z, [ D 6 ] - D M S Ο) δ · 6.8 5 - 6.3 5 (A r ο m a t i c-Η、7H)、5.00-4.98(s-br、2H)、4.59-4.58(s-br、2H)、 3,94-3,9 3 (m、2H)、2.89-2.87(m、2H)、2.66-2.64(m、2H) (合成比較例胺基苯基)-5 -胺基D引哄[Diamine-5] 之合成 [化 38]RT 1 - (4· -55-201226390 nitrophenyl)-6-amino-1,2,3,4-tetrahydroquinoline 10.0 g obtained in the third step in a 500 mL four-necked flask (37.1 mmol), 100% by mass of palladium carbon 1. 〇〇g, 300 mL of ethanol was added, and the mixture was sufficiently substituted with nitrogen to form a hydrogen gas atmosphere, and the mixture was vigorously stirred at room temperature. After completion of the reaction, palladium carbon was used as a glass filter. Filtration was carried out and the filtrate was removed using a rotary evaporator. The obtained residue was dissolved in acetone, and the activated carbon was temporarily stirred, and the activated carbon was filtered, and acetone was removed by a rotary evaporator, followed by a mixed solution of η-hexane and ethyl acetate (5:1 by mass). Crystallization gave 7.30 g of a pale purple solid of the desired diamine (diamine-4) (yield: 82%). This structure was confirmed by 1H-NMR spectroscopy. The measurement data is as follows. *HNMR (4 0 0 Μ H z, [ D 6 ] - DMS Ο) δ · 6.8 5 - 6.3 5 (A r ο mati c-Η, 7H), 5.00-4.98 (s-br, 2H), 4.59- 4.58 (s-br, 2H), 3, 94-3, 9 3 (m, 2H), 2.89-2.87 (m, 2H), 2.66-2.64 (m, 2H) (Synthetic Comparative Example Aminophenyl)- Synthesis of 5-amino D-inducing [Diamine-5] [Chem. 38]
(第一步驟)1-(4-硝基苯基)-5-硝基吲哚之合成 -56- 201226390 [化 39](First step) Synthesis of 1-(4-nitrophenyl)-5-nitroguanidine -56- 201226390 [Chem. 39]
O^NO^N
NaH DMF RT, 2hr 〇,Ν〇ΡNaH DMF RT, 2hr 〇, Ν〇Ρ
N〇2 0 將氫化鈉(純度 55%)4.48g(l〇1.8mmol)、脫水 DMF 50 mL加入於500mL二頸燒瓶中,於氮氣氛下,一邊進行攪 拌一邊將 5-硝基吲哚之 DMF溶液(5-硝基吲哚: 15.0g(92.5mmol)、DKlF·· lOOmL)以不超過 30°C般地進行 滴下。滴下結束後以室溫攪拌2小時。將4-氟硝基苯之 DMF 溶液(4-氟硝基苯:13.1g(92.5mmol)、DMF: lOOmL) 滴下於此反應溶液中,於氮氣氛下以室溫攪拌6小時。 反應結束後,一邊攪拌反應溶液一邊緩慢注入純水 1 OOmL ’使固體析出,將析出的固體過濾並使再度溶解於 DMF中’注入於純水5〇〇mL中使再沈澱,再次將固體過 濾回收。將所得到的固體使用甲醇、n—己烷進行分散洗 淨’並藉由真空乾燥而得到黃色的固體 25.0g(收率 9 5%) ° (第一步驟)1-(4-胺基苯基)-5-胺基卩引哄[Diamine-5]之 合成 -57- 201226390 [化 40] 0 >〇> [Diamine-5] N〇2 όN〇2 0 Sodium hydride (purity 55%) 4.48 g (l〇1.8 mmol) and dehydrated DMF 50 mL were placed in a 500 mL two-necked flask, and 5-nitroguanidine was stirred while stirring under a nitrogen atmosphere. The DMF solution (5-nitroguanidine: 15.0 g (92.5 mmol), DKlF··100 mL) was dropped at a temperature not exceeding 30 °C. After the completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours. A 4-fluoronitrobenzene DMF solution (4-fluoronitrobenzene: 13.1 g (92.5 mmol), DMF: 100 mL) was added dropwise to the reaction solution, and the mixture was stirred at room temperature for 6 hours under a nitrogen atmosphere. After the completion of the reaction, the reaction solution was stirred while slowly injecting 100 mL of pure water to precipitate a solid, and the precipitated solid was filtered and dissolved again in DMF to be injected into 5 mL of pure water to reprecipitate, and the solid was again filtered. Recycling. The obtained solid was subjected to dispersion washing with methanol and n-hexane, and dried under vacuum to obtain 25.0 g (yield: 95%) of a yellow solid (first step) 1-(4-aminobenzene) Synthesis of 5-amine-based ruthenium [Diamine-5]-57- 201226390 [Chemical 40] 0 >〇> [Diamine-5] N〇2 ό
Pd/c h2Pd/c h2
EtOH, Reflux H2N 於5 0 0m L四頸燒瓶中秤取於第一步驟所得到的1 · (4 _ 硝基苯基)-5-硝基吲哚20.0g(70.6mmol)、10質量%鈀碳 2.00g,加入乙醇300mL,以氮充分地取代後,使成爲氫 氣體氣氛,使迴流42小時。 反應結束後,將鈀碳使用玻璃濾器進行過濾,濾液使 用旋轉蒸發器將溶媒除去。使所得的殘渣溶解於丙酮中, 加入活性碳暫時地攪拌,過濾活性碳,並使用旋轉蒸發器 除去丙酮後,藉由使用η-己烷將殘渣進行洗淨,得到目 的之二胺(Diamine_5)微粉紅色的固體 15.0g(收率: 9 5%)。該構造利用1H-NMR光譜進行確認。測定數據如下 所示。 'H NMR(400MHz,[D6]-DMSO)5 : 7.2 5 - 6.2 8 (A r 0 m a t i c-Η、9H)、5.20(s-br、2H)、4.56(s-br、2H) [聚醯胺酸及聚醯亞胺之合成以及液晶配向劑之調製] 下述所使用化合物之簡稱如同以下。又’在各實施例 及比較例所合成聚合物之原料及液晶配向劑之組成如表1 及表2所示。 <四羧酸二酐> -58- 201226390 CBDA: 1,2,3,4-環丁烷四羧酸二酐 TDA: 3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二酐 CBDE: 1,2,3,4-環丁烷四羧酸二甲基酯EtOH, Reflux H2N 1⁄4 (4 _ nitrophenyl)-5-nitroindole 20.0 g (70.6 mmol), 10 mass % palladium obtained in the first step in a 500 ml L four-necked flask Carbon (2.00 g) was added to 300 mL of ethanol, and the mixture was sufficiently substituted with nitrogen to form a hydrogen gas atmosphere, followed by reflux for 42 hours. After completion of the reaction, palladium carbon was filtered using a glass filter, and the filtrate was removed by a rotary evaporator. The obtained residue was dissolved in acetone, the activated carbon was temporarily stirred, the activated carbon was filtered, and acetone was removed by a rotary evaporator, and then the residue was washed with η-hexane to obtain the desired diamine (Diamine_5). 15.0 g of a slightly pink solid (yield: 9 5%). This structure was confirmed by 1H-NMR spectrum. The measured data is as follows. 'H NMR (400MHz, [D6]-DMSO) 5 : 7.2 5 - 6.2 8 (A r 0 mati c-Η, 9H), 5.20 (s-br, 2H), 4.56 (s-br, 2H) Synthesis of Proline and Polyimine and Modulation of Liquid Crystal Aligning Agent] The abbreviations of the compounds used below are as follows. Further, the composition of the polymer synthesized in each of the examples and the comparative examples and the composition of the liquid crystal alignment agent are shown in Tables 1 and 2. <tetracarboxylic dianhydride> -58- 201226390 CBDA: 1,2,3,4-cyclobutane tetracarboxylic dianhydride TDA: 3,4-dicarboxy-1,2,3,4-tetrahydrogen -1-naphthalene succinic acid dianhydride CBDE: 1,2,3,4-cyclobutane tetracarboxylic acid dimethyl ester
<二胺> P-PDA : 1,4-苯二胺 DDM: 4,4-二胺基二苯基甲烷 C16DAB : 4-十六基氧-1,3-二胺基苯 [化 42] h2n<Diamine> P-PDA : 1,4-phenylenediamine DDM: 4,4-diaminodiphenylmethane C16DAB: 4-hexadecyloxy-1,3-diaminobenzene H2n
ΧΤΗ: p-PDA ΗίΝχταΝΗ2ΧΤΗ: p-PDA ΗίΝχταΝΗ2
DDMDDM
a ηΆβΚ»χχ C16DAB <縮合劑> DMT-MM : 4-(4,6-二甲氧基-1,3,5-三吖哄-2-基)4 -甲 氧基嗎福啉氯化物-η -水合物 <有機溶媒> Ν Μ P : Ν -甲基-2 -吡咯啶嗣 γ-BL : γ·丁內酯 BC : 丁基賽璐蘇 DPM:二丙二醇單甲基醚 -59- 201226390 <分子量之測定> 藉由聚合反應所得到的聚合物之分子量,係將該聚合 物使用GPC(常溫凝膠滲透色譜法)裝置進行測定,並以聚 乙二醇、聚環氧乙烷換算値算出數平均分子量與重量平均 分子量。 GPC 裝置:Shodex 公司製(GPC-101) 管柱:Shodex公司製(KD 803、KD 805之串連)a ηΆβΚ»χχ C16DAB <condenser> DMT-MM : 4-(4,6-dimethoxy-1,3,5-trian-2-yl)4-methoxymorpholine chloride -η-Hydrate<Organic Solvent> Ν Μ P : Ν-Methyl-2-pyrrolidinium γ-BL : γ· Butyrolactone BC : Butyl cyanoside DPM: Dipropylene glycol monomethyl ether -59-201226390 <Measurement of Molecular Weight> The molecular weight of the polymer obtained by the polymerization reaction was measured by a GPC (normal temperature gel permeation chromatography) apparatus, and polyethylene glycol, poly The number average molecular weight and the weight average molecular weight were calculated from the conversion of ethylene oxide. GPC device: manufactured by Shodex Co., Ltd. (GPC-101) Pipe column: made by Shodex (series of KD 803, KD 805)
管柱溫度:5 0 °C 溶離液:30mmol/L之N,N-二甲基甲醯胺(作爲添加劑 爲溴化鋰-水合物(LiBr.H2〇)、30mmol/L之磷酸.酐結晶 (〇-磷酸)、l〇mL/L之四氫呋喃(THF)) 流速:1 .OmL/分 檢量線作成用標準樣品:TOSOH公司製TSK標準聚 環氧乙烷(分子量約 900,000、150,000、100,000、30,000), 及 Polymer Laboratories公司製聚乙二醇(分子量約 1 2,000 ' 4,000、1,000)= <醯亞胺化率之測定> 聚醯亞胺之醯亞胺化率係如以下般來進行測定。將聚 醯亞胺粉末20mg置入於NMR樣品管(草野科學公司製 NMR sample tube standard)中,添加重氬化二甲亞颯 (DMSO-d6 ' 〇.〇5%TMS混合品)0.53mL,施予超音波使完 全地溶解。使用JEOL DATUM(股)製NMR測定器(JNW-ECA500)測定500MHz之質子NMR。醯亞胺化率,係將來 自於醯亞胺化前後之構造未變化之質子作爲基準質子來決 -60- 201226390 定,將此質子之峰累積値,與出現於9.5〜10.0Ppm附近 之來自於醯胺酸之NH基之質子峰累積値,藉由使用以下 之式所求得。尙,在上述式中,X爲來自於醯胺酸之NH 基之質子峰累積値、y爲基準質子之峰累積値、α爲當聚 醯胺酸(醯亞胺化率爲〇%)時,相對於醯胺酸之1個ΝΗ基 質子之基準質子之個數比例。Column temperature: 50 °C Dissolution: 30 mmol/L of N,N-dimethylformamide (as an additive for lithium bromide-hydrate (LiBr.H2〇), 30 mmol/L of phosphoric acid. Anhydride crystals (〇 -phosphoric acid), l〇mL/L of tetrahydrofuran (THF)) Flow rate: 1.0 mL/min. calibrated line Standard sample: TSK standard polyethylene oxide manufactured by TOSOH Co., Ltd. (molecular weight: about 900,000, 150,000, 100,000, 30 , 000), and polyethylene glycol manufactured by Polymer Laboratories (molecular weight: about 1 2,000 '4,000, 1,000) = <Measurement of oxime imidization rate> The ruthenium imidization ratio of polyimine is as follows The measurement was carried out. 20 mg of polyimine powder was placed in an NMR sample tube (NMR sample tube standard manufactured by Kusano Scientific Co., Ltd.), and 0.53 mL of heavy argon dimethyl hydrazine (DMSO-d6 '〇.〇5% TMS mixture) was added. The ultrasound is applied to dissolve completely. Proton NMR at 500 MHz was measured using a JEOL DATUM (NMR) NMR analyzer (JNW-ECA500). The imidization rate of ruthenium is determined by using protons whose structure has not changed before and after imidization as the reference proton, and the peak of this proton is accumulated and appears near 9.5~10.0Ppm. The proton peak accumulation of the NH group of proline is determined by using the following formula.尙, in the above formula, X is the proton peak cumulative 値 from the NH group of the proline, y is the peak cumulative 値 of the reference proton, and α is when the polyproline (〇 imidization is 〇%) The ratio of the number of reference protons relative to one of the ruthenium protons.
醯亞胺化率(%) = (l-〇fX/y)xlOO (實施例1)使用CBDA/Diamine-1之聚醯胺酸之合成 在50mL四頸燒瓶中,作爲二胺成分,加入合成實施 例 1 所得到的 Diamine·1 1 · 5 0 g ( 6.6 5 m m ο 1) ' NMP 1 5.3 g > 冷卻到約 l〇°C ’加入 CBDA 1.22g(6.20mmol),回復至室 溫,並使於氮氣氛下反應6小時,得到聚醯胺酸(PAA-1) 之濃度15質量%之溶液。 將此聚醯胺酸(PAA-1)溶液15.0g移動到50mL三角燒 瓶中,加入NMP 15.0g、BC 7.50g進行稀釋’製成聚醯胺 酸(PAA-1)爲6質量%、NMP爲74質量%、BC爲20質量 %之溶液,得到本發明之液晶配向劑-1。此聚醯胺酸之數 平均分子量爲12,300、重量平均分子量爲33,100。 (實施例2)使用CBDA/Diamine-2之聚醯胺酸之合成 在5 OmL四頸燒瓶中,作爲二胺成分,加入合成實施 例 2 所得到的 Diamine-2 1.50g(6.25mmol)、NMP 15.〇g, 冷卻到約l〇°C,加入CBDA 1.14g(5.80mmol) ’回復至室 -61 - 201226390 溫,並使於氮氣氛下反應6小時,得到聚醯胺酸(p a A - 2 ) 之濃度1 5質量%之溶液。 將此聚醯胺酸(PAA-2)溶液15.0g移動到50mL三角燒 瓶中,加入NMP 15.0g、BC 7.50g進行稀釋,製成聚醯胺 酸(PAA-2)爲6質量%、NMP爲74質量%、bC爲20質量 %之溶液,得到本發明之液晶配向劑-2。此聚醯胺酸之數 平均分子量爲13,700、重量平均分子量爲35,600。 (實施例3)使用CBDA/Diamine-3之聚醯胺酸之合成 在50mL四頸燒瓶中’作爲二胺成分,加入合成實施 例 3 所得到的 Diamine-3 1 . 5 0 g (5.8 0mm ο 1) ' NMP 14.3g, 冷卻到約1 〇°C,加入CBDA 1.02g(5.20mmol),回復至室 溫,並使於氮氣氛下反應6小時,得到聚醯胺酸(p a A - 3 ) 之濃度15質量%之溶液。 將此聚醯胺酸(PAA-3)溶液15.0g移動到50mL三角燒 瓶中,加入NMP 15.0g、BC 7.50g進行稀釋,製成聚醯胺 酸(PAA-3)爲6質量%、NMP爲74質量%、BC爲20質量 %之溶液,得到本發明之液晶配向劑-3。此聚醯胺酸之數 平均分子量爲11,〇〇〇、重量平均分子量爲31,300。 (實施例4)使用CBDA/Diamine-4之聚醯胺酸之合成 在5 OmL四頸燒瓶中,作爲二胺成分,加入合成實施 例 4 所得到的 Diamine-4 1.50g(6_25mmol)、NMP 15.0g, 冷卻到約 l〇°C,加入 CBDA 1.14g(5.80mmol),回復至室 -62- 201226390 溫,並使於氮氣氛下反應6小時,得到聚醯胺酸(PAA-4) 之濃度15質量%之溶液。 將此聚醯胺酸(PAA-4)溶液15.0g移動到50mL三角燒 瓶中,加入NMP 15.0g、BC 7.50g進行稀釋,製成聚醯胺 酸(PAA-4)爲6質量%、NMP爲74質量%、BC爲20質量 %之溶液,得到本發明之液晶配向劑-4。此聚醯胺酸之數 平均分子量爲14,200、重量平均分子量爲3 6,700 » (比較例1)使用CBDA/Diamine-5之聚醯胺酸之合成 在5 OmL四頸燒瓶中,作爲二胺成分,加入合成比較 例 1 所得到的 Diamine-5 1 . 5 0 g (6.7 5 mmo 1) ' NMP 15.4g » 冷卻到約l〇°C,加入CBDA 1.23g(6.25mmol),回復至室 溫,並使於氮氣氛下反應6小時,得到聚醯胺酸(p A A - 5) 之濃度15質量%之溶液。 將此聚醯胺酸(PAA-5)溶液15.0g移動到50mL三角燒 瓶中’加入NMP 15.0g、BC 7.50g進行稀釋,製成聚醯胺 酸(PAA-5)爲6質量%、NMP爲74質量%、BC爲20質量 %之溶液,得到作爲比較對象之液晶配向劑-5。此聚醯胺 酸之數平均分子量爲1 2,300、重量平均分子量爲 32,100。 (實施例5)使用CBDA/Diamine-1、C16DAB之可溶性 聚醯亞胺之合成 在5 OmL四頸燒瓶中,作爲二胺成分,加入合成實施 -63- 201226390 例 1 所得到的 Diamine-1 2.OOg(8.88mmol)、C16DAB 0.774g(2.22mmol)、NMP 27.2g,冷卻到約 10°C,加入 CBDA 1.81g(10.3mmol),回復至室溫,並使於氮氣氛下反 應6小時,得到聚醯胺酸(PAA-6)之濃度15質量%之溶 液。 於聚醯胺酸(PAA-6)溶液20g中加入NMP 30.0g進行 稀釋,並加入乙酸酐2.19g與吡啶0.90g,以40°C使反應 3小時。將此反應溶液冷卻至室溫程度後,一邊攪拌一邊 緩慢地注入於已冷卻至約l〇°C之甲醇180mL中,使固體 析出。將沈澱的固體回收,進一步以甲醇l〇〇mL進行合 計2次的分散洗淨,藉由以1 00°C進行減壓乾燥,得到聚 醯亞胺(SPI-1)之微紫色粉末。此聚醯亞胺之數平均分子量 爲9,200、重量平均分子量爲23,500。又,醯亞胺化率爲 8 1%。 於聚醯亞胺(SPI-l)2.00g中加入γ-BL 18.0g,以50°C 攪拌20小時。於攪拌結束之時間點聚醯亞胺已完全溶 解。更,加入γ-BL 8.0g、BC 12.0g於此溶液中,以50°C 攪拌20小時,得到聚醯亞胺(SPI-1)爲5質量%、γ-BL爲 6 5質量%、B C爲3 0質量%之液晶配向劑-6。 (實施例6)使用CBDA/Diamine-2、C 1 6DAB之可溶性 聚醯亞胺之合成Ruthenium amination rate (%) = (l-〇fX/y) xlOO (Example 1) Synthesis of polyamidic acid using CBDA/Diamine-1 In a 50 mL four-necked flask, as a diamine component, it was added to the synthesis. Example 1 Diamine·1 1 · 50 g (6.6 5 mm ο 1) 'NMP 1 5.3 g > was cooled to about 10 ° C. Add CBDA 1.22 g (6.20 mmol), and return to room temperature. The reaction was carried out for 6 hours under a nitrogen atmosphere to obtain a solution having a concentration of polyamine acid (PAA-1) of 15% by mass. 15.0 g of this polyaminic acid (PAA-1) solution was transferred to a 50 mL Erlenmeyer flask, and 15.0 g of NMP and 7.50 g of BC were added and diluted to prepare a polyglycine (PAA-1) of 6 mass%, and NMP was A solution of 74% by mass and BC of 20% by mass gives the liquid crystal alignment agent-1 of the present invention. The polyamino acid had an average molecular weight of 12,300 and a weight average molecular weight of 33,100. (Example 2) Synthesis of polyamino acid using CBDA/Diamine-2 In a 50 mL four-necked flask, Diamine-2 1.50 g (6.25 mmol) obtained in Synthesis Example 2 was added as a diamine component, and NMP was added. 15. 〇g, cooled to about l ° ° C, added CBDA 1.14g (5.80mmol) 'return to room -61 - 201226390 temperature, and allowed to react under nitrogen atmosphere for 6 hours to get poly-proline (pa A - 2) A solution having a concentration of 15% by mass. 15.0 g of this poly-proline (PAA-2) solution was transferred to a 50 mL Erlenmeyer flask, and 15.0 g of NMP and 7.50 g of BC were added and diluted to obtain a polyamine acid (PAA-2) of 6 mass%, and NMP was A solution of 74% by mass and bC of 20% by mass gave the liquid crystal alignment agent-2 of the present invention. The polyamino acid had an average molecular weight of 13,700 and a weight average molecular weight of 35,600. (Example 3) Synthesis of polyaminic acid using CBDA/Diamine-3 As a diamine component in a 50 mL four-necked flask, Diamine-3 obtained by Synthesis Example 3 was added to 1.50 g (5.8 0 mm). 1) 'NMP 14.3g, cooled to about 1 〇 ° C, added CBDA 1.02g (5.20mmol), returned to room temperature, and allowed to react under nitrogen atmosphere for 6 hours to obtain poly-proline (pa A - 3 ) A solution having a concentration of 15% by mass. 15.0 g of this polyaminic acid (PAA-3) solution was transferred to a 50 mL Erlenmeyer flask, and 15.0 g of NMP and 7.50 g of BC were added and diluted to obtain a polyamine acid (PAA-3) of 6 mass%, and NMP was A solution of 74% by mass and BC of 20% by mass gives the liquid crystal alignment agent-3 of the present invention. The polyamino acid had an average molecular weight of 11, and had a weight average molecular weight of 31,300. (Example 4) Synthesis of polyamino acid using CBDA/Diamine-4 In a 50 mL four-necked flask, Diamine-4 obtained in Synthesis Example 4 was added as a diamine component 1.50 g (6-25 mmol), NMP 15.0. g, cooled to about 10 ° C, added CBDA 1.14g (5.80mmol), returned to room -62- 201226390 temperature, and allowed to react under nitrogen atmosphere for 6 hours to obtain the concentration of poly-proline (PAA-4) 15% by mass solution. 15.0 g of this poly-proline (PAA-4) solution was transferred to a 50 mL Erlenmeyer flask, and 15.0 g of NMP and 7.50 g of BC were added and diluted to obtain a polyamine acid (PAA-4) of 6 mass%, and NMP was A solution of 74% by mass and BC of 20% by mass gives the liquid crystal alignment agent-4 of the present invention. The polyamino acid had a number average molecular weight of 14,200 and a weight average molecular weight of 3,600 » (Comparative Example 1) Synthesis of polyamino acid using CBDA/Diamine-5 in a 50 mL four-necked flask as a diamine component. Diamine-5 1 . 5 0 g (6.7 5 mmo 1) 'NMP 15.4g obtained by the synthesis of Comparative Example 1 was added. After cooling to about 10 ° C, CBDA 1.23 g (6.25 mmol) was added and returned to room temperature. The reaction was carried out for 6 hours under a nitrogen atmosphere to obtain a solution having a concentration of polyamine acid (p AA - 5 ) of 15% by mass. 15.0 g of this polyaminic acid (PAA-5) solution was transferred to a 50 mL Erlenmeyer flask. 'NMP 15.0 g and 7.50 g of BC were added and diluted to obtain a polyamine acid (PAA-5) of 6 mass%, and NMP was A solution of 74% by mass and BC of 20% by mass was obtained as a liquid crystal alignment agent-5 to be compared. The polyamine has a number average molecular weight of 1,2,300 and a weight average molecular weight of 32,100. (Example 5) Synthesis of soluble polyimine using CBDA/Diamine-1 and C16DAB In a 50 mL four-necked flask, Diamine-1 2 obtained by synthesizing -63-201226390 Example 1 was added as a diamine component. .OOg (8.88 mmol), C16DAB 0.774 g (2.22 mmol), NMP 27.2 g, cooled to about 10 ° C, added 1.81 g (10.3 mmol) of CBDA, returned to room temperature, and allowed to react under nitrogen for 6 hours. A solution having a concentration of polyamine acid (PAA-6) of 15% by mass was obtained. To 20 g of a polyaminic acid (PAA-6) solution, 30.0 g of NMP was added and diluted, and 2.19 g of acetic anhydride and 0.90 g of pyridine were added, and the reaction was carried out at 40 ° C for 3 hours. After the reaction solution was cooled to room temperature, it was slowly poured into 180 mL of methanol cooled to about 10 ° C while stirring to precipitate a solid. The precipitated solid was recovered, and further dispersed and washed twice in methanol (1 mL), and dried under reduced pressure at 100 ° C to obtain a micro-purple powder of polyimine (SPI-1). The polyimine had a number average molecular weight of 9,200 and a weight average molecular weight of 23,500. Further, the sulfhydrylation rate was 8 1%. 18.0 g of γ-BL was added to 2.00 g of polyimine (SPI-1), and the mixture was stirred at 50 ° C for 20 hours. The polyimine was completely dissolved at the end of the stirring. Further, 8.0 g of γ-BL and 12.0 g of BC were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a polyamidimide (SPI-1) of 5% by mass and γ-BL of 6.5 mass%, BC. It is 30% by mass of the liquid crystal alignment agent-6. (Example 6) Synthesis of soluble polybendimimine using CBDA/Diamine-2, C 1 6DAB
在5 0m L四頸燒瓶中,作爲二胺成分,加入合成實施 例 2 所得到的 Diamine-2 2.00g(8.36mmol)、C16DABIn a 50 m L four-necked flask, Diamine-2 obtained by the synthesis of Example 2 was added as a diamine component, 2.00 g (8.36 mmol), C16DAB.
-64- 201226390 0.728g(2.09mmol) ' NMP 6.3g,冷卻到約 10 °C,力D 入 CBDA 1.90g(9.71mmol),回復至室溫,並使於氮氣氛下反 應6小時,得到聚醯胺酸(PAA-7)之濃度15質量%之溶 液。 於聚醯胺酸(PAA-7)溶液20g中加入NMP 30.0g進行 稀釋,並加入乙酸酐2.12g與吡啶0.88g,以40°C使反應 3小時。將此反應溶液冷卻至室溫程度後,一邊攪拌一邊 緩慢地注入於已冷卻至約l〇°C之甲醇160mL中,使固體 析出》將沈澱的固體回收,進一步以甲醇lOOmL進行合 計2次的分散洗淨,藉由以100°C進行減壓乾燥,得到聚 醯亞胺(SP 1-2)之微紫色粉末。此聚醯亞胺之數平均分子量 爲9,800、重量平均分子量爲24,200。又,醯亞胺化率爲 8 0%。 於聚醯亞胺(SPI-2)2.00g中加入γ-BL 18.0g,以50°C 攪拌20小時。於攪拌結束之時間點聚醯亞胺已完全溶 解。更,加入γ-BL 8.0g、BC 12.0g於此溶液中,以50°C 攪拌20小時,得到聚醯亞胺(SPI-2)爲5質量%、γ-BL爲 6 5質量%、B C爲3 0質量%之液晶配向劑· 7。 (實施例7)使用CBDA/Diamine-3、C16DAB之可溶性 聚醯亞胺之合成 在50mL四頸燒瓶中,作爲二胺成分,加入合成實施 例 3 所得到的 Diamine-3 2.00g(7.47mmol)、C16DAB 0.65 1 g(l .87mmol)、NMP 24.7g,冷卻到約 10 °C,力口入 -65- 201226390 CBDA 1.51g(8.68mmol),回復至室溫,並使於氮氣氛下反 應6小時,得到聚醯胺酸(PAA-8)之濃度15質量%之溶 液。 於聚醯胺酸(PAA-8)溶液20g中加入NMP 30.0g進行 稀釋,並加入乙酸酐2.00g與吡啶0.83g,以40°C使反應 3小時。將此反應溶液冷卻至室溫程度後,一邊攪拌一邊 緩慢地注入於已冷卻至約l〇°C之甲醇160mL中,使固體 析出。將沈澱的固體回收,進一步以甲醇lOOmL進行合 計2次的分散洗淨,藉由以100 °C進行減壓乾燥,得到聚 醯亞胺(SPI-3)之微紫色粉末。此聚醯亞胺之數平均分子量 爲9,500、重量平均分子量爲22,200。又,醯亞胺化率爲 8 1%。 於聚醯亞胺(SPI-3)2.00g中加入γ-BL 18.0g,以50°C 攪拌20小時。於攪拌結束之時間點聚醯亞胺已完全溶 解。更,加入γ-BL 8.0g、BC 12.0g於此溶液中,以50°C 攪拌20小時,得到聚醯亞胺(SPI-3)爲5質量%、γ-BL爲 6 5質量%、B C爲3 0質量%之液晶配向劑-8。 (實施例8)使用CBDA/Diamine-4、C16DAB之可溶性 聚醯亞胺之合成 在50mL四頸燒瓶中,作爲二胺成分,加入合成實施 例 4 所得到的 Diamine-4 2.00g(8.36mmol)、C16DAB 0.728g(2.09mmol)、NMP 6.3g,冷卻到約 10°C,加入 CBDA 1.90g(9.71mmol),回復至室溫,並使於氮氣氛下反 201226390 應6小時,得到聚醯胺酸(PAA-8)之濃度15質量%之溶 液。 於聚醯胺酸(PAA-8)溶液20g中加入NMP 30.0g進行 稀釋,並加入乙酸酐2.12g與吡啶〇.88g,以40°C使反應 3小時。將此反應溶液冷卻至室溫程度後,一邊攪拌一邊 緩慢地注入於已冷卻至約l〇°C之甲醇180mL中,使固體 析出》將沈澱的固體回收,進一步以甲醇lOOmL進行合 計2次的分散洗淨,藉由以100 °C進行減壓乾燥,得到聚 醯亞胺(SPI-4)之微紫色粉末。此聚醯亞胺之數平均分子量 爲1 0,200、重量平均分子量爲2 8,900。又,醯亞胺化率 爲 82%。 於聚醯亞胺(SPI-4)2.00g中加入γ-BL 18.0g,以50°C 攪拌20小時。於攪拌結束之時間點聚醯亞胺已完全溶 解。更,加入γ-BL 8.0g、BC 12.0g於此溶液中,以50°C 攪拌20小時,得到聚醯亞胺(SPI-4)爲5質量%、γ-BL爲 65質量% ' BC爲30質量%之液晶配向劑-9。 (比較例2)使用CBDA/Diamine-5、C16DAB之可溶性 聚醯亞胺之合成 在5 OmL四頸燒瓶中,作爲二胺成分,加入合成比較 例 1 所得到的 Diamine-5 2.00g(8.96mmol)、C16DAB 0.78 1 g(2.24mmol)、NMP 27.3g,冷卻到約 10°C,加入 CBDA 2.04g(10.4mmol),回復至室溫,並使於氮氣氛下反 應6小時,得到聚醯胺酸(PAA-9)之濃度15質量%之溶 -67- 201226390 液。 於聚醯胺酸(PAA-9)溶液20g中加入NMP 30.0g進行 稀釋,並加入乙酸酐2.2 0g與吡啶〇.91g,以40°C使產生 反應,但經過些許時間即開始產生凝膠化,變得無法攪 拌。無法調製可溶性聚醯亞胺(SPI-5)。因而無法調製比較 對象之液晶配向劑-1 〇。 (實施例9) <使用CBDA/Diamine-1、DDM之聚醯胺酸之合成> 在50mL四頸燒瓶中,作爲二胺成分,加入合成實施 例 1 所得到的 Diamine-1 2.50g(ll.lmmol)、DDM 0.943g(4_77mmol)、NMP 17.9g、γ-BL 17.9g,冷卻到約 l〇°C,加入CBDA 2.89g(14.8mmol),回復至室溫,並使於 氮氣氛下反應6小時,得到聚醯胺酸(PAA-10)之濃度15 質量%之溶液。 將此聚醯胺酸(PAA-10)溶液30.0g移動到100mL三角 燒瓶中,加入 NMP 28.0g、γ-BL 2.20g、BC 15.0g 進行稀 釋,製成聚醯胺酸(PAA-10)爲6質量%、NMP爲54質量 %、γ-BL爲20質量%、BC爲20質量%之溶液,得到摻合 用聚醯胺酸溶液(BL-PAA1)。此聚醯胺酸之數平均分子量 爲10,400、重量平均分子量爲29,100。 <使用TDA/p-PDA,C16DAB之可溶性聚醯亞胺之合成>-64- 201226390 0.728g (2.09mmol) ' NMP 6.3g, cooled to about 10 ° C, force D into CBDA 1.90g (9.71mmol), returned to room temperature, and allowed to react under nitrogen atmosphere for 6 hours to obtain poly A solution of 15% by mass of proline (PAA-7). To 20 g of a polyaminic acid (PAA-7) solution, 30.0 g of NMP was added and diluted, and 2.12 g of acetic anhydride and 0.88 g of pyridine were added, and the reaction was carried out at 40 ° C for 3 hours. After cooling the reaction solution to room temperature, it was slowly poured into 160 mL of methanol cooled to about 10 ° C while stirring to precipitate a solid, and the precipitated solid was recovered, and further totaled in methanol 100 mL. The mixture was washed, and dried under reduced pressure at 100 ° C to obtain a micro-purple powder of polyimine (SP 1-2). The polyimine had a number average molecular weight of 9,800 and a weight average molecular weight of 24,200. Further, the sulfhydrylation rate was 80%. 18.0 g of γ-BL was added to 2.00 g of polyimine (SPI-2), and the mixture was stirred at 50 ° C for 20 hours. The polyimine was completely dissolved at the end of the stirring. Further, 8.0 g of γ-BL and 12.0 g of BC were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain phthalocyanine (SPI-2) of 5% by mass and γ-BL of 6.5 mass%, BC. It is 30% by mass of liquid crystal alignment agent·7. (Example 7) Synthesis of soluble polyimine using CBDA/Diamine-3 and C16DAB In a 50 mL four-necked flask, Diamine-3 obtained in Synthesis Example 3 was added as a diamine component. 2.00 g (7.47 mmol) C16DAB 0.65 1 g (1.87 mmol), NMP 24.7 g, cooled to about 10 ° C, and then poured into -65-201226390 CBDA 1.51 g (8.68 mmol), returned to room temperature, and allowed to react under nitrogen atmosphere 6 In an hour, a solution of a concentration of polyamine acid (PAA-8) of 15% by mass was obtained. To 20 g of a polyamine acid (PAA-8) solution, 30.0 g of NMP was added and diluted, and 2.00 g of acetic anhydride and 0.83 g of pyridine were added, and the reaction was carried out at 40 ° C for 3 hours. After the reaction solution was cooled to room temperature, it was slowly poured into 160 mL of methanol cooled to about 10 ° C while stirring to precipitate a solid. The precipitated solid was recovered, and further dispersed and washed twice in methanol (100 mL), and dried under reduced pressure at 100 ° C to obtain a micro-purple powder of polyimine (SPI-3). The polyimine had a number average molecular weight of 9,500 and a weight average molecular weight of 22,200. Further, the sulfhydrylation rate was 8 1%. 18.0 g of γ-BL was added to 2.00 g of polyimine (SPI-3), and the mixture was stirred at 50 ° C for 20 hours. The polyimine was completely dissolved at the end of the stirring. Further, 8.0 g of γ-BL and 12.0 g of BC were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a bismuthimide (SPI-3) of 5% by mass and γ-BL of 6.5 mass%, BC. It is 30% by mass of the liquid crystal alignment agent-8. (Example 8) Synthesis of Soluble Polyimine Using CBDA/Diamine-4 and C16DAB Diamine-4 2.00 g (8.36 mmol) obtained in Synthesis Example 4 was added as a diamine component to a 50 mL four-necked flask. , C16DAB 0.728g (2.09mmol), NMP 6.3g, cooled to about 10 ° C, added 1.90g (9.71mmol) of CBDA, returned to room temperature, and reacted under the nitrogen atmosphere for 201226390 for 6 hours to obtain polydecylamine. A solution of 15% by mass of acid (PAA-8). To 20 g of a polyproline (PAA-8) solution, 30.0 g of NMP was added and diluted, and 2.12 g of acetic anhydride and .88 g of pyridinium were added, and the reaction was allowed to proceed at 40 ° C for 3 hours. After cooling the reaction solution to room temperature, it was slowly poured into 180 mL of methanol which had been cooled to about 10 ° C while stirring to precipitate a solid, and the precipitated solid was recovered, and further totaled in methanol 100 mL. The mixture was washed, and dried under reduced pressure at 100 ° C to obtain a micro-purple powder of polyimine (SPI-4). The polyimine has a number average molecular weight of 10,200 and a weight average molecular weight of 28,900. Further, the sulfhydrylation rate was 82%. 18.0 g of γ-BL was added to 2.00 g of polyimine (SPI-4), and the mixture was stirred at 50 ° C for 20 hours. The polyimine was completely dissolved at the end of the stirring. Further, 8.0 g of γ-BL and 12.0 g of BC were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain phthalocyanine (SPI-4) of 5% by mass and γ-BL of 65% by mass. 30% by mass of liquid crystal alignment agent-9. (Comparative Example 2) Synthesis of Soluble Polyimine Using CBDA/Diamine-5 and C16DAB Diamine-5 2.00 g (8.96 mmol) obtained in Synthesis Comparative Example 1 was added as a diamine component to a 50 mL four-necked flask. ), C16DAB 0.78 1 g (2.24 mmol), NMP 27.3 g, cooled to about 10 ° C, added CBDA 2.04 g (10.4 mmol), returned to room temperature, and allowed to react under nitrogen for 6 hours to obtain polydecylamine. The concentration of the acid (PAA-9) is 15% by mass of the solution -67-201226390. 30.0g of NMP was added to 20g of polylysine (PAA-9) solution for dilution, and 2.20g of acetic anhydride and .91g of pyridinium were added to react at 40 ° C, but gelation started after a little time. It became impossible to stir. Unable to modulate soluble polyimine (SPI-5). Therefore, the liquid crystal alignment agent -1 〇 of the comparison object cannot be prepared. (Example 9) <Synthesis of polyaminic acid using CBDA/Diamine-1 and DDM> Diamine-1 2.50 g obtained in Synthesis Example 1 was added as a diamine component in a 50 mL four-necked flask ( Ll.lmmol), DDM 0.943g (4_77mmol), NMP 17.9g, γ-BL 17.9g, cooled to about 10 ° C, added CBDA 2.89g (14.8mmol), returned to room temperature, and under nitrogen atmosphere After reacting for 6 hours, a solution of a concentration of polyamine acid (PAA-10) of 15% by mass was obtained. 30.0 g of this polyaminic acid (PAA-10) solution was transferred to a 100 mL Erlenmeyer flask, and NMP 28.0 g, γ-BL 2.20 g, and BC 15.0 g were added and diluted to prepare polyglycine (PAA-10). A solution of 6 mass%, NMP of 54% by mass, γ-BL of 20% by mass, and BC of 20% by mass gave a polylysine solution (BL-PAA1) for blending. The polyamine had a number average molecular weight of 10,400 and a weight average molecular weight of 29,100. <Synthesis of Soluble Polyimine of C16DAB Using TDA/p-PDA>
在5 0mL四頸燒瓶中,作爲二胺成分,加入p-PDA 2.00g( 1 8.5mmol) ' C16DAB 0.7 1 8 g( 2.0 6 mm ο 1) 、 NMP -68- 201226390 3 5.4g,冷卻到約 10°C,加入 TDA 6.12g(20.4mmol),於氮 氣氛下以40°C使反應20小時,得到聚醯胺酸(paA-15)之 濃度20質量%之溶液。 於聚醯胺酸(PAA-15)溶液40.0g中加入NMP 93.3g進 行稀釋,並加入乙酸酐9.51g與吡啶7.36g,以40°C使反 應3小時。將此反應溶液冷卻至室溫程度後,一邊攪拌一 邊緩慢地注入於已冷卻至約l〇°C之甲醇500mL中,使固 體析出。將沈澱的固體回收,進一步以甲醇300mL進行 合計2次的分散洗淨,藉由以100 °C進行減壓乾燥,得到 聚醯亞胺(SP 1-6)之白色粉末。此聚醯亞胺之數平均分子量 爲9,500、重量平均分子量爲20,900。又,醯亞胺化率爲 8 5%。In a 50 mL four-necked flask, p-PDA 2.00 g (1 8.5 mmol) of 'C16DAB 0.7 1 8 g (2.0 6 mm ο 1), NMP-68-201226390 3 5.4 g was added as a diamine component, and cooled to about At 10 ° C, 6.12 g (20.4 mmol) of TDA was added, and the reaction was carried out at 40 ° C for 20 hours under a nitrogen atmosphere to obtain a solution of a concentration of polyglycine (paA-15) of 20% by mass. To 40.0 g of a polyaminic acid (PAA-15) solution, 93.3 g of NMP was added for dilution, and 9.51 g of acetic anhydride and 7.36 g of pyridine were added, and the reaction was allowed to proceed at 40 ° C for 3 hours. After the reaction solution was cooled to room temperature, it was slowly poured into 500 mL of methanol which had been cooled to about 10 ° C while stirring to precipitate a solid. The precipitated solid was recovered, and further dispersed and washed twice in 300 mL of methanol, and dried under reduced pressure at 100 ° C to obtain a white powder of polyimine (SP 1-6). The polyimine had a number average molecular weight of 9,500 and a weight average molecular weight of 20,900. Further, the sulfhydrylation rate was 85%.
於聚醯亞胺(SPI-6)7.00g中加入γ-BL 80.5g,以50°C 攪拌20小時。於攪拌結束之時間點聚醯亞胺已完全溶 解。更,加入γ-BL 29.2g於此溶液中,以50°C攪拌20小 時,得到作爲聚醯亞胺(SP 1-6)爲6質量%、γ-BL爲94質 量%之溶液之摻合用聚醯亞胺溶液(BL-SPI)。 <摻合系液晶配向劑之調製> 將已調製的摻合用聚醯胺酸溶液(BL-PAA1)分別秤取 40g於2 00mL三角燒瓶中,加入已調製的摻合用聚醯亞胺 溶液(BL-SPI)lO.Og,於氮氣氛下使攪拌20小時,得到摻 合系液晶配向劑BL-1。 (實施例1 0) -69- 201226390 <使用CBDA/Diamine-2、DDM之聚醯胺酸之合成> 在5 OmL四頸燒瓶中,作爲二胺成分,加入合成實施 例 2 所得到的 Diamine-2 2.50g( 10.4mmol)、DDM 0.887g(4.47mmol)、NMP 17.3g、γ-BL 17.3g,冷卻到約 10°C,加入CBDA 2.7 2g(13.9mmol),回復至室溫後於氮 氣氛下使反應6小時,得到聚醯胺酸(P A A - 1 1 )之濃度1 5 質量%之溶液。 將此聚醯胺酸(PAA-11)溶液30.0g移動到lOOmL三角 燒瓶中,加入 NMP 28.0g、γ-BL 2.20g、BC 15.0g 進行稀 釋,製成聚醯胺酸(PAA-11)爲6質量%、NMP爲54質量 %、γ - B L爲2 0質量%、B C爲2 0質量%之溶液,得到摻合 用聚醯胺酸溶液(BL-PAA2)。此聚醯胺酸之數平均分子量 爲11,200、重量平均分子'量爲31,000。 <摻合系液晶配向劑之調製> 將已調製的摻合用聚醯胺酸溶液(BL-P A Α2)分別秤取 40g於2 OOmL三角燒瓶中,加入與實施例9爲使用相同之 方法所調製的摻合用聚醯亞胺溶液(BL-SPI)lO.Og,於氮 氣氛下使攪拌20小時,得到摻合系液晶配向劑BL-2。 (實施例11) <使用CBDA/Diamine-3、DDM之聚醯胺酸之合成> 在5 OmL四頸燒瓶中,作爲二胺成分,加入合成實施 例 3 所得到的 Diamine-3 2.50g(9.35mmol)、DDM 0.794g(4.01mmol)、NMP 16.2g、γ-BL 16.2g,冷卻到約80.5 g of γ-BL was added to 7.00 g of polyimine (SPI-6), and the mixture was stirred at 50 ° C for 20 hours. The polyimine was completely dissolved at the end of the stirring. Further, 29.2 g of γ-BL was added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a solution of a solution of phthalocyanine (SP 1-6) of 6 mass% and γ-BL of 94 mass%. Polyimine solution (BL-SPI). <Preparation of blended liquid crystal alignment agent> 40 g of the prepared polyglycine solution (BL-PAA1) was separately weighed into a 200 mL Erlenmeyer flask, and the prepared polyimine solution for blending was added. (BL-SPI) 10 g of Og was stirred under a nitrogen atmosphere for 20 hours to obtain a blended liquid crystal alignment agent BL-1. (Example 1 0) -69-201226390 <Synthesis of Polylysine Using CBDA/Diamine-2 and DDM> In a 50 mL four-necked flask, the synthesis example 2 was added as a diamine component. Diamine-2 2.50g (10. 4mmol), DDM 0.887g (4.47mmol), NMP 17.3g, γ-BL 17.3g, cooled to about 10 ° C, added CBDA 2.7 2g (13.9mmol), returned to room temperature after The reaction was allowed to proceed for 6 hours under a nitrogen atmosphere to obtain a solution of a polyamine acid (PAA-1 1 ) concentration of 15 mass%. 30.0 g of this polyaminic acid (PAA-11) solution was transferred to a 100 mL Erlenmeyer flask, and NMP 28.0 g, γ-BL 2.20 g, and BC 15.0 g were added and diluted to prepare polylysine (PAA-11). A solution of 6 mass%, NMP of 54 mass%, γ-BL of 20 mass%, and BC of 20 mass% was obtained, and a polylysine solution (BL-PAA2) for blending was obtained. The polyamine has a number average molecular weight of 11,200 and a weight average molecular amount of 31,000. <Preparation of blended liquid crystal alignment agent> 40 g of the prepared polyglycine solution (BL-P A Α 2) was separately weighed into a 200 mL Erlenmeyer flask, and was added in the same manner as in Example 9. The blended polyimine solution (BL-SPI) of the method was stirred for 20 hours under a nitrogen atmosphere to obtain a blended liquid crystal alignment agent BL-2. (Example 11) <Synthesis of polyaminic acid using CBDA/Diamine-3 and DDM> Diamine-3 2.50 g obtained in Synthesis Example 3 was added as a diamine component in a 50 mL four-necked flask. (9.35 mmol), DDM 0.794 g (4.01 mmol), NMP 16.2 g, γ-BL 16.2 g, cooled to about
-7〇- S 201226390 l〇°C ’加入CBDA 2.43g(12.4mmol),回復至室溫後於氮 氣氛下使反應6小時,得到聚醯胺酸(pa A-12)之濃度15 質量%之溶液。 將此聚醯胺酸(PAA-12)溶液30.0g移動到100mL三角 燒瓶中,加入 NMP 28.0g、γ-BL 2.20g、BC 15.0g 進行稀 釋’製成聚醯胺酸(PAA-12)爲6質量%、NMP爲54質量 %、γ-BL爲20質量%、BC爲20質量%之溶液,得到摻合 用聚醯胺酸溶液(BL-P A A3)。此聚醯胺酸之數平均分子量 爲1 3,600、重量平均分子量爲36,000。 <摻合系液晶配向劑之調製> 將已調製的摻合用聚醯胺酸溶液(BL-PAA3)分別秤取 4〇g於2OOmL三角燒瓶中,加入與實施例9爲使用相同之 方法所調製的摻合用聚醯亞胺溶液(BL-SPI)lO.Og,於氮 氣氛下使攪拌20小時,得到摻合系液晶配向劑BL-3。 (實施例12) <使用CBDA/Di amine-4 ' DDM之聚醯胺酸之合成> 在50mL四頸燒瓶中,作爲二胺成分,加入合成實施 例 4 所得到的 Diamine-4 2.50g(10.4mmol) 、DDM O.88 7g(4.47mmol)、NMP 17.3g、γ-BL 17.3g,冷卻到約 l〇°C,加入CBDA 2.72g(13.9mmol),回復至室溫後於氮 氣氛下使反應6小時,得到聚醯胺酸(PAA-13)之濃度15 質量%之溶液。 將此聚醯胺酸(PAA-13)溶液30.0g移動到lOOmL三角 -71 - 201226390 燒瓶中,加入 NMP 28.0g、γ-BL 2.20g、BC 15.0g 進行稀 釋,製成聚醯胺酸(PAA-13)爲6質量%、NMP爲54質量 %、γ-BL爲20質量%、BC爲20質量%之溶液,得到摻合 用聚醯胺酸溶液(BL-P A A4)。此聚醯胺酸之數平均分子量 爲1 2,500、重量平均分子量爲30,800。 <摻合系液晶配向劑之調製> 將已調製的摻合用聚醯胺酸溶液(BL-P A A4)分別秤取 40g於200mL三角燒瓶中,加入與實施例9爲使用相同之 方法所調製的摻合用聚醯亞胺溶液(BL-SPI)lO.Og,於氮 氣氛下使攪拌20小時,得到摻合系液晶配向劑BL-4。 (比較例3 ) <使用CBDA/Diamine-5、DDM之聚醯胺酸之合成> 在50mL四頸燒瓶中,作爲二胺成分,加入合成比較 例 1 所得到的 D i a m i n+e - 5 2 · 5 0 g (1 1 · 2 m m ο 1) 、 D D Μ 0.952g(4.80mmol)、NMP 18.1g、γ-BL 18.1g,冷卻到約 10°C,加入CBDA 2.92g(14.9mmol),回復至室溫後於氮 氣氛下使反應6小時,得到聚醯胺酸(PAA-14)之濃度15 質量%之溶液。 將此聚醯胺酸(PAA-14)溶液30.0g移動到lOOmL三角 燒瓶中,加入 NMP 28.0g、γ-BL 2.20g、BC 15.0g 進行稀 釋,製成聚醯胺酸(PAA-14)爲6質量%、NMP爲54質量 %、γ-BL爲20質量%、BC爲20質量%之溶液,得到摻合 用聚醯胺酸溶液(BL-PAA5)。此聚醯胺酸之數平均分子量 -72- 201226390 爲13,600、重量平均分子量爲37,700。 <摻合系液晶配向劑之調製> 將已調製的摻合用聚醯胺酸溶液(BL-P A A4)分別秤取 40g於2 OOmL三角燒瓶中,加入與實施例9爲使用相同之 方法所調製的摻合用聚醯亞胺溶液(BL-SPI)lO.Og,於氮 氣氛下使攪拌20小時,得到摻合系液晶配向劑BL-5。 (實施例13) 〈摻合用PAE> 在 1 OOmL 四頸燒瓶中加入 CBDE 6.35g(24.4mmol)、 及作爲二胺成分之 p-PDA 250g(23.1mmol)、C16DAB 0.8 96g(2.57mmol) 、 NMP 71 ,5g 、 三 乙基胺 〇.60g(5.90mmol) « 冷卻到約 10°C ,加入 DMT-MM 21.3g(77.1mm〇l),回復至室溫後於氮氣氛下使反應24小 時,得到聚醯胺酸酯(PAE-1)之濃度12質量%之溶液。 於此聚醯胺酸(PAE-1)溶液中加入NMP 81.2g,一邊 攪拌一邊緩慢地注入於已冷卻至約l〇t之甲醇1.0L中, 使固體析出。將沈澱的固體回收,進一步以甲醇5 OOmL 進行合計2次的分散洗淨,藉由以l〇〇°C進行減壓乾燥, 得到聚醯胺酸酯(PAE-1)之白色粉末。此聚醯胺酸酯之數 平均分子量爲12,300、重量平均分子量爲27,000。 於此聚醯胺酸酯(PAE-l)7.00g中加入γ-BL 80.5g,以 5〇°C攪拌20小時。於攪拌結束之時間點聚醯亞胺已完全 溶解。更,加入γ-BL 29.2g於此溶液中,以5(TC攪拌20 -73- 201226390 小時,製成聚醯胺酸酯(PAE-l)爲6質量%、γ-BL爲 量%之溶液,得到摻合用聚醯胺酸酯溶液(BL-PAE)。 <摻合系液晶配向劑之調製> 將使用與實施例.9爲相同之方法所調製的摻合月 胺酸溶液(BL-PAA1)秤取40g於200mL三角燒瓶中’ 已調製的摻合用聚醯胺酸酯溶液(BL-PAE) lO.Og,Μ 氛下使攪拌20小時,得到摻合系液晶配向劑BL-6。 (實施例14) 將與實施例10爲相同地調製的摻合用聚醯胺匪 (BL-PAA2)秤取40g於200mL三角燒瓶中,加入與f 13爲相同地調製的摻合用聚醯胺酸酯溶液(BL 10.〇g,於氮氣氛下使攪拌20小時,得到摻合系液| 劑 BL-7。 (實施例15) 將與實施例11爲相向地調製的摻合用聚醯胺S (BL-PAA3)秤取40g於200mL三角燒瓶中,加入與f 13爲相同地調製的摻合用聚醯胺酸酯溶液(BL 10.· 〇g,於氮氣氛下使攪拌20小時’得到摻合系液違 劑 BL-8。 (實施例1 6) 將與實施例1 2爲相同地調製的摻合用聚醯胺 94質 聚醯 加入 氮氣 溶液 施例 P AE) 配向 溶液 施例 PAE) 配向 溶液 -74- 201226390 (BL-ΡΑΑ4)秤取4〇g於200mL三角燒瓶中,加入與實施例 13爲相同地調製的摻合用聚醯胺酸酯溶液(BL-PAE) l〇.〇g,於氮氣氛下使攪拌20小時,得到摻合系液晶配向 齊!I B L - 9 〇 (比較例4) 將與比較例3爲相同地調製的摻合用聚醯胺酸溶液 (BL-PAA5)秤取40g於200mL三角燒瓶中,加入與實施例 13爲相同地調製的摻合用聚醯胺酸酯溶液(BL-PAE) 10.〇g,於氮氣氛下使攪拌20小時,得到摻合系液晶配向 劑BL-10(比較例)。 (試驗例1)清漆(液晶配向劑)印刷性試驗 藉由將實施例1〜1 6及比較例1〜4所調製的液晶配 向劑,使用配向膜印刷機(日本寫真印刷公司製 「angstromer」)於已洗淨的Cr板上進行快乾印刷,來進 行塗佈性試驗。將約1 · OmL之液晶配向劑滴下於網紋輥, 實施空運轉10次後,停止印刷機1 〇分鐘’使印刷版乾 燥。之後,對於1片的Cr基板進行印刷’印刷後的基板 放置於70°C加熱板上5分鐘,進行塗膜之預乾燥’並進行 膜狀態之觀察。觀察爲以目視與光學顯微鏡(nikon公司製 「ECLIPSE ME600」),以50倍進行觀察。未觀察到針孔 時以良好,觀察到針孔時以不良;又’未產生邊緣部之膜 厚不均勻時以良好,產生邊緣部之膜厚不均勻時以不良來 -75- 201226390 進行評價。結果如表3所示。 [液晶晶胞之製作] 對於實施例1〜1 6及比較例1〜4所調製的液晶配向 劑,以如以下般地製作液晶晶胞。將液晶配向劑旋轉塗怖 至附有透明電極之玻璃基板上,以在8 0 °C之加熱板上使乾 燥70秒鐘後,於22(TC之加熱板上進行10分鐘之鍛燒, 使形成膜厚l〇〇nm之塗膜。關於藉由磨擦之液晶配向處 理,係將此塗膜面以輥徑120mm之磨擦裝置使用嫘縈 布,以輥回轉數 lOOOrpm、輥行進速度 50mm/sec、壓入 量〇.3mm之條件進行磨擦,得到附有液晶配向膜之基 板。 準備已進行有如此般液晶配向處理之附有液晶配向膜 之基板2片,將6μιη之間隔物散布於其中1片之液晶配 向膜面上後,由其上方印刷封口劑,並使另1片之基板, 以液晶配向膜面爲相對地且磨擦方向爲正交地進行貼合 (ΤΝ型液晶晶胞),使封口劑硬化而製作空晶胞。此空晶 胞,藉由減壓注入法,將ΤΝ型晶胞時之液晶 MLC-2〇〇3(莫克公司製)注入,將注入口封止,得到ΤΝ型液晶 晶胞。 (試驗例2)高溫老化試驗前後離子密度之測定-7〇- S 201226390 l〇°C 'Add 2.43g (12.4mmol) of CBDA, return to room temperature and react for 6 hours under nitrogen atmosphere to obtain the concentration of poly-proline (pa A-12) 15% by mass. Solution. 30.0 g of this polyaminic acid (PAA-12) solution was transferred to a 100 mL Erlenmeyer flask, and NMP 28.0 g, γ-BL 2.20 g, and BC 15.0 g were added for dilution to prepare polyglycine (PAA-12). A solution of 6 mass%, NMP of 54% by mass, γ-BL of 20% by mass, and BC of 20% by mass gave a polylysine solution (BL-P A A3) for blending. The polyamine has a number average molecular weight of 1,3,600 and a weight average molecular weight of 36,000. <Preparation of blended liquid crystal alignment agent> The prepared blended polylysine solution (BL-PAA3) was separately weighed 4 〇g in a 200 mL Erlenmeyer flask, and the same method as in Example 9 was used. The prepared blended polyimine solution (BL-SPI) 10 Og was stirred under a nitrogen atmosphere for 20 hours to obtain a blended liquid crystal alignment agent BL-3. (Example 12) <Synthesis of polyaminic acid using CBDA/Di amine-4 'DDM> In a 50 mL four-necked flask, Diamine-4 2.50 g obtained in Synthesis Example 4 was added as a diamine component. (10.4mmol), DDM O.88 7g (4.47mmol), NMP 17.3g, γ-BL 17.3g, cooled to about 10 ° C, added 2.72g (13.9mmol) of CBDA, returned to room temperature after nitrogen atmosphere The reaction was allowed to proceed for 6 hours to obtain a solution of a polyamine acid (PAA-13) concentration of 15% by mass. 30.0 g of this polyaminic acid (PAA-13) solution was transferred to a 100 mL triangle-71 - 201226390 flask, and NMP 28.0 g, γ-BL 2.20 g, and BC 15.0 g were added for dilution to prepare polylysine (PAA). -13) A solution of 6 mass%, NMP of 54 mass%, γ-BL of 20 mass%, and BC of 20 mass%, and a polylysine solution (BL-P A A4) for blending was obtained. The polyamine has a number average molecular weight of 1,2,500 and a weight average molecular weight of 30,800. <Preparation of blended liquid crystal alignment agent> 40 g of the prepared polyglycine solution (BL-P A A4) was separately weighed into a 200 mL Erlenmeyer flask, and the same method as in Example 9 was used. The prepared blended polyimine solution (BL-SPI) 10 Og was stirred under a nitrogen atmosphere for 20 hours to obtain a blended liquid crystal alignment agent BL-4. (Comparative Example 3) <Synthesis of polyaminic acid using CBDA/Diamine-5 and DDM> In a 50 mL four-necked flask, D iami n+e obtained by synthesizing Comparative Example 1 was added as a diamine component. 5 2 · 50 g (1 1 · 2 mm ο 1) , DD Μ 0.952 g (4.80 mmol), NMP 18.1 g, γ-BL 18.1 g, cooled to about 10 ° C, and added CBDA 2.92 g (14.9 mmol) After returning to room temperature, the reaction was allowed to proceed for 6 hours under a nitrogen atmosphere to obtain a solution of a polyamine acid (PAA-14) concentration of 15% by mass. 30.0 g of this polyaminic acid (PAA-14) solution was transferred to a 100 mL Erlenmeyer flask, and NMP 28.0 g, γ-BL 2.20 g, and BC 15.0 g were added and diluted to prepare polylysine (PAA-14). A solution of 6 mass%, NMP of 54% by mass, γ-BL of 20% by mass, and BC of 20% by mass gave a polylysine solution (BL-PAA5) for blending. The polyamino acid had a number average molecular weight of -72 to 201226390 of 13,600 and a weight average molecular weight of 37,700. <Preparation of blended liquid crystal alignment agent> 40 g of the prepared polyglycine solution (BL-P A A4) was separately weighed into a 200 mL Erlenmeyer flask, and was added in the same manner as in Example 9. The blended polyimine solution (BL-SPI) of the method was stirred for 20 hours under a nitrogen atmosphere to obtain a blended liquid crystal alignment agent BL-5. (Example 13) <PAE for blending> 6.35 g (24.4 mmol) of CBDE and 250 g (23.1 mmol) of p-PDA as a diamine component, C16DAB 0.8 96 g (2.57 mmol), NMP were added to a 100 mL four-necked flask. 71,5g, triethylamine oxime. 60g (5.90mmol) « Cooled to about 10 ° C, added DMT-MM 21.3g (77.1mm 〇l), returned to room temperature and allowed to react under nitrogen atmosphere for 24 hours. A solution having a concentration of polyacetate (PAE-1) of 12% by mass was obtained. To the polyacetic acid (PAE-1) solution, 81.2 g of NMP was added, and while stirring, the mixture was slowly poured into 1.0 L of methanol which had been cooled to about 1 Torr to precipitate a solid. The precipitated solid was recovered, and further washed with a total of 500 mL of methanol for 2 times, and dried under reduced pressure at 10 ° C to obtain a white powder of polyamine (PAE-1). The polyperurethane had a number average molecular weight of 12,300 and a weight average molecular weight of 27,000. To the 7.00 g of the polyperurate (PAE-1), 80.5 g of γ-BL was added, and the mixture was stirred at 5 ° C for 20 hours. The polyimine was completely dissolved at the end of the stirring. Further, 29.2 g of γ-BL was added to the solution, and 5 (TC agitation of 20 -73 to 201226390 hours) was used to prepare a solution in which the polyglycolate (PAE-1) was 6 mass% and the γ-BL was a quantity %. A blending polyglycolate solution (BL-PAE) was obtained. <Preparation of blended liquid crystal alignment agent> A blended proline solution (BL) prepared in the same manner as in Example 9. -PAA1) Weigh 40g of the prepared polyglycolate solution (BL-PAE) lO.Og in a 200 mL Erlenmeyer flask, and stir for 20 hours under an atmosphere to obtain a blended liquid crystal alignment agent BL-6. (Example 14) 40 g of a blended polyamidoguanidine (BL-PAA2) prepared in the same manner as in Example 10 was weighed and placed in a 200 mL Erlenmeyer flask, and a blending polyamine prepared in the same manner as that of f 13 was added. The ester solution (BL 10.〇g, stirred under a nitrogen atmosphere for 20 hours to obtain a blending liquid | Agent BL-7. (Example 15) Polyamine prepared for blending in the same manner as in Example 11 S (BL-PAA3) was weighed and weighed 40 g in a 200 mL Erlenmeyer flask, and a blending polyglycolate solution (BL 10.·〇g, stirred under a nitrogen atmosphere for 20 hours) was added in the same manner as that of f 13 . Blending the liquid wicking agent BL-8. (Example 1 6) The blending polyamine 94 having the same preparation as in Example 12 was added to a nitrogen solution. Example P AE) Alignment solution (PAE) The alignment solution-74-201226390 (BL-ΡΑΑ4) was weighed and weighed 4 〇g in a 200 mL Erlenmeyer flask, and a blending polyamine solution (BL-PAE) prepared in the same manner as in Example 13 was added. The mixture was stirred for 20 hours under a nitrogen atmosphere to obtain a blended liquid crystal alignment! IBL - 9 〇 (Comparative Example 4) A blending polylysine solution (BL-PAA5) scale prepared in the same manner as in Comparative Example 3 was used. 40 g of a polyacetate solution (BL-PAE) prepared in the same manner as in Example 13 was added to a 200 mL Erlenmeyer flask, and the mixture was stirred for 20 hours under a nitrogen atmosphere to obtain a blended liquid crystal. The alignment agent BL-10 (Comparative Example). (Test Example 1) Varnish (Liquid Crystal Alignment Agent) Printability Test Using the alignment film prepared by using the liquid crystal alignment agents prepared in Examples 1 to 16 and Comparative Examples 1 to 4 Machine ("angstromer" manufactured by Nippon Photo Printing Co., Ltd.) performs quick-drying printing on a washed Cr plate for coating. Approximately 1. OmL of the liquid crystal alignment agent was dropped on the anilox roller, and after 10 runs were performed, the printing machine was stopped for 1 minute to dry the printing plate. Then, one piece of the Cr substrate was printed. The substrate was placed on a hot plate at 70 ° C for 5 minutes to perform pre-drying of the coating film and the film state was observed. The observation was carried out by visual observation and optical microscopy ("ECLIPSE ME600" manufactured by Nikon Corporation) at 50 times. When the pinhole was not observed, it was good, and when the pinhole was observed, it was bad; and when the film thickness of the edge portion was not uneven, it was good, and when the film thickness at the edge portion was uneven, it was evaluated as -75-201226390. . The results are shown in Table 3. [Production of Liquid Crystal Cell] The liquid crystal alignment agents prepared in Examples 1 to 16 and Comparative Examples 1 to 4 were prepared as follows. The liquid crystal alignment agent was spin-coated on a glass substrate with a transparent electrode, dried on a hot plate at 80 ° C for 70 seconds, and then calcined on a hot plate of 22 (TC) for 10 minutes. A coating film having a film thickness of 1 〇〇nm was formed. Regarding the liquid crystal alignment treatment by rubbing, the coating film surface was rubbed with a roll diameter of 120 mm, and the roll was rotated at a number of 100 rpm and the roll traveling speed was 50 mm/sec. The substrate having the liquid crystal alignment film was obtained by rubbing under the condition of a pressure of 33 mm. A substrate having a liquid crystal alignment film having such a liquid crystal alignment treatment was prepared, and a spacer of 6 μm was dispersed therein. After the liquid crystal alignment film of the film is applied to the film surface, the sealing agent is printed thereon, and the other substrate is bonded to the substrate with the liquid crystal alignment film surface and the rubbing direction is orthogonal (ΤΝ-type liquid crystal cell). The sealing agent is hardened to form an empty cell. The empty cell is injected into the liquid crystal MLC-2〇〇3 (manufactured by Mok Corporation) in the case of a ruthenium type cell, and the injection port is sealed. A ΤΝ-type liquid crystal cell was obtained. (Test Example 2) Before high temperature aging test Determination of post ion density
對於使用上述[液晶晶胞之製作]記載之方法所製作的 液晶晶胞,測定初期狀態之離子密度,又,進行以1 00°C -76- 201226390 保持30小時(高溫老化)後之離子密度之測定。離子密度 測定中,係測定將液晶晶胞外加電壓±10V、頻率0.01Hz 之三角波時之離子密度。測定溫度爲以8 (TC來進行。測定 裝置方面,任一種之測定均爲使用TOYO Corporation製 6 2 4 5型液晶物性評價裝置。結果如表3所示。 (試驗例3)高溫老化試驗前後之儲存電荷(RDC)測定 對於製作好的液晶晶胞,於2 3 °C之溫度下將直流電壓 以0.1 V間隔由0V外加至1 .0V,測定在各電壓之閃爍振 幅等級,製作閃爍振幅與外加直流電壓之檢量線。於接地 5分鐘後,外加輝度變成一半時的交流電壓(V5Q)與直流電 壓5.0 V ’測定1小時後的閃爍振幅等級,並藉由與已事 先作好的檢量線之對照動作來估算RD C (閃爍參照法)。之 後’使直流電壓成爲0V,藉由以相同之方法來估算:〇分 後之RDC,以測定RDC之緩和。將如何般測定後的RDC 表示在表3的「DCon lh後(儲存)及DCoff l〇min後之 RDC(緩和)」之欄中。尙,表3中所示RDC之數據,爲將 液晶晶胞以1 〇 0 °C保持3 0小時(高溫老化)後的r d C之結 果。 (試驗例4)配向性之評價 以目視觀察已製作的液晶晶胞,並觀察液晶之配向狀 態。若液晶爲無缺陷配向時,以良好;產生配向缺陷時, 以不良,結果如表3所示。 -77- 201226390 此結果,實施例1〜4及比較例1爲作爲二胺與 CBDA之均聚合物(聚醯胺酸)之評價,但相較於未使用本 發明之二胺化合物之比較例1,使用本發明之二胺化合物 之實施例1〜4之RDC之儲存(DCon 1時間後之RDC値) 與緩和(DCoff 10分後之RDC値)顯著爲小。又,由於是 單獨的聚醯胺酸,故印刷性未確認到大的差異;相較於比 較例1,實施例1〜4之初期狀態及高溫老化後之離子密 度均爲小,爲實用上無問題之値。然後,實施例1〜4, 液晶爲無缺陷地配向著,但比較例1則液晶有產生缺陷, 相較於實施例1〜4配向性爲差。 實施例5〜8及比較例2爲作爲可溶性聚醯亞胺之評 價’使用本發明之二胺之實施例5〜8時,可製成可溶性 聚醯亞胺,又,未產生印刷時之相分離或析出,亦未有針 孔及膜不均勻,印刷性良好。又,實施例5〜8,R D C之 儲存與緩和均爲顯著地小。然後,初期狀態及高溫老化後 之離子密度均爲小,爲實用上無問題之値。另一方面,使 用專利文獻3二胺之Diamine-5之比較例2,無法製成可 溶性聚醯亞胺。又,實施例5〜8,液晶爲無缺陷地配向 著。 實施例9〜12及比較例3爲可溶性聚醯亞胺與使用本 發明之二胺之聚醯胺酸之摻合系材料之評價,因爲本發明 之二胺與可溶性聚醯亞胺之相溶性優異,故在實施例9〜 12之液晶配向劑中,未產生印刷時的相分離或析出,亦 未有針孔及膜不均勻,印刷性良好。另一方面,比較例3 -78- 201226390 時,可溶性聚醯亞胺與聚醯胺酸產生局部化而相分離,且 在本印刷試驗中爲分離,邊緣部印刷性之結果爲差。又, 實施例9〜12時,RDC之儲存與緩和相較於比較例3爲 顯著地小。然後,相較於比較例3,實施例9〜1 2之初期 狀態及高溫老化後之離子密度均爲小,爲實用上無問題之 値。又,實施例9〜12中任一項之液晶皆爲無缺陷地配向 著。 實施例13〜16及比較例4爲聚醯胺酸酯與使用本發 明等之二胺之聚醯胺酸之摻合系材料之評價,因爲本發明 之二胺與聚醯胺酸酯之相溶性優異,故在實施例13〜16 之液晶配向劑中,未產生印刷時的相分離或析出,亦未有 針孔及膜不均勻,印刷性良好。另一方面,比較例4之液 晶配向劑時,與比較例3相同地,相分離性爲差,印刷時 有分離之傾向,邊緣部之印刷性爲差之結果。又,實施例 13〜16時,RDC之儲存與緩和相較於比較例4爲顯著地 小。然後,相較於比較例4,實施例1 3〜1 6之初期狀態 及高溫老化後之離子密度均爲小,爲實用上無問題之値。 又,實施例1 3〜1 6中任一項之液晶皆爲無缺陷地配向 著。 由此等結果可確認到,使用本發明之二胺之液晶配向 劑及液晶配向膜,印刷性爲良好,且可得到儲存電荷少、 已儲存電荷之緩和快之液晶配向膜。 -79 - 201226390 [表1] 聚合物 名稱 酸二酐或酸二酯 二胺成分 PM-1 CBDA(0.93) Diarriine-l(l.OO) —— PAA-2 CBDAC0.93) Dianiine-2(1.00) 一 PAA-3 CBDA(0.93) Diamine-3(1.00) — PAA-4 CBDA(0.93) Dkrine^l.OO) . — PM-5 CBDA(0.93) Dianiine-5(1.00) — SR-1 CBDA(0.93) Dianiine-1(0.80) C16DAB(0.3 SR-2 CBDA(0.93) Diamine-2(0.80) C16DAB(0.^ SR-3 CBDA(0.93) Diamine-3(0.80) C16DAB(0.2) SFM CBDA(0.93) Diairin&-4(0.80) C16DAB(0.^ SH-5 CBDA(0_93) Diamine-5(0.90) C16DAB(0.1) PAA-10 CBDA(0.93) Diamine-1(0.70) DDM(0.30) PAA-11 CBDA(0.93) Dkmin&*2(0.70) DDM(0.30) PM-12 CBDA(0.93) Diamin&-3(0.70) DDM(0.30) PM-13 CBDA(0.93) Diarnine-4(〇.7〇) DDM(0.30) PM-14 CBDA(0.93) Diamine-5(0.70) DDM(0.30) SPI-6 TDA(0.99) p-PDA(0.90) C16DAB(0.1) PAE-1 CBDH0.95) p-PDA(0.90) C16DAB(0.1) ※括弧內示爲莫耳比。 -80- 201226390 [表2] 液晶 配向劑名 聚合物 成分 溶媒(質量%) 固形分 (%) 實施例1 1 PAA-1 NMPC740) BCC20.0) - 6.0 實施例2 2 PM-2 NMPC74.0) BCX20.0) - 6.0 實施例3 3 PM-3 NMK74.0) BC(20.0) - 6.0 實施例4 4 PAA-4 NMPC740) BC(2〇.〇) - 6.0 比較例1 5 PM-5 NMPC74.0) BC(20.0) - 6.0 實施例5 6 SPI-1 v—BU65.0) BC(30.0) - 5.0 實施例6 7 SH-2 V—Hi65.0) BCOO-O) - 5.0 實施例7 8 SR-3 v—Hj(65.0) BC(30.0) - 5.0 實施例8 9 SPI-4 y-BL(65.0) BCX3a〇) - 5.0 比較例2 10 阴-5 無法調整 實施例9 BL-1 PM-KX0.80) SH-6(0.20) NMP(43.2!) 7—BU348) Bcaao) 6.0 實施例10 BL-2 PAA-lKO.80) SK〇_20) NMP(43.2J 7—BLC34.8) Bcaao) 6.0 實施例11 KL-3 PM-12C0.80) SR-6(0.20) NMP(43.2!) 7-^(34.8) BO16.0) 6.0 實施例12 BL-4 PM-13(0.80) ^-6(0.20) NMK43.25 γ—BU34.8) Bai6.0) 6.0 比較例3 BL-5 PM-14(0.80) SR-6(020) NMP(43.2) 7—BU34.8) Bcaao) 6.0 實施例13 BL-6 PAA-KX0.80) PAE-K0.20) NMPC43.25 T^L(34.8) Bai6.0) 6.0 實施例14 BL-7 PAA-lKO.80) PAE-1(0^0) NMK43.2) 7—BU34.8) BC(16.0) &0 實施例15 BL-8 PAA-12(0.80) PAE-K0.20) NMK43.2D 7—BU34.8) Bcaao) 6.0 實施例16 BL-9 PAA-13(0.80) PAE-KO20) NMP(43.^ 7—BLj(34.8) BC(16.0) 6.0 比較例4 BL-10 PM-14(0.80) PAE-K0.20) NMF<43.^ 7^BU34.8) Bcaao) 6.0 ※括弧內示爲莫耳比。 -81 - 201226390 m 3] 液晶 配向性 印刷性 離子密度(pC) RDC(V) 100X:30h 後 針孔 邊緣膜厚 不均勻 初期 loot: 30 h後 DCon lh後 (儲存) DCoff lOmin 後 (緩和) 實施例1 良好 良好 良好 68 92 0.25 0 實施例2 良好 良好 良好 58 87 0.25 0 實施例3 良好 良好 m 59 86 0.27 0 實施例4 良好 m m 62 86 0.23 0 比較例1 不良 m m 75 96 0.60 0.32 實施例5 良好 m m 44 55 0.30 0 實施例6 良好 m m 43 57 0.28 0 實施例7 良好 良好 良好 52 56 0.31 0 實施例8 m m m 49 54 0.28 0 比較例2 無法以晶胞冒 m 實施例9 鲥 m m 45 76 0.18 0 實施例10 m 良好 m 43 72 0.20 0 實施例11 m m m 43 78 0.18 0 實施例12 良好 m m 41 79 0.20 0 比較例3 不良 不良 湘働 不良 湘分_ 56 92 .0.44 0.23 實施例13 良好 m 良好 55 87 0.22 0 實施例14 m 赂 m 53 82 0.21 0 實施例15 m m m 52 90 0.23 0 實施例16 良好 m m 53 89 0.22 0 比較例4 不良 不良 不良 62 103 0.45 0.18 [產業利用性] 使用本發明之二胺之液晶配向劑,印刷性良好,且可 得到儲存電荷少、已儲存電荷之緩和快之液晶配向膜。因 此,使用本發明之液晶配向劑所製作的液晶表示元件,可 成爲信賴性高的液晶表示裝置,適合使用於TN(Twisted Nematic)液晶表示元件、STN液晶表示元件、TFT液晶表 示元件、VA液晶表示元件、IPS液晶表示元件、 OCB(Optically sel f-Compensated Birefringence)液晶表示 元件等,藉由各種方式之表示元件。 -82-The liquid crystal cell produced by the method described in the above [Production of Liquid Crystal Cell] was measured for ion density in an initial state, and ion density was maintained at 100 ° C -76 - 201226390 for 30 hours (high temperature aging). Determination. In the ion density measurement, the ion density when a triangular wave having a voltage of ±10 V and a frequency of 0.01 Hz was applied to the liquid crystal cell was measured. The measurement temperature was 8 (TC). The measurement device used was a 6 2 4 5 liquid crystal physical property evaluation device manufactured by TOYO Corporation. The results are shown in Table 3. (Test Example 3) Before and after the high temperature aging test Storage charge (RDC) measurement For the prepared liquid crystal cell, the DC voltage was applied from 0 V to 1.0 V at a temperature of 23 ° C at a temperature of 23 ° C, and the flicker amplitude level at each voltage was measured to prepare a flicker amplitude. The calibration line with the applied DC voltage. After 5 minutes of grounding, the external voltage (V5Q) and the DC voltage of 5.0 V ' when the applied luminance is half is measured, and the flashing amplitude level is measured after 1 hour. The calibrated action of the calibration curve is used to estimate RD C (flicker reference method). After that, the DC voltage is made 0V, and the RDC is calculated by the same method to determine the relaxation of RDC. How will it be measured? The RDC is shown in the column of “DCon lh (storage) and RDC (mitigation) after DCoff l〇min in Table 3. 尙, the data of RDC shown in Table 3 is to set the liquid crystal cell to 1 〇0. °C for 30 hours (high temperature aging) (Test Example 4) Evaluation of the alignment property The observed liquid crystal cell was visually observed, and the alignment state of the liquid crystal was observed. When the liquid crystal was in a defect-free alignment, it was good; when an alignment defect was generated, it was defective. The results are shown in Table 3. -77-201226390 As a result, Examples 1 to 4 and Comparative Example 1 were evaluated as a homopolymer (polyglycine) of a diamine and CBDA, but compared with the unused Comparative Example 1 of the diamine compound of the invention, the storage of RDCs of Examples 1 to 4 using the diamine compound of the present invention (RDC値 after DCon 1 time) and relaxation (RDC値 after DCoff 10 minutes) were remarkably small Further, since it is a single polylysine, a large difference is not confirmed in printability; compared with Comparative Example 1, the initial state of Examples 1 to 4 and the ion density after high temperature aging are both small, practically Then, in Examples 1 to 4, the liquid crystal was aligned without defects, but in Comparative Example 1, the liquid crystal was defective, and the alignment was inferior to those in Examples 1 to 4. Examples 5 to 8 and Comparative Example 2 is used as an evaluation of soluble polyimine In the case of Examples 5 to 8 of the diamine of the invention, soluble polyimine was produced, and phase separation or precipitation at the time of printing was not produced, and pinholes and film unevenness were not obtained, and the printability was good. In Examples 5 to 8, the storage and relaxation of RDC were both remarkably small. Then, the ion density after the initial state and high temperature aging was small, which was practically no problem. On the other hand, Patent Document 3 diamine was used. In Comparative Example 2 of Diamine-5, soluble polyimine was not produced. Further, in Examples 5 to 8, the liquid crystal was aligned without defects. Examples 9 to 12 and Comparative Example 3 were soluble polyimine and used. In the evaluation of the blending material of the polyamine of the diamine of the present invention, since the diamine of the present invention is excellent in compatibility with the soluble polyimine, it is not produced in the liquid crystal alignment agents of Examples 9 to 12. The phase separation or precipitation at the time of printing does not cause pinholes and film unevenness, and the printability is good. On the other hand, in Comparative Example 3 -78 to 201226390, the soluble polyimine was localized and separated from the poly-proline, and was separated in the printing test, and the printability at the edge portion was poor. Further, in Examples 9 to 12, the storage and relaxation of the RDC were remarkably small as compared with Comparative Example 3. Then, compared with Comparative Example 3, the initial state of Examples 9 to 12 and the ion density after high temperature aging were small, which was practically no problem. Further, the liquid crystals of any of Examples 9 to 12 were aligned without defects. Examples 13 to 16 and Comparative Example 4 are evaluations of a blending material of a polyglycolate and a polyamine having a diamine of the present invention because of the phase of the diamine of the present invention and a polyphthalate. Since the solubility is excellent, in the liquid crystal alignment agents of Examples 13 to 16, no phase separation or precipitation at the time of printing occurred, and pinholes and film unevenness were not obtained, and the printability was good. On the other hand, in the case of the liquid crystal alignment agent of Comparative Example 4, as in Comparative Example 3, the phase separation property was poor, and there was a tendency to separate during printing, and the printability at the edge portion was poor. Further, in Examples 13 to 16, the storage and relaxation of the RDC were remarkably smaller than in Comparative Example 4. Then, compared with Comparative Example 4, the initial state of Examples 13 to 16 and the ion density after high temperature aging were both small, which was practically no problem. Further, the liquid crystals of any of Examples 1 to 3 were aligned without defects. As a result of the above, it was confirmed that the liquid crystal alignment agent and the liquid crystal alignment film of the diamine of the present invention are excellent in printability, and a liquid crystal alignment film having a small storage charge and a relaxed charge charge can be obtained. -79 - 201226390 [Table 1] Polymer name Acid dianhydride or acid diester diamine component PM-1 CBDA (0.93) Diarriine-l (l.OO) —— PAA-2 CBDAC0.93) Dianiine-2 (1.00 ) PAA-3 CBDA (0.93) Diamine-3 (1.00) — PAA-4 CBDA (0.93) Dkrine^l.OO) . — PM-5 CBDA (0.93) Dianiine-5(1.00) — SR-1 CBDA ( 0.93) Dianiine-1(0.80) C16DAB(0.3 SR-2 CBDA(0.93) Diamine-2(0.80) C16DAB(0.^ SR-3 CBDA(0.93) Diamine-3(0.80) C16DAB(0.2) SFM CBDA(0.93 Diairin&-4(0.80) C16DAB(0.^ SH-5 CBDA(0_93) Diamine-5(0.90) C16DAB(0.1) PAA-10 CBDA(0.93) Diamine-1(0.70) DDM(0.30) PAA-11 CBDA(0.93) Dkmin&*2(0.70) DDM(0.30) PM-12 CBDA(0.93) Diamin&-3(0.70) DDM(0.30) PM-13 CBDA(0.93) Diarnine-4(〇.7〇) DDM (0.30) PM-14 CBDA (0.93) Diamine-5 (0.70) DDM (0.30) SPI-6 TDA (0.99) p-PDA (0.90) C16DAB (0.1) PAE-1 CBDH0.95) p-PDA (0.90) C16DAB(0.1) *In the brackets, it is shown as a molar ratio. -80- 201226390 [Table 2] Liquid crystal alignment agent polymer component solvent (% by mass) Solid content (%) Example 1 1 PAA-1 NMPC740) BCC20.0 ) - 6.0 Example 2 2 PM-2 NMPC74.0) BCX20.0) - 6.0 Example 3 3 PM-3 NMK74.0) BC(20.0) - 6.0 Example 4 4 PAA-4 NMPC740) BC(2〇.〇) - 6.0 Comparative Example 1 5 PM -5 NMPC74.0) BC(20.0) - 6.0 Example 5 6 SPI-1 v-BU65.0) BC(30.0) - 5.0 Example 6 7 SH-2 V-Hi65.0) BCOO-O) - 5.0 Example 7 8 SR-3 v-Hj(65.0) BC(30.0) - 5.0 Example 8 9 SPI-4 y-BL(65.0) BCX3a〇) - 5.0 Comparative Example 2 10 Yin-5 Unable to adjust Example 9 BL -1 PM-KX0.80) SH-6(0.20) NMP(43.2!) 7-BU348) Bcaao) 6.0 Example 10 BL-2 PAA-lKO.80) SK〇_20) NMP (43.2J 7-BLC34 .8) Bcaao) 6.0 Example 11 KL-3 PM-12C0.80) SR-6(0.20) NMP(43.2!) 7-^(34.8) BO16.0) 6.0 Example 12 BL-4 PM-13( 0.80) ^-6(0.20) NMK43.25 γ-BU34.8) Bai6.0) 6.0 Comparative Example 3 BL-5 PM-14(0.80) SR-6(020) NMP(43.2) 7-BU34.8) Bcaao) 6.0 Example 13 BL-6 PAA-KX0.80) PAE-K0.20) NMPC43.25 T^L(34.8) Bai6.0) 6.0 Example 14 BL-7 PAA-lKO.80) PAE-1 (0^0) NMK43.2) 7-BU34.8) BC(16.0) &0 Example 15 BL-8 PAA-12(0.80) PAE-K0.20) NMK43.2D 7—BU34.8) Bcaao 6.0 Example 16 BL-9 PAA-13 (0.8 0) PAE-KO20) NMP (43.^ 7—BLj(34.8) BC(16.0) 6.0 Comparative Example 4 BL-10 PM-14(0.80) PAE-K0.20) NMF<43.^ 7^BU34.8 ) Bcaao) 6.0 * The brackets are shown as Moerby. -81 - 201226390 m 3] Liquid crystal alignment printable ion density (pC) RDC(V) 100X: 30h After the pinhole edge film thickness is uneven Initial Loot: After 30 h DCon lh (storage) DCoff lOmin (moderate) Example 1 Good Good Good 68 92 0.25 0 Example 2 Good Good Good 58 87 0.25 0 Example 3 Good Good m 59 86 0.27 0 Example 4 Good mm 62 86 0.23 0 Comparative Example 1 Bad mm 75 96 0.60 0.32 Example 5 Good mm 44 55 0.30 0 Example 6 Good mm 43 57 0.28 0 Example 7 Good good good 52 56 0.31 0 Example 8 mmm 49 54 0.28 0 Comparative Example 2 Failure to act as a unit cell Example 9 鲥mm 45 76 0.18 0 Example 10 m Good m 43 72 0.20 0 Example 11 mmm 43 78 0.18 0 Example 12 Good mm 41 79 0.20 0 Comparative Example 3 Poor bad Xiang Xiang bad Xiang _ 56 92 .0.44 0.23 Example 13 Good m Good 55 87 0.22 0 Example 14 m mm m 53 82 0.21 0 Example 15 mmm 52 90 0.23 0 Example 16 Good mm 53 89 0.22 0 Comparative Example 4 Adverse failure 62 103 0.45 0.18 [Industrial Applicability] With the liquid crystal alignment agent of the diamine of the present invention, the printability is good, and a liquid crystal alignment film having a small storage charge and a moderate relaxation of stored charges can be obtained. Therefore, the liquid crystal display element produced by using the liquid crystal alignment agent of the present invention can be used as a highly reliable liquid crystal display device, and is suitably used for a TN (Twisted Nematic) liquid crystal display element, an STN liquid crystal display element, a TFT liquid crystal display element, and a VA liquid crystal. A display element, an IPS liquid crystal display element, an OCB (Optically sel f-Compensated Birefringence) liquid crystal display element, or the like is represented by various means. -82-
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010195171 | 2010-08-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201226390A true TW201226390A (en) | 2012-07-01 |
| TWI436980B TWI436980B (en) | 2014-05-11 |
Family
ID=45772846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW100131309A TWI436980B (en) | 2010-08-31 | 2011-08-31 | Diamine, polyimide precursor, polyimide, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
Country Status (5)
| Country | Link |
|---|---|
| JP (2) | JP5839200B2 (en) |
| KR (1) | KR101875240B1 (en) |
| CN (1) | CN103180294B (en) |
| TW (1) | TWI436980B (en) |
| WO (1) | WO2012029763A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI494347B (en) * | 2012-12-25 | 2015-08-01 | Taiwan Textile Res Inst | Dinitro monomer, diamine monomer, polyimide and modified polyimide |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102058764B1 (en) * | 2012-03-30 | 2019-12-23 | 닛산 가가쿠 가부시키가이샤 | Polyimide-based liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| JP6146077B2 (en) * | 2012-06-29 | 2017-06-14 | Jsr株式会社 | Method for producing liquid crystal alignment film |
| CN105446012A (en) * | 2014-09-19 | 2016-03-30 | 株式会社日本显示器 | Liquid crystal display device and material for alignment film |
| WO2016063834A1 (en) * | 2014-10-20 | 2016-04-28 | 日産化学工業株式会社 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element using same |
| CN110300921B (en) * | 2016-12-15 | 2022-08-09 | 日产化学株式会社 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same |
| JP7193783B2 (en) * | 2018-01-19 | 2022-12-21 | 日産化学株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using the same |
| WO2019189637A1 (en) * | 2018-03-30 | 2019-10-03 | 日産化学株式会社 | Novel liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element |
| CN111732516B (en) * | 2020-07-31 | 2021-01-05 | 南昌大学 | A kind of preparation method of N-aryl substituted heterocyclic compound |
| CN111732528B (en) * | 2020-07-31 | 2021-01-01 | 南昌大学 | Preparation method of N-aryl indoline derivative |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06337424A (en) * | 1993-05-28 | 1994-12-06 | Hitachi Chem Co Ltd | Composition for liquid crystal oriented film, manufacture of liquid crystal oriented film, liquid crystal oriented film, liquid crystal sandwiching substrate and liquid crystal display element |
| JP4088985B2 (en) * | 1997-05-09 | 2008-05-21 | コニカミノルタホールディングス株式会社 | Organic electroluminescence device using new amino compound |
| US7303592B2 (en) * | 2002-03-04 | 2007-12-04 | The Procter & Gamble Company | Hair coloring compositions for use in oxidative hair dyeing |
| WO2004021076A1 (en) * | 2002-08-29 | 2004-03-11 | Nissan Chemical Industries, Ltd. | Material for liquid crystal alignment and liquid crystal displays made by using the same |
| JP4840137B2 (en) * | 2004-04-28 | 2011-12-21 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element using the same |
| JP5428336B2 (en) * | 2006-07-18 | 2014-02-26 | 日産化学工業株式会社 | Coating liquid, liquid crystal alignment film and liquid crystal display element using the same |
| JP2008218987A (en) * | 2007-02-06 | 2008-09-18 | Sumitomo Chemical Co Ltd | Composition and light-emitting device using the composition |
| JP5359643B2 (en) * | 2008-08-20 | 2013-12-04 | Jnc株式会社 | Diamine, liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element |
-
2011
- 2011-08-30 KR KR1020137007446A patent/KR101875240B1/en active Active
- 2011-08-30 CN CN201180051325.7A patent/CN103180294B/en active Active
- 2011-08-30 JP JP2012531885A patent/JP5839200B2/en active Active
- 2011-08-30 WO PCT/JP2011/069576 patent/WO2012029763A1/en not_active Ceased
- 2011-08-31 TW TW100131309A patent/TWI436980B/en active
-
2015
- 2015-09-14 JP JP2015181099A patent/JP6249182B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI494347B (en) * | 2012-12-25 | 2015-08-01 | Taiwan Textile Res Inst | Dinitro monomer, diamine monomer, polyimide and modified polyimide |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140009126A (en) | 2014-01-22 |
| JP2016029058A (en) | 2016-03-03 |
| CN103180294B (en) | 2015-09-23 |
| JPWO2012029763A1 (en) | 2013-10-28 |
| TWI436980B (en) | 2014-05-11 |
| JP6249182B2 (en) | 2017-12-20 |
| WO2012029763A1 (en) | 2012-03-08 |
| KR101875240B1 (en) | 2018-07-05 |
| JP5839200B2 (en) | 2016-01-06 |
| CN103180294A (en) | 2013-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI436980B (en) | Diamine, polyimide precursor, polyimide, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
| JP6070958B2 (en) | Novel diamine, polymer, liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display device using the same | |
| JP6152914B2 (en) | Novel dicarboxylic acid anhydride and process for producing the same | |
| TWI526419B (en) | Novel diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device using the same | |
| TWI596158B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TW200948860A (en) | Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element | |
| CN104718491B (en) | Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells | |
| TWI502054B (en) | A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device | |
| TW201905178A (en) | Method for manufacturing zero-face anchor film and liquid crystal display element | |
| TWI454504B (en) | A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device | |
| TW201615695A (en) | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element | |
| JPWO2017111117A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI600683B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TW201422677A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI819102B (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal element and manufacturing method thereof | |
| TWI461462B (en) | A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device | |
| TWI596201B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI683857B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TW201137037A (en) | Liquid crystal-aligning agent, liquid crystal alignment film, and liquid crystal display element using same |